U.S. Well Services (USWS) 10-K/A 17 May 21 2020 FY Annual report (amended) Financial data

Document And Entity Information

Document And Entity Information - USD ($)	12 Months Ended
	Dec. 31, 2020	Mar. 02, 2021	Jun. 30, 2020
Document Information [Line Items]
Document Type	10-K/A
Amendment Flag	true
Amendment Description	This Amendment No. 1 to the Annual Report on Form 10-K/A (this “Amendment”) amends the Annual Report on Form 10-K of U.S. Well Services, Inc. (the “Company,” “we,” “us” or “our”) for the year ended December 31, 2020, as filed with the Securities and Exchange Commission (“SEC”) on March 11, 2021 (the “Original Form 10-K”). This Amendment restates the Company’s previously issued consolidated financial statements as of and for the years ended December 31, 2020, 2019 and 2018, and for the interim periods within the years ended December 31, 2020 and 2019 (collectively, the “Affected Periods”). The correction to the financial statements made in connection with the restatement involves only non-cash adjustments.   On April 12, 2021, the Staff of the SEC (the “SEC Staff”) issued a public statement entitled “Staff Statement on Accounting and Reporting Considerations for Warrants issued by Special Purpose Acquisition Companies (“SPACs”)” (the “SEC Staff Statement”). In the SEC Staff Statement, the SEC Staff expressed its view that certain terms and conditions common to SPAC warrants may require the warrants to be classified as liabilities of the entity measured at fair value, with changes in fair value each reporting period in earnings, as opposed to being treated as equity. Following the issuance of the SEC Staff Statement, on May 11, 2021, the Audit Committee of our Board of Directors, after considering the recommendation of and consultation with management and Company’s independent registered public accounting firm, concluded that the Company’s previously issued audited consolidated financial statements included in the Company’s previously filed Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q for the Affected Periods should be restated to reflect the impact of the SEC Staff Statement and accordingly, should no longer be relied upon. Similarly, any previously furnished or filed reports, related earnings releases, investor presentations and similar communications of the Company describing the Company’s financial results for the Affected Periods should no longer be relied upon. The Company issued public warrants and private placement warrants (collectively, the “public and private placement warrants”) in connection with its initial public offering in November 2018. Additionally, the Company issued warrants to certain institutional investors in connection with its private placement of Series A Preferred Stock on May 24, 2019 (the “Series A warrants,” and together with the public and private placement warrants, the “warrants”). The Company accounted for the warrants as equity based on its initial evaluation of the accounting treatment for the warrants and believed its positions to be appropriate at those times. As a result of the SEC Staff Statement, the Company has determined that the warrants should be classified as liabilities measured at fair value upon issuance, with subsequent changes in fair value reported in the Company’s consolidated statements of operations each reporting period pursuant to Accounting Standards Codification Topic 815, Derivatives and Hedging.   The change in accounting for the warrants did not have any impact on the Company’s previously reported revenues, operating income, or non-GAAP financial measures, Adjusted EBITDA and Adjusted EBITDA margin, for any of the Affected Periods.   The Company is amending and restating, in this Amendment, its financial statements for the following periods:     • audited consolidated financial statements as of and for the years ended December 31, 2020, 2019 and 2018;   • unaudited interim financial information as of and for the three months ended March 31, 2020 and 2019;   • unaudited interim financial information as of and for the three and six months ended June 30, 2020 and 2019; and   • unaudited interim financial information as of and for the three and nine months ended September 30, 2020 and 2019, in each case to reflect the change in accounting treatment (collectively, the “Restatement”).   This Amendment presents the Original Form 10-K, amended and restated with modifications as necessary to reflect the Restatement. The following items have been amended to reflect the Restatement:     • Part I, Item 1A. Risk Factors.   • Part II, Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations.   • Part II, Item 8. Financial Statements and Supplementary Data.   • Part II, Item 9A. Controls and Procedures.   • Part IV, Item 15. Exhibits, Financial Statement Schedules.   In addition, in accordance with Rule 12b-15 under the Securities Exchange Act of 1934, as amended, the Company is also including with this Amendment currently dated certifications of the Company’s Chief Executive Officer and Principal Financial Officer (attached as Exhibits 31.1, 31.2, 32.1, and 32.2).   Refer to Note 2 to the Notes to the Consolidated Financial Statements included in Part II, Item 8 of this Amendment for additional information on the Restatement and the related financial statement effects.   Refer to Part II, Item 9A. “Controls and Procedures” of this Amendment for a discussion of management’s consideration of our disclosure controls and procedures, internal control over financial reporting, and the identified material weakness in our internal control over financial reporting related to the accounting for a significant and unusual transaction related to the warrants.     The Company has not amended its previously filed Annual Reports on Form 10-K for the years ended December 31, 2019 or 2018 or its previously filed Quarterly Reports on Form 10-Q for the interim periods within the years ended December 31, 2020 and 2019. The financial information that has been previously filed or otherwise reported in such previously filed reports is superseded by the information in this Amendment, and the financial statements and related financial information contained in such previously filed reports should no longer be relied upon. In order to preserve the nature and character of the disclosures set forth in the Original Form 10-K, this Amendment speaks as of the date of the filing of the Original Form 10-K and the disclosures contained in this Amendment have not been updated to reflect events occurring subsequent to that date, other than those associated with the Restatement as described above. Among other things, forward-looking statements made in the Original Form 10-K have not been revised to reflect events that occurred or facts that became known to the Company after the filing of the Original Form 10-K, and such forward looking statements should be read in their historical context.
Document Period End Date	Dec. 31, 2020
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	FY
Entity Registrant Name	U.S. WELL SERVICES, INC.
Entity Central Index Key	0001670349
Current Fiscal Year End Date	--12-31
Entity Well-known Seasoned Issuer	No
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
ICFR Auditor Attestation Flag	false
Entity Shell Company	false
Entity File Number	001-38025
Entity Public Float			$ 21,639,925
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	81-1847117
Entity Address, Address Line One	1360 Post Oak Boulevard
Entity Address, Address Line Two	Suite 1800
Entity Address, City or Town	Houston
Entity Address, State or Province	TX
Entity Address, Postal Zip Code	77056
City Area Code	832
Local Phone Number	562-3730
Entity Interactive Data Current	Yes
Document Annual Report	true
Document Transition Report	false
Documents Incorporated by Reference	Certain information required to be disclosed in Part III of this report is incorporated by reference from the registrant’s definitive proxy statement or an amendment to this report, which will be filed with the SEC not later than 120 days after the end of the fiscal year covered by this report.
Common Class A [Member]
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		83,600,445
Title of each class	CLASS A COMMON SHARES $0.0001, par value
Trading Symbol	USWS
Name of each exchange on which registered	NASDAQ
Common Class B [Member]
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		2,296,525
Warrants [Member]
Document Information [Line Items]
Title of each class	WARRANTS
Trading Symbol	USWSW
Name of each exchange on which registered	NASDAQ

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Dec. 31, 2020	Dec. 31, 2019
CURRENT ASSETS:
Cash and cash equivalents	$ 3,693	$ 33,794
Restricted cash	1,569	7,610
Accounts receivable (net of allowance for doubtful accounts of $12,000 and $22 in 2020 and 2019, respectively)	44,393	79,542
Inventory, net	7,965	9,052
Prepaids and other current assets	10,707	13,332
Total current assets	68,327	143,330
Property and equipment, net	235,332	441,610
Intangible assets, net	13,466	21,826
Goodwill	4,971	4,971
Deferred financing costs, net	1,127	1,045
TOTAL ASSETS	323,223	612,782
CURRENT LIABILITIES:
Accounts payable	36,362	70,170
Accrued expenses and other current liabilities	14,781	40,481
Notes payable	998	8,068
Current portion of long-term equipment financing	3,519	5,564
Current portion of long-term capital lease obligation	54	10,474
Current portion of long-term debt	10,000	6,250
Total current liabilities	65,714	141,007
Warrant liabilities	1,619	8,147
Long-term equipment financing	9,347	10,501
Long-term debt	274,555	274,391
Other long-term liabilities	3,539	215
TOTAL LIABILITIES	354,774	434,261
Commitments and contingencies (NOTE 18)
STOCKHOLDERS' EQUITY (DEFICIT)
Additional paid in capital	217,212	225,382
Accumulated deficit	(322,431)	(93,091)
Total stockholders' equity (deficit) attributable to U.S. Well Services, Inc.	(105,212)	132,297
Noncontrolling interest		10,633
Total Stockholders' Equity (Deficit)	(105,212)	142,930
TOTAL LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS' EQUITY (DEFICIT)	323,223	612,782
Series A Convertible Redeemable Preferred Stock [Member]
MEZZANINE EQUITY
Redeemable Convertible Preferred Stock	50,975	35,591
Series B Convertible Redeemable Preferred Stock [Member]
MEZZANINE EQUITY
Redeemable Convertible Preferred Stock	22,686
Common Class A [Member]
STOCKHOLDERS' EQUITY (DEFICIT)
Common stock	7	5
Total Stockholders' Equity (Deficit)	$ 7	5
Common Class B [Member]
STOCKHOLDERS' EQUITY (DEFICIT)
Common stock		1
Total Stockholders' Equity (Deficit)		$ 1

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands	Dec. 31, 2020	Dec. 31, 2019
Allowance for doubtful accounts	$ 12,000	$ 22
Series A Convertible Redeemable Preferred Stock [Member]
Mezzanine Equity, par value	$ 0.0001	$ 0.0001
Mezzanine Equity, authorized	55,000	55,000
Mezzanine Equity, issued	50,000	55,000
Mezzanine Equity, outstanding	50,000	55,000
Mezzanine Equity, liquidation preference	$ 60,418	$ 59,050
Common Class A [Member]
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, authorized	400,000,000	400,000,000
Common stock, issued	72,515,342	62,857,624
Common stock, outstanding	72,515,342	62,857,624
Common Class B [Member]
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, authorized	20,000,000	20,000,000
Common stock, issued	2,302,936	5,500,692
Common stock, outstanding	2,302,936	5,500,692
Series B Convertible Redeemable Preferred Stock [Member]
Mezzanine Equity, par value	$ 0.0001	$ 0.0001
Mezzanine Equity, authorized	22,050	0
Mezzanine Equity, issued	22,050	0
Mezzanine Equity, outstanding	22,050	0
Mezzanine Equity, liquidation preference	$ 24,100	$ 0

CONSOLIDATED STATEMENTS OF OPER

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Revenue	$ 244,007	$ 514,757
Costs and expenses:
Depreciation and amortization	80,353	154,149
Selling, general and administrative expenses	43,632	31,856
Impairment of long-lived assets	147,543
Loss on disposal of assets	7,112	20,065
Loss from operations	(222,436)	(75,270)
Interest expense, net	(25,226)	(30,109)
Change in fair value of warrant liabilities	6,342	12,113
Loss on extinguishment of debt		(12,558)
Other income	108	1,768
Loss before income taxes	(241,212)	(104,056)
Income tax benefit	(824)	(77)
Net loss	(240,388)	(103,979)
Net loss attributable to noncontrolling interest	(11,048)	(22,169)
Net loss attributable to U.S. Well Services, Inc.	(229,340)	(81,810)
Deemed and imputed dividends on Series A preferred stock	(13,022)	(11,796)
Deemed dividends on Series B preferred stock	(564)
Net loss attributable to U.S. Well Services, Inc. common stockholders	$ (252,189)	$ (97,656)
Loss per common share (See Note 14):
Basic and diluted	$ (3.81)	$ (1.89)
Weighted average common shares outstanding:
Basic and diluted	64,791,247	50,243,506
Series A Convertible Redeemable Preferred Stock [Member]
Costs and expenses:
Dividends accrued on preferred stock	$ (7,214)	$ (4,050)
Series B Convertible Redeemable Preferred Stock [Member]
Costs and expenses:
Dividends accrued on preferred stock	(2,049)
Service [Member]
Costs and expenses:
Cost of services (excluding depreciation and amortization)	$ 187,803	$ 383,957

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (240,388)	$ (103,979)
Adjustments to reconcile net loss to cash provided by operating activities
Depreciation and amortization	80,353	154,149
Change in fair value of warrant liabilities	(6,342)	(12,113)
Impairment of long-lived assets	147,543
Provision for losses on accounts receivable	12,031	434
Provision for losses on inventory obsolescence	620	359
Loss on disposal of assets	7,112	20,065
Amortization of discount on debt	3,609	1,581
Deferred financing costs amortization	1,287	1,410
Loss on extinguishment of debt		12,558
Share-based compensation expense	10,056	7,755
Changes in assets and liabilities:
Accounts receivable	23,118	(21,950)
Inventory	468	2
Prepaids and other current assets	6,288	3,226
Accounts payable	(23,999)	(12,316)
Accrued liabilities	(6,208)	5,463
Accrued interest	(6,932)	18,200
Net cash provided by operating activities	8,616	74,844
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of property and equipment	(55,943)	(209,101)
Proceeds from sale of property and equipment and insurance proceeds from damaged property and equipment	20,944	807
Net cash used in investing activities	(34,999)	(208,294)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from revolving credit facility	68,957	49,960
Repayments of revolving credit facility	(85,497)	(65,844)
Proceeds from issuance of long-term debt	31,996	285,000
Repayments of long-term debt	(3,750)	(75,000)
Payment of fees related to debt extinguishment		(6,560)
Proceeds from issuance of note payable	1,121	9,928
Repayments of note payable	(7,507)	(6,421)
Repayments of amounts under equipment financing	(3,199)	(70,619)
Principal payments under finance lease obligation	(10,474)	(16,699)
Proceeds from issuance of preferred stock and warrants, net	19,596	54,524
Proceeds from issuance of common stock, net	400
Deferred financing costs	(21,402)	(13,451)
Net cash (used in) provided by financing activities	(9,759)	144,818
Net (decrease) increase in cash and cash equivalents and restricted cash	(36,142)	11,368
Cash and cash equivalents and restricted cash, beginning of period	41,404	30,036
Cash and cash equivalents and restricted cash, end of period	5,262	41,404
Supplemental cash flow disclosure:
Interest paid	26,287	8,838
Income tax paid	144	116
Non-cash investing and financing activities:
Beneficial conversion feature of Series A preferred stock		22,104
Conversion of Series A preferred stock to Class A common stock	4,852
Deemed and imputed dividends on Series A preferred stock	13,022	11,796
Changes in accrued and unpaid capital expenditures	9,818	6,874
Assets under capital lease obligations	229	10,513
Financed equipment purchases		66,342
Common Class A [Member]
Non-cash investing and financing activities:
Issuance of stock to senior secured term loan lenders	1,438
Series B Convertible Redeemable Preferred Stock [Member]
Non-cash investing and financing activities:
Issuance of stock to senior secured term loan lenders	1,050
Dividends accrued on preferred stock	2,049
Series A Convertible Redeemable Preferred Stock [Member]
Non-cash investing and financing activities:
Dividends accrued on preferred stock	$ 7,214	$ 4,050

CONSOLIDATED STATEMENTS OF STOC

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) - USD ($) $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment [Member]	Common Class A [Member]	Common Class B [Member]	Additional Paid in Capital [Member]	Accumulated Deficit [Member]	Accumulated Deficit [Member]Cumulative Effect, Period of Adoption, Adjustment [Member]	Noncontrolling Interests [Member]	Noncontrolling Interests [Member]Cumulative Effect, Period of Adoption, Adjustment [Member]
Balance at Dec. 31, 2018	$ 211,239	$ 122	$ 5	$ 1	$ 169,811	$ (11,376)	$ 95	$ 52,798	$ 27
Balance (in shares) at Dec. 31, 2018			49,254,760	13,937,332
Net loss	(47,206)
Balance at Mar. 31, 2019	175,306
Balance at Dec. 31, 2018	211,239	122	$ 5	$ 1	169,811	(11,376)	95	52,798	27
Balance (in shares) at Dec. 31, 2018			49,254,760	13,937,332
Deemed and imputed dividends on Series A preferred stock	(1,582)
Net loss	(69,128)
Balance at Jun. 30, 2019	187,206
Balance at Dec. 31, 2018	211,239	122	$ 5	$ 1	169,811	(11,376)	95	52,798	27
Balance (in shares) at Dec. 31, 2018			49,254,760	13,937,332
Deemed and imputed dividends on Series A preferred stock	(6,158)
Net loss	(72,790)
Balance at Sep. 30, 2019	179,499
Balance at Dec. 31, 2018	211,239	$ 122	$ 5	$ 1	169,811	(11,376)	$ 95	52,798	$ 27
Balance (in shares) at Dec. 31, 2018			49,254,760	13,937,332
Accounting Standards Update [Extensible List]		us-gaap:AccountingStandardsUpdate201409Member					us-gaap:AccountingStandardsUpdate201409Member		us-gaap:AccountingStandardsUpdate201409Member
Exercise of warrants	21,535				21,535
Exercise of warrants (in shares)			2,925,712
Conversion of Class B common stock to Class A common stock (in shares)			8,436,640	(8,436,640)
Change in noncontrolling interest					21,515			(21,515)
Restricted stock granted to employees (in shares)			2,218,183
Class A Common stock granted to board members	418				331			87
Class A Common stock granted to board members (in shares)			46,875
Share-based compensation	7,337				5,932			1,405
Restricted stock forfeitures (in shares)			(24,546)
Beneficial conversion feature of Series A preferred stock	22,104				22,104
Deemed and imputed dividends on Series A preferred stock	(11,796)				(11,796)
Accrued Series A preferred stock dividends	(4,050)				(4,050)
Net loss	(103,979)					(81,810)		(22,169)
Balance at Dec. 31, 2019	142,930		$ 5	$ 1	225,382	(93,091)		10,633
Balance (in shares) at Dec. 31, 2019			62,857,624	5,500,692
Balance at Mar. 31, 2019	175,306
Deemed and imputed dividends on Series A preferred stock	(1,582)
Net loss	(21,922)
Balance at Jun. 30, 2019	187,206
Deemed and imputed dividends on Series A preferred stock	(4,576)
Net loss	(3,662)
Balance at Sep. 30, 2019	179,499
Balance at Dec. 31, 2019	142,930		$ 5	$ 1	225,382	(93,091)		10,633
Deemed and imputed dividends on Series A preferred stock	(6,972)
Net loss	(176,618)
Balance at Mar. 31, 2020	(40,403)
Balance at Dec. 31, 2019	142,930		$ 5	$ 1	225,382	(93,091)		10,633
Balance (in shares) at Dec. 31, 2019			62,857,624	5,500,692
Deemed and imputed dividends on Series A preferred stock	(12,114)
Net loss	(196,220)
Balance at Jun. 30, 2020	(64,816)
Balance at Dec. 31, 2019	142,930		$ 5	$ 1	225,382	(93,091)		10,633
Balance (in shares) at Dec. 31, 2019			62,857,624	5,500,692
Class A common stock issuance	1,817		$ 1		1,816
Class A common stock issuance (in shares)			6,321,880
Reclassification of warrant liability upon forfeiture	203				203
Conversion of Class B common stock to Class A common stock			$ 1	$ (1)
Conversion of Class B common stock to Class A common stock (in shares)			3,197,756	(3,197,756)
Conversion of Series A preferred stock to Class A common stock	4,852				4,852
Conversion of Series A preferred stock to Class A common stock (in shares)			876,448
Share-based compensation	7,729				7,314			415
Tax withholding related to vesting of share-based compensation	(70)				(70)
Tax withholding related to vesting of share-based compensation (in shares)			(154,253)
Restricted stock forfeitures (in shares)			(584,113)
Deemed and imputed dividends on Series A preferred stock	(13,022)				(13,022)
Accrued Series A preferred stock dividends	(7,214)				(7,214)
Accrued Series B preferred stock dividends	(2,049)				(2,049)
Net loss	(240,388)					(229,340)		$ (11,048)
Balance at Dec. 31, 2020	(105,212)		$ 7		$ 217,212	$ (322,431)
Balance (in shares) at Dec. 31, 2020			72,515,342	2,302,936
Balance at Mar. 31, 2020	(40,403)
Deemed and imputed dividends on Series A preferred stock	(5,142)
Net loss	(19,602)
Balance at Jun. 30, 2020	$ (64,816)

Description of Business

Description of Business	12 Months Ended
	Dec. 31, 2020
Organization Consolidation And Presentation Of Financial Statements [Abstract]
Description of Business	U.S. WELL SERVICES, INC. NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (in thousands, except share and per share amounts) NOTE 1 – DESCRIPTION OF BUSINESS U.S. Well Services, Inc. (the “Company,” “we,” “us” or “our” The Company’s fleets consist of mobile hydraulic fracturing units and other auxiliary heavy equipment to perform fracturing services. The Company has two designs for hydraulic fracturing units: (1) Conventional Fleets, which are powered by diesel fuel and utilize traditional internal combustion engines, transmissions, and radiators and (2) Clean Fleet ® Substantially all the Company’s assets and operations are held and conducted by U.S. Well Services, LLC (“USWS LLC”), a wholly owned subsidiary of USWS Holdings, LLC (“USWS Holdings”), and the Company’s only assets are equity interests representing 97% ownership of USWS Holdings as of December 31, 2020.

Restatement of Previously Issue

Restatement of Previously Issued Consolidated Financial Statements	12 Months Ended
	Dec. 31, 2020
Prior Period Adjustment [Abstract]
Restatement of Previously Issued Financial Statements (As Restated)	NOTE 2 - RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (As Restated) On April 12, 2021, the Staff of the Securities and Exchange Commission As a result of the SEC Staff Statement and in light of evolving views as to certain provisions commonly included in warrants issued by SPACs, we re-evaluated the accounting for our warrants (as described in “Note 9 – Warrant Liabilities” and “Note 12 – Mezzanine Equity Derivatives and Hedging—Contracts in Entity’s Own Equity As a result of the SEC Staff Statement, the Company has determined that the warrants should be classified as liabilities Impact of the Restatement The impact of the restatement on the consolidated balance sheets and statements of operations for the Affected Periods is presented below. The restatement had no impact on net cash flows from operating, investing or financing activities. CONSOLIDATED BALANCE SHEETS As Previously Reported Adjustments As Restated As of December 31, 2020 Warrant liabilities $ - $ 1,619 $ 1,619 Total liabilities 353,155 1,619 354,774 Series A Redeemable Convertible Preferred Stock 52,776 (1,801 ) 50,975 Additional paid in capital 241,465 (24,253 ) 217,212 Accumulated deficit (346,866 ) 24,435 (322,431 ) Total stockholders' equity (deficit) (105,394 ) 182 (105,212 ) As of December 31, 2019 Warrant liabilities $ - $ 8,147 $ 8,147 Total liabilities 426,114 8,147 434,261 Series A Redeemable Convertible Preferred Stock 38,928 (3,337 ) 35,591 Additional paid in capital 248,302 (22,920 ) 225,382 Accumulated deficit (111,201 ) 18,110 (93,091 ) Total stockholders' equity attributable to U.S. Well Services, Inc. 137,107 (4,810 ) 132,297 Total stockholders' equity 147,740 (4,810 ) 142,930 As of December 31, 2018 Warrant liabilities $ - $ 29,110 $ 29,110 Total liabilities 239,881 29,110 268,991 Additional paid in capital 204,928 (35,117 ) 169,811 Accumulated deficit (17,383 ) 6,007 (11,376 ) Total stockholders' equity attributable to U.S. Well Services, Inc. 187,551 (29,110 ) 158,441 Total stockholders' equity 240,349 (29,110 ) 211,239 CONSOLIDATED STATEMENTS OF OPERATIONS As Previously Reported Adjustments As Restated For the year ended December 31, 2020 Interest expense, net $ (25,209 ) $ (17 ) $ (25,226 ) Change in fair value of warrant liabilities - 6,342 6,342 Loss before income taxes (247,537 ) 6,325 (241,212 ) Net loss (246,713 ) 6,325 (240,388 ) Net loss attributable to U.S. Well Services, Inc. (235,665 ) 6,325 (229,340 ) Deemed and imputed dividends on Series A preferred stock (11,666 ) (1,356 ) (13,022 ) Net loss attributable to U.S. Well Services, Inc. common stockholders (257,158 ) 4,969 (252,189 ) Loss per common share - Basic and diluted $ (3.88 ) $ 0.07 $ (3.81 ) For the year ended December 31, 2019 Interest expense, net $ (30,099 ) $ (10 ) $ (30,109 ) Change in fair value of warrant liabilities - 12,113 12,113 Loss before income taxes (116,159 ) 12,103 (104,056 ) Net loss (116,082 ) 12,103 (103,979 ) Net loss attributable to U.S. Well Services, Inc. (93,913 ) 12,103 (81,810 ) Deemed and imputed dividends on Series A preferred stock (11,206 ) (590 ) (11,796 ) Net loss attributable to U.S. Well Services, Inc. common stockholders (109,169 ) 11,513 (97,656 ) Loss per common share - Basic and diluted $ (2.11 ) $ 0.22 $ (1.89 ) For the year ended December 31, 2018 Change in fair value of warrant liabilities $ - $ 6,007 $ 6,007 Loss before income taxes (70,462 ) 6,007 (64,455 ) Net loss (70,814 ) 6,007 (64,807 ) Net loss attributable to U.S. Well Services, Inc. (65,896 ) 6,007 (59,889 ) Loss per common share - Basic and diluted $ (1.33 ) $ 0.12 $ (1.21 ) CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited) As Previously Reported Adjustments As Restated As of September 30, 2020 Warrant liabilities $ - $ 1,187 $ 1,187 Total liabilities 322,100 1,187 323,287 Series A Redeemable Convertible Preferred Stock 50,907 (183 ) 50,724 Additional paid in capital 240,547 (26,073 ) 214,474 Accumulated deficit (317,642 ) 25,069 (292,573 ) Total stockholders' equity (deficit) (77,088 ) (1,004 ) (78,092 ) As of June 30, 2020 Warrant liabilities $ - $ 2,966 $ 2,966 Total liabilities 328,069 2,966 331,035 Series A Redeemable Convertible Preferred Stock 53,277 (1,976 ) 51,301 Additional paid in capital 237,872 (24,281 ) 213,591 Accumulated deficit (301,705 ) 23,291 (278,414 ) Total stockholders' equity (deficit) (63,826 ) (990 ) (64,816 ) As of March 31, 2020 Warrant liabilities $ - $ 1,599 $ 1,599 Total liabilities 410,090 1,599 411,689 Series A Redeemable Convertible Preferred Stock 46,928 (2,615 ) 44,313 Additional paid in capital 242,143 (23,643 ) 218,500 Accumulated deficit (283,568 ) 24,659 (258,909 ) Total stockholders' equity (deficit) (41,419 ) 1,016 (40,403 ) As of September 30, 2019 Warrant liabilities $ - $ 16,391 $ 16,391 Total liabilities 431,877 16,391 448,268 Series A Redeemable Convertible Preferred Stock 31,968 (3,735 ) 28,233 Additional paid in capital 232,080 (22,522 ) 209,558 Accumulated deficit (78,008 ) 9,866 (68,142 ) Total stockholders' equity attributable to U.S. Well Services, Inc. 154,078 (12,656 ) 141,422 Total stockholders' equity 192,155 (12,656 ) 179,499 As of June 30, 2019 Warrant liabilities $ - $ 33,978 $ 33,978 Total liabilities 458,611 33,978 492,589 Series A Redeemable Convertible Preferred Stock 25,892 (3,905 ) 21,987 Additional paid in capital 236,398 (22,352 ) 214,046 Accumulated deficit (61,039 ) (7,721 ) (68,760 ) Total stockholders' equity attributable to U.S. Well Services, Inc. 175,365 (30,073 ) 145,292 Total stockholders' equity 217,279 (30,073 ) 187,206 As of March 31, 2019 Warrant liabilities $ - $ 38,049 $ 38,049 Total liabilities 394,659 38,049 432,708 Additional paid in capital 206,008 (25,339 ) 180,669 Accumulated deficit (39,560 ) (12,710 ) (52,270 ) Total stockholders' equity attributable to U.S. Well Services, Inc. 166,454 (38,049 ) 128,405 Total stockholders' equity 213,355 (38,049 ) 175,306 CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited) Three Months Ended September 30, 2020 June 30, 2020 March 31, 2020 September 30, 2019 June 30, 2019 March 31, 2019 Interest expense, net As Previously Reported $ (5,744 ) $ (5,661 ) $ (7,952 ) $ (8,449 ) $ (7,820 ) $ (5,115 ) Adjustments (4 ) (4 ) (4 ) (4 ) (2 ) - As Restated (5,748 ) (5,665 ) (7,956 ) (8,453 ) (7,822 ) (5,115 ) Change in fair value of warrant liabilities As Previously Reported $ - $ - $ - $ - $ - $ - Adjustments 1,783 (1,364 ) 6,553 17,591 4,991 (18,717 ) As Restated 1,783 (1,364 ) 6,553 17,591 4,991 (18,717 ) Loss before income taxes As Previously Reported $ (16,075 ) $ (18,221 ) $ (183,917 ) $ (21,210 ) $ (26,605 ) $ (28,365 ) Adjustments 1,779 (1,368 ) 6,549 17,587 4,989 (18,717 ) As Restated (14,296 ) (19,589 ) (177,368 ) (3,623 ) (21,616 ) (47,082 ) Net loss As Previously Reported $ (15,988 ) $ (18,234 ) $ (183,167 ) $ (21,249 ) $ (26,911 ) $ (28,489 ) Adjustments 1,779 (1,368 ) 6,549 17,587 4,989 (18,717 ) As Restated (14,209 ) (19,602 ) (176,618 ) (3,662 ) (21,922 ) (47,206 ) Net income (loss) attributable to U.S. Well Services, Inc. As Previously Reported $ (15,937 ) $ (18,137 ) $ (172,367 ) $ (16,969 ) $ (21,479 ) $ (22,272 ) Adjustments 1,779 (1,368 ) 6,549 17,587 4,989 (18,717 ) As Restated (14,158 ) (19,505 ) (165,818 ) 618 (16,490 ) (40,989 ) Deemed and imputed dividends on Series A preferred stock As Previously Reported $ (467 ) $ (4,504 ) $ (6,249 ) $ (4,406 ) $ (1,560 ) $ - Adjustments 3 (638 ) (723 ) (170 ) (22 ) - As Restated (464 ) (5,142 ) (6,972 ) (4,576 ) (1,582 ) - Net loss attributable to U.S. Well Services, Inc. common stockholders As Previously Reported $ (18,939 ) $ (25,152 ) $ (180,367 ) $ (23,045 ) $ (23,699 ) $ (22,272 ) Adjustments 1,782 (2,006 ) 5,826 17,417 4,967 (18,717 ) As Restated (17,157 ) (27,158 ) (174,541 ) (5,628 ) (18,732 ) (40,989 ) Loss per common share - Basic and diluted As Previously Reported $ (0.28 ) $ (0.38 ) $ (3.00 ) $ (0.45 ) $ (0.46 ) $ (0.45 ) Adjustments 0.03 (0.03 ) 0.10 0.34 0.09 (0.39 ) As Restated (0.25 ) (0.41 ) (2.90 ) (0.11 ) (0.37 ) (0.84 ) CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited) Nine Months Ended September 30, Six Months Ended June 30, 2020 2019 2020 2019 Interest expense, net As Previously Reported $ (19,357 ) $ (21,384 ) $ (13,613 ) $ (12,935 ) Adjustments (12 ) (6 ) (8 ) (2 ) As Restated (19,369 ) (21,390 ) (13,621 ) (12,937 ) Change in fair value of warrant liabilities As Previously Reported $ - $ - $ - $ - Adjustments 6,972 3,865 5,189 (13,726 ) As Restated 6,972 3,865 5,189 (13,726 ) Loss before income taxes As Previously Reported $ (218,213 ) $ (76,180 ) $ (202,138 ) $ (54,970 ) Adjustments 6,960 3,859 5,181 (13,728 ) As Restated (211,253 ) (72,321 ) (196,957 ) (68,698 ) Net loss As Previously Reported $ (217,389 ) $ (76,649 ) $ (201,401 ) $ (55,400 ) Adjustments 6,960 3,859 5,181 (13,728 ) As Restated (210,429 ) (72,790 ) (196,220 ) (69,128 ) Net loss attributable to U.S. Well Services, Inc. As Previously Reported $ (206,441 ) $ (60,720 ) $ (190,504 ) $ (43,751 ) Adjustments 6,960 3,859 5,181 (13,728 ) As Restated (199,481 ) (56,861 ) (185,323 ) (57,479 ) Deemed and imputed dividends on Series A preferred stock As Previously Reported $ (11,220 ) $ (5,966 ) $ (10,753 ) $ (1,560 ) Adjustments (1,358 ) (192 ) (1,361 ) (22 ) As Restated (12,578 ) (6,158 ) (12,114 ) (1,582 ) Net loss attributable to U.S. Well Services, Inc. common stockholders As Previously Reported $ (224,458 ) $ (69,016 ) $ (205,519 ) $ (45,971 ) Adjustments 5,602 3,667 3,820 (13,750 ) As Restated (218,856 ) (65,349 ) (201,699 ) (59,721 ) Loss per common share - Basic and diluted As Previously Reported $ (3.46 ) $ (1.36 ) $ (3.25 ) $ (0.92 ) Adjustments 0.09 0.07 0.06 (0.27 ) As Restated (3.37 ) (1.29 ) (3.19 ) (1.19 )

Significant Accounting Policies

Significant Accounting Policies	12 Months Ended
	Dec. 31, 2020
Accounting Policies [Abstract]
SIGNIFICANT ACCOUNTING POLICIES	NOTE 3 – SIGNIFICANT ACCOUNTING POLICIES (As Restated) Basis of Presentation The accompanying consolidated financial statements and related notes have been prepared in conformity with generally accepted accounting principles in the United States of America (“GAAP”) and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Our operations are organized into a single business segment, which consists of hydraulic fracturing services, and we have one reportable geographical business segment, the United States. Principles of Consolidation The consolidated financial statements comprise the financial statements of the Company, its wholly owned subsidiaries, and subsidiaries that it controls due to ownership of a majority voting interest. Subsidiaries are fully consolidated from the date of acquisition, being the date on which the Company obtains control, and continue to be consolidated until the date when such control ceases. The financial statements of the subsidiaries are prepared for the same reporting period as the Company. All significant intercompany balances and transactions are eliminated upon consolidation. Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. We regularly evaluate estimates and judgments based on historical experience and other relevant facts and circumstances. Significant estimates included in these financial statements primarily relate to allowance for doubtful accounts, allowance for inventory obsolescence, useful lives for depreciation and amortization of property and equipment and intangibles, impairment assessments of goodwill and long-lived assets, Level 2 inputs used in fair value estimation of warrant liabilities, term loans and certain liability-classified share-based compensation, and the assumptions used in our Black-Scholes and Monte Carlo option pricing models associated with the valuation of warrant liabilities, share-based compensation and certain equity instruments. Actual results could differ from those estimates. Cash and Cash Equivalents Cash equivalents are highly liquid investments with an original maturity at the date of acquisition of three months or less. Cash and cash equivalents consist of cash on deposit with domestic banks and, at times, may exceed federally insured limits. Restricted Cash Cash and cash equivalents that are restricted as to withdrawal or use under the terms of certain contractual agreements, or are reserved for a specific purpose, that are not readily available for immediate or general use are recorded in restricted cash in our consolidated balance sheets. The restricted cash in our consolidated balance sheet represents cash transferred into a trust account to support our workers’ compensation obligations and cash held for use in approved capital expenditures amounting to $513 and $1,056, respectively, as of December 31, 2020, and $513 and $7,097, respectively, as of December 31, 2019. The following table provides a reconciliation of the amount of cash and cash equivalents reported on the consolidated balance sheets to the total of cash and cash equivalents and restricted cash shown on the consolidated statements of cash flows: As of December 31, 2020 2019 Cash and cash equivalents $ 3,693 $ 33,794 Restricted cash 1,569 7,610 Cash and cash equivalents and restricted cash $ 5,262 $ 41,404 Inventory Inventory consists of proppant, chemicals, and other consumable materials and supplies used in our high-pressure hydraulic fracturing operations. Inventories are stated at the lower of cost or net realizable value. Cost is determined principally on a first-in-first-out cost basis. All inventories are purchased and used by the Company in the delivery of its services with no inventory being sold separately to outside parties. Inventory quantities on hand are reviewed regularly and write-downs for obsolete inventory are recorded based on our forecast of the inventory item demand in the near future . As of December 31, 20 20 and 201 9 , the Company ha d established inventory reserves of $ 315 and $ , respectively, for obsolete and slow-moving inventory. The following table shows the change in the inventory reserves: As of December 31, 2020 2019 Balance at beginning of period $ 579 $ 572 Charges to costs and expenses 620 359 Recoveries and write-offs (884 ) (352 ) Balance at end of period $ 315 $ 579 Property and Equipment Property and equipment are carried at cost, with depreciation provided on a straight-line basis over their estimated useful lives. Expenditures for renewals and betterments that extend the lives of the assets are capitalized. Amounts spent for maintenance and repairs, which do not improve or extend the life of the related asset, are charged to expense as incurred. The Company separately identifies and accounts for certain critical components of its hydraulic fracturing units including the engine, transmission, and pump, which requires us to separately estimate the useful lives of these components. For our other service equipment, we do not separately identify and track depreciation of specific original components. When we replace components of these assets, we typically estimate the net book values of the components that are retired, which are based primarily upon their replacement costs, their ages, and their original estimated useful lives. In the first quarter of 2020, our review of impairment of long-lived assets (refer to “Note 6 – Goodwill and Intangible Assets”) necessitated a review of the useful lives of our property and equipment. Current trends in hydraulic fracturing equipment operating conditions, such as increasing treating pressures and higher pumping rates, along with the increase in daily pumping time are shortening the useful life of certain critical components we use. We determined that the average useful life of fluid ends and fuel injectors is now less than one year, resulting in our determination that costs associated with the replacement of these components will no longer be capitalized, but instead expensed as they are used in operations. This change in accounting estimate was made effective in March 2020 and accounted for prospectively. Long-lived Assets Long-lived assets, such as property and equipment and amortizable identifiable intangible assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. When making this assessment, the following factors are considered: current operating results, trends, and prospects, as well as the effects of obsolescence, demand, competition, and other economic factors. We determine recoverability by evaluating whether the undiscounted estimated future net cash flows of the asset or asset group are less than its carrying value. When impairment is indicated, we proceed to Step 2 of the impairment test and measure the impairment as the amount by which the assets carrying value exceeds its fair value. Management considers several factors such as estimated future cash flows, appraisals, and current market value analysis in determining fair value. Assets are written down to fair value if the concluded current fair value is below the net carrying value. Impairment loss on long-lived assets of $147,543 was recorded during the first quarter of 2020 (refer to “Note 6 – Goodwill and Intangible Assets”). Goodwill Goodwill is not amortized, but is reviewed for impairment annually, or more frequently when events or changes in circumstances indicate that the carrying value may not be recoverable. Judgements regarding indicators of potential impairment are based on market conditions and operational performance of the business. As of December 31 of each year, or as required, the Company performs an impairment analysis of goodwill. The Company may assess its goodwill for impairment initially using a qualitative approach to determine whether conditions exist that indicate it is more likely than not that a reporting unit’s carrying value is greater than its fair value, and if such conditions are identified, then a quantitative analysis will be performed to determine if there is any impairment. The Company may also elect to perform a single step quantitative analysis in which the carrying amount of the reporting unit is compared to its fair value, which the Company estimates using a guideline public company method, a form of the market approach. The guideline public company method utilized the trading multiples of similarly traded public companies as they related to the Company’s operating metrics. An impairment charge would be recognized for the amount by which the carrying amount of the reporting unit exceeds the reporting unit’s fair value, and only limited to the total amount of goodwill allocated to the reporting unit. Deferred Financing Costs Costs incurred to obtain financing are capitalized and amortized to interest expense using the effective interest method over the contractual term of the debt. At the balance sheet date, deferred financing costs related to term loans are presented as a direct deduction from the debt liability, while deferred financing costs related to the revolver facility are presented as deferred financing costs, net, on the consolidated balance sheets. Warrant Liabilities The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480, Distinguishing Liabilities from Equity Derivatives and Hedging—Embedded Derivatives The Company issued public warrants and private placement warrants (collectively, the “public and private placement warrants”) in connection with its initial public offering (the “IPO”) in November 2018. Additionally, the Company issued warrants to certain institutional investors in connection with its private placement of Series A Preferred Stock on May 24, 2019 (“Series A warrants,” and together with the public and private placement warrants, the “warrants”). All of our outstanding warrants are recognized as liabilities. Accordingly, we recognize the warrant instruments as liabilities at fair value upon issuance and adjust the instruments to fair value at the end of each reporting period. Any change in fair value is recognized in our consolidated statement of operations. The public warrants are valued using their quoted market price since they are publicly traded and thus had an observable market price. The private placement warrants are valued using a Monte Carlo simulation model. The Series A warrants are valued using the Black-Scholes option pricing model. Fair Value of Financial Instruments Fair value is defined under ASC 820, Fair Value Measurement Level 1–inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2–inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly. Level 3–inputs are unobservable for the asset or liability. The following is a summary of the carrying amounts and estimated fair values of our financial instruments as of December 31, 2020 and December 31, 2019: Senior Secured Term Loan . The fair value of the Senior Secured Term Loan is $198.0 Equipment financing . The carrying value of the equipment financing approximates fair value as its terms are consistent with and comparable to current market rates as of December 31, 2020 and December 31, 2019, respectively. See “Note 9 – Warrant Liabilities” for fair value measurements associated with the Company’s warrants. Revenue Recognition Effective January 1, 2019, the Company adopted ASC 606, Revenue from Contracts with Customers, Under the standard, revenue recognition is based on the customer’s ability to benefit from the services rendered in an amount that reflects the consideration expected to be received in exchange for those services. Taxes collected from customers and remitted to governmental authorities are accounted for on a net basis and therefore excluded from revenues in the Company’s financial statements. The Company’s revenues consist of providing hydraulic fracturing services for either a pre-determined term or number of stages/wells to E&P companies operating in the onshore oil and natural gas basins of the United States. In the performance of these services, and at the request of our customers, we may also provide consumables such as chemicals and sand. Revenues are earned as services are rendered, which is generally on a per stage or daily rate basis. Customers are invoiced according to contract terms upon the completion of a well or monthly with payment due typically 30 days from invoice date. Hydraulic fracturing is a well-stimulation technique intended to optimize hydrocarbon flow paths during the completion phase of wellbores. The process involves the injection of water, sand, and chemicals under high pressure into shale formations. The Company’s performance obligations are satisfied over time, typically measured in number of stages completed or the number of pumping days a fleet is available to pump for a customer in a month. A field ticket is created for each stage completed that records all services performed, including any chemicals and proppant we provided and consumed in completing the stage. The field ticket is signed by a customer representative and evidences the amounts to which the Company has a right to invoice and thus to recognize as revenue. All revenue is recognized when a contract with a customer exists, collectability of amounts subject to invoice is probable, the performance obligations under the contract have been satisfied over time, and the amount to which the Company has the right to invoice has been determined. A portion of the Company’s contracts contain variable consideration; however, this variable consideration is typically unknown at the time of contract inception, and is not known until the job is complete, at which time the variability is resolved. The Company has elected to use the “as invoiced” practical expedient to recognize revenue based upon the amount it has a right to invoice upon the completion of each performance obligation per the terms of the contract. The practical expedient permits an entity to recognize revenue in the amount to which it has a right to invoice the customer if that amount corresponds directly with the value to the customer of the entity’s performance completed to date. The Company believes that this is an accurate reflection of the value transferred to the customer as each incremental obligation is performed. The Company has elected to expense sales commissions paid upon the successful signing of a new customer contract as incurred if the related contract will be fully satisfied within one year. For contracts that will not be fully satisfied within one year, these incremental costs of obtaining a contract with a customer will be recognized as a contract asset and amortized on a straight-line basis over the life of the contract. Accounts Receivable Accounts receivable are recorded at their outstanding balances adjusted for an allowance for doubtful accounts. The allowance for doubtful accounts is determined by analyzing the payment history and credit worthiness of each debtor. Receivable balances are charged off when they are considered uncollectible by management. Recoveries of receivables previously charged off are recorded as income when received. The Company held a reserve for doubtful accounts of $12,000 and $22 as of December 31, 2020 and 2019, respectively. The reserve was recorded due to growing uncertainty as to collectability of billed amounts from customers weakened by the economic downturn in 2020. The following table shows the change in allowance for doubtful accounts: As of December 31, 2020 2019 Balance at beginning of period $ 22 $ 189 Charges to costs and expenses 12,031 434 Recoveries and write-offs (53 ) (601 ) Balance at end of period $ 12,000 $ 22 Major Customer and Concentration of Credit Risk The concentration of our customers in the oil and natural gas industry may impact our overall exposure to credit risk, either positively or negatively, in that customers may be similarly affected by changes in economic and industry conditions. We perform ongoing credit evaluations of our customers and do not generally require collateral in support of our trade receivables. The following table shows the percentage of revenues from our significant customers: Years Ended December 31, 2020 2019 Customer A 11.2% 18.4% Customer B 19.7% * Customer C 18.4% * Customer D * 18.3% Customer E 13.2% * Customer F 18.2% * Customer G * 15.7% An asterisk indicates that revenue is less than ten percent. The following table shows the percentage of trade receivables from our significant customers: Years Ended December 31, 2020 2019 Customer A * 12.0% Customer B 32.2% 10.3% Customer C 17.0% * Customer D * 12.1% Customer E * * Customer F 12.7% * Customer G 12.5% 34.5% Customer H * 15.9% Customer I 13.5% * An asterisk indicates that trade receivable is less than ten percent. Share-Based Compensation Share based compensation is measured on the grant date and fair value is recognized as expense over the requisite service period, which is generally the vesting period of the award. The Company recognizes forfeitures as they occur rather than estimating expected forfeitures. The fair value of time-based restricted stock, DSUs, or other performance incentive awards is determined based on the number of shares or units granted and the closing price of Class A common stock on the date of grant. The fair value of stock options is determined by applying the Black-Sholes model on the grant-date market value of the underlying Class A common stock. Restricted stock with market conditions is valued using a Monte Carlo simulation analysis. Deferred compensation expense associated with liability-based awards, such as certain performance incentive awards that could be settled either in cash or through issuance of a variable number of shares based on a fixed monetary amount at inception, is recognized at the fixed monetary amount at inception and is amortized on a straight-line basis over the requisite service period, which is generally the vesting period. However, the Company considers any delayed settlement as a post-vesting restriction which impacts the determination of the grant-date fair value of the award. The Company estimates fair value by using a risk-adjusted discount rate, which reflects the weighted average cost of capital of similarly traded public companies. Fair Value of Preferred Stock The fair value of Series A preferred stock at the date of issuance was estimated by calculating the present value of its one-year The fair value of Series B preferred stock is the stated value, which is equal to the proceeds received from issuance. Embedded Conversion Features The Company evaluates embedded conversion features within a convertible instrument under ASC 815, Derivatives and Hedging Debt with Conversion and Other Options The Company records a beneficial conversion feature (“BCF”) when the convertible instrument is issued with conversion features at fixed or adjustable rates that are below market value when issued. The BCF for convertible instruments is recognized and measured by allocating a portion of the proceeds equal to the intrinsic value of that feature to additional paid-in capital. The intrinsic value is generally calculated at the commitment date as the difference between the conversion price and the fair value of the common stock or other securities into which the security is convertible, multiplied by the number of shares into which the security is convertible. If certain other securities are issued with the convertible security, the proceeds are allocated among the different components. The portion of the proceeds allocated to the convertible security is divided by the contractual number of the conversion shares to determine the effective conversion price, which is used to measure the BCF. The effective conversion price is used to compute the intrinsic value. The value of the BCF is limited to the basis that is initially allocated to the convertible security. The BCF for the convertible instrument is recorded as a reduction, or discount, to the carrying amount of the convertible instrument equal to the fair value of the conversion feature. The discount is then amortized as deemed dividends over the period from the date of the convertible instrument’s issuance to the earliest redemption date, provided that the convertible instrument is not currently redeemable but probable of becoming redeemable in the future. Income Taxes The Company, under ASC 740, uses the asset and liability method of accounting for income taxes, under which deferred tax assets and liabilities are recognized for the future tax consequences of (i) temporary differences between the financial statement carrying amounts and the tax bases of existing assets and liabilities and (ii) operating loss and tax credit carryforwards. Deferred income tax assets and liabilities are based on enacted tax rates applicable to the future period when those temporary differences are expected to be recovered or settled. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in income in the period the rate change is enacted. A valuation allowance is provided for deferred tax assets when it is more likely than not the deferred tax assets will not be realized. Our deferred tax calculation and valuation allowance requires us to make certain estimates about future operations. Changes in state or federal tax laws, as well as changes in our financial condition or the carrying value of existing assets and liabilities, could affect those estimates. The effect of a change in tax rates is recognized as income or expense in the period that the rate is enacted. ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties at December 31, 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals, or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.

Accounting Standards

Accounting Standards	12 Months Ended
	Dec. 31, 2020
Accounting Policies [Abstract]
Accounting Standards	NOTE 4 – ACCOUNTING STANDARDS (As Restated) Recently Adopted Accounting Pronouncements The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended, (the “Securities Act”), as modified by the Jumpstart our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. In January 2017, the FASB issued ASU 2017-04, Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework-Changes to the Disclosure Requirements for Fair Value Measurement In March 2020, the FASB issued ASU 2020-03, Codification Improvements to Financial Instruments ASU 2020 03 In June 2020, the FASB issued ASU 2020-05, Revenue from Contracts with Customers (Topic 606) and Leases (Topic 842) - Effective Dates for Certain Entities Recent Accounting Pronouncements Not Yet Adopted In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842) liabilities and right-of-use assets upon our adoption of Topic 842, which will increase our total assets and total liabilities that we report relative to such amounts prior to adoption. The Company will use the modified retrospective with applied transition method upon adoption of the standard. Under this adoption method, all leases that are in effect and in existence as of, and after transition date will be applied as of the transition date, with a cumulative impact to retained earnings in that period. Prior period financial statements would be stated under the old guidance ASC 840 with no change to prior periods or disclosures associated with prior period. In June 2016, the FASB issued ASU 2016-13, Financial Instruments – Credit Losses (Topic 326) In August 2018, the FASB issued ASU 2018-15, Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That is a Service Contract, In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes In August 2020, the FASB issued ASU 2020-06 Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity , which simplifies accounting for convertible instruments by removing major separation models required under current GAAP. It also amends the accounting for certain contracts in an entity’s own equity that are currently accounted for as derivatives because of specific settlement provisions. In addition, the new guidance modifies how particular convertible instruments and certain contracts that may be settled in cash or shares impact the diluted EPS computation. The new guidance will be effective for small reporting companies for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Early adoption is permitted. The Company is currently evaluating the impact of adopting the new guidance on the consolidated financial statements.

Prepaids and Other Current Asse

Prepaids and Other Current Assets	12 Months Ended
	Dec. 31, 2020
Prepaid Expense And Other Assets Current [Abstract]
PREPAIDS AND OTHER CURRENT ASSETS	NOTE 5 – PREPAIDS AND OTHER CURRENT ASSETS Prepaids and other current assets include the following: As of December 31, 2020 2019 Prepaid insurance $ 3,162 $ 11,127 Recoverable costs from insurance 4,635 - Income tax receivable 1,567 810 Other current assets 1,343 1,395 Total prepaid expenses and other current assets $ 10,707 $ 13,332 During the third quarter of 2020, certain pieces of equipment were damaged. The Company has insurance coverage in place covering, among other things, property damage up to certain specified amounts and amounts. During the year ended December 31, 2020, the Company received $ 4,854 as insurance reimbursement. Recoverable costs from insurance as of December 31, 2020 was $ 4,635 , which represents net book value of equipment damaged that we expect to recover from insurance .

Goodwill and Intangible Assets

Goodwill and Intangible Assets	12 Months Ended
	Dec. 31, 2020
Goodwill And Intangible Assets Disclosure [Abstract]
GOODWILL AND INTANGIBLE ASSETS	NOTE 6 – GOODWILL AND INTANGIBLE ASSETS Goodwill Goodwill represents the difference between the purchase price and the estimated fair value of identifiable assets acquired and liabilities assumed. The Company performs an impairment analysis related to goodwill as of December 31 st In the first quarter of 2020, the Company performed a quantitative goodwill impairment test utilizing the single-step approach to compare the carrying value of the reporting unit to its estimated fair value. The estimated fair value of the reporting unit was determined using a guideline public company method, a form of the market approach. The guideline public company method utilized the trading multiples of similarly traded public companies as they related to our operating metrics. Based on the impairment test, the Company determined that goodwill was not impaired as the reporting unit’s carrying value, after accounting for the impairment charges of long-lived assets, did not exceed the reporting unit’s fair value. As of December 31, 2020, the Company performed the qualitative analysis of the goodwill impairment assessment by reviewing relevant qualitative factors. The Company determined there were no events that would indicate the carrying amount of its goodwill may not be recoverable, and as such, no impairment charge was recorded. Intangible Assets Intangible assets consisted of the following: Estimated Useful Life (in years) Gross Carrying Value Accumulated Amortization Net Book Value As of December 31, 2020 Trademarks 10 $ 1,415 $ 156 $ 1,259 Patents 20 12,775 568 12,207 $ 14,190 $ 724 $ 13,466 As of December 31, 2019 Trademarks 10 3,132 913 2,219 Patents 20 22,955 3,348 19,607 $ 26,087 $ 4,261 $ 21,826 The intangible assets are amortized over the period the Company expects to receive the related economic benefit. Amortization expense related to amortizable intangible assets was $1,090 and $6,064 for the year ended December 31, 2020, and 2019, respectively. As discussed above, the Company identified a triggering event in the first quarter of 2020 and performed a quantitative impairment test on long-lived assets. The expected present value method, a form of the income approach, was utilized to determine the fair value of long-lived assets. This method is based on expected cash flows using a risk-adjusted discount rate, which reflects the weighted average cost of capital of similarly traded public companies. As a result of the impairment test performed, the Company recorded in the first quarter of 2020 an impairment charge of $7.2 million to reduce the carrying value of intangible assets from $21.4 million to $14.2 million, representing its fair value on the date of impairment. As of December 31, 2020, the Company determined there were no events that would indicate the carrying amount of these assets may not be recoverable, and as such, no further impairment charge was recognized. The estimated amortization expense for future periods is as follows: Fiscal Year Estimated Amortization Expense 2021 $ 966 2022 966 2023 966 2024 966 2025 966 Thereafter 8,636 Total $ 13,466

Property and Equipment, Net

Property and Equipment, Net	12 Months Ended
	Dec. 31, 2020
Property Plant And Equipment [Abstract]
PROPERTY AND EQUIPMENT, NET	NOTE 7 – PROPERTY AND EQUIPMENT, NET Property and equipment consisted of the following: Estimated Useful Life (in years) December 31, 2020 December 31, 2019 Fracturing equipment 1.5 to 25 $ 263,869 $ 651,162 Light duty vehicles 5 2,483 8,188 Furniture and fixtures 5 67 277 IT equipment 3 1,676 6,724 Auxiliary equipment 2 to 20 11,058 38,502 Leasehold improvements Term of lease 287 725 279,440 705,578 Less: Accumulated depreciation and amortization (44,108 ) (263,968 ) Property and equipment, net $ 235,332 $ 441,610 Depreciation and amortization expense related to property and equipment during the years ended December 31, 2020 and 2019 was $79,263 and $148,149, respectively. As a result of the impairment test on long-lived assets described in “Note 6 – Goodwill and Intangible Assets,” the Company recorded in the first quarter of 2020 an impairment charge of $ 140.3 414.1 273.8

Accrued Expenses and Other Curr

Accrued Expenses and Other Current Liabilities	12 Months Ended
	Dec. 31, 2020
Payables And Accruals [Abstract]
Accrued Expenses and Other Current Liabilities	NOTE 8 – ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES Accrued expenses and other current liabilities consisted of the following: As of December 31, 2020 2019 Accrued payroll and benefits $ 7,208 $ 9,356 Accrued taxes 5,380 9,817 Accrued interest 317 18,190 Other current liabilities 1,876 3,118 Accrued expenses and other current liabilities $ 14,781 $ 40,481

Warrant Liabilities (As Restate

Warrant Liabilities (As Restated)	12 Months Ended
	Dec. 31, 2020
Warrant Liabilities [Abstract]
Warrant Liabilities (As Restated)	NOTE 9 – WARRANT LIABILITES (As Restated) Warrants Pursuant to the Company’s IPO, 32,500,000 warrants (the “public warrants”) were issued and 15,500,000 warrants (the “private placement warrants”) were sold simultaneously to Matlin & Partners Acquisition Sponsor, LLC (the “Sponsor”) and Cantor Fitzgerald (the “Underwriter”). Each warrant entitles its holder to purchase one half of one share of Class A common stock at an exercise price of $5.75 per half share ($11.50 for full share equivalent), to be exercised only for a whole number of shares of our Class A common stock. The warrants became exercisable 30 days after the completion of the transaction and expire five years after that date or earlier upon redemption or liquidation. Once the warrants became exercisable, the Company may redeem the outstanding warrants at a price of $0.01 per warrant upon a minimum of 30 days’ prior written notice of redemption, if the last sale price of the Company’s common stock equals or exceeds $24.00 per share for any 20 trading days within a 30-trading day period ending on the third business day before the Company sends the notice of redemption to the warrant holders. The private placement warrants, however, are nonredeemable so long as they are held by the Sponsor, the Underwriter or their permitted transferees. In March 2019, the Company entered into privately negotiated warrant exchange agreements with certain warrant holders to exchange 10,864,391 public warrants for Class A common stock at a ratio of 0.13 Class A common shares per warrant. In April 2019, pursuant to a previously announced public warrant exchange offer on March 14, 2019, the Company exchanged an additional 11,640,974 public warrants for Class A common stock at a ratio of 0.13 Class A common shares per warrant. See “Note 12 – Mezzanine Equity” for the discussion of the Series A warrants issued pursuant to the Series A preferred stock purchase agreement. During the year ended December 31, 2020, certain warrant holders elected to forfeit 6,327,218 warrants for $0 consideration. As of December 31, 2020, there remained 9,994,635 public warrants and 9,172,782 private placement warrants outstanding, the total of both are exercisable for 9,583,709 shares of Class A common stock. In addition, as of December 31, 2020, 4,844,441 Series A warrants were outstanding pursuant to the Series A preferred stock purchase agreement, and exercisable for 4,844,441 shares of Class A common stock. Fair Value Measurement The Company’s warrants are accounted for as liabilities The following tables present the Company's fair value hierarchy for liabilities measured at fair value on a recurring basis: Quoted prices in active markets (Level 1) Other observable inputs (Level 2) Unobservable inputs (Level 3) Total As of December 31, 2020 Public warrants $ 254 $ - $ - $ 254 Private placement warrants - 248 - 248 Series A warrants - 1,117 - 1,117 $ 254 $ 1,365 $ - $ 1,619 As of December 31, 2019 Public warrants $ 1,299 $ - $ - $ 1,299 Private placement warrants - 2,108 - 2,108 Series A warrants - 4,740 - 4,740 $ 1,299 $ 6,848 $ - $ 8,147 Public warrants . The fair value of the public warrants are classified as Level 1 in the fair value hierarchy and valued using quoted market prices, as they are traded in active markets. Private placement The fair value of the private placement warrants are classified as a Level 2 in the fair value hierarchy and determined using a Monte Carlo simulation model. Inherent in a Monte Carlo simulation are assumptions related to expected stock-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility of its common stock warrants based on implied volatility from the Company’s publicly traded warrants and from historical volatility of select peer company common stock that matches the expected remaining life of the warrants. The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve on the grant date for a maturity similar to the expected remaining life of the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the historical rate, which the Company anticipates remaining at zero. per half share ($11.50 for full share equivalent) , stock price of $9.91, expected remaining life of 5 years, volatility of 16.7%, risk-free interest rate of 3.0% and dividend rate of 0%. As of December 31, 2020, the valuation for the private placement warrants used the following assumptions: stock price of $0.41, expected remaining life of 2.86 years, volatility of 115.8%, risk-free interest rate of 0.2% and dividend rate of 0%. Series A warrants . The fair value of the Series A warrants are classified as a Level 2 in the fair value hierarchy and is determined using the Black-Scholes valuation method. On the May 24, 2019, the Company estimated the fair value of the Series A warrants at $12,786 using the Black-Scholes option pricing model using the following primary assumptions: exercise price of $7.66, contractual term of 6.5 years, volatility rate of 53.0%, risk-free interest rate of 2.2% and expected dividend rate of 0%. As of December 31, 2020, the valuation for the Series A warrants used the following assumptions: stock price of $0.41, expected remaining term of 4.9 years, volatility of 115.8%, risk-free interest rate of 0.4% and expected dividend rate of 0%. As of December 31, 2019, the valuation for the Series A warrants used the following assumptions: stock price of $1.89, expected remaining term of 5.9 years, volatility of 70.9%, risk-free interest rate of 1.8% and expected dividend rate of 0%. The following table summarizes the activities, including changes in fair values of the Company’s warrant liabilities for the years ended December 31, 2020 and 2019: As of December 31, 2020 2019 Balance at beginning of period $ 8,147 $ 29,110 Issuance of Series A warrants, net - 12,675 Exercise of warrants - (21,535 ) Reclassification of warrant liability upon forfeiture (203 ) - Change in fair value of warrant liabilities (6,342 ) (12,113 ) Amortization of warrant issuance costs 17 10 Balance at end of period $ 1,619 $ 8,147

Notes Payable

Notes Payable	12 Months Ended
	Dec. 31, 2020
Debt Disclosure [Abstract]
Notes Payable	NOTE 10 – NOTES PAYABLE In 2020 and 2019, the Company entered into various premium finance agreements with a credit finance institution to pay the premiums on insurance policies for its directors’ and officers’ liability, general liability, workers’ compensation, umbrella, auto and pollution coverage needs. For the years ended December 31, 2020 and 2019, the aggregate amount of the premiums financed was $1,121 and $9,928, respectively, payable in equal monthly installments at an interest rate of 5.3% and 4.8%, respectively. These premium finance agreements had a total balance of $998 and $8,068 as of December 31, 2020 and 2019, respectively.

Debt

Debt	12 Months Ended
	Dec. 31, 2020
Debt Disclosure [Abstract]
Debt	NOTE 11 – DEBT Long-term debt consisted of the following: As of December 31, 2020 2019 Senior Secured Term Loan $ 246,250 $ 250,000 ABL Credit Facility 23,710 40,090 PPP Loan 10,000 - USDA Loan 21,996 - Equipment financing 12,866 16,065 Capital leases 229 10,474 Total debt principal balance 315,051 316,629 Unamortized discount on debt and debt issuance costs (17,576 ) (9,449 ) Current maturities (13,573 ) (22,288 ) Net Long-term debt $ 283,902 $ 284,892 Senior Secured Term Loan On May 7, 2019, the Company, USWS LLC, as the borrower, and all the other subsidiaries of the Company entered into a $250,000 Senior Secured Term Loan Credit Agreement (as amended, the “Senior Secured Term Loan”) with CLMG Corp., as administrative and collateral agent, and the lenders party thereto. The Company is required to make quarterly principal payments of 2.0% per annum of the initial principal balance, commencing on January 15, 2020, with final payment due at maturity on May 7, 2024. The Company recorded the related debt discount and debt issuance costs amounting to $5,000 and $5,758, respectively, as a direct deduction to the face amount of the Senior Secured Term Loan and records the amortization of debt discount and debt issue costs to interest expense based on the effective interest rate method over the term of the Senior Secured Term Loan. The Senior Secured Term Loan bears interest at a variable rate per annum equal to the applicable LIBOR rate, subject to a 2.0% floor, plus 8.25%. The Senior Secured Term Loan is not subject to financial covenants but is subject to certain non-financial covenants, including but not limited to, reporting, insurance, notice and collateral maintenance covenants as well as limitations on the incurrence of indebtedness, permitted investments, liens on assets, dispositions of assets, paying dividends, transactions with affiliates, mergers and consolidations. The Senior Secured Term Loan requires mandatory prepayments upon certain dispositions of property or issuance of other indebtedness, as defined, and quarterly a percentage of excess cash flow, if any, equal to 100% (depending on total debt outstanding) commencing in September 2019. Certain mandatory prepayments (excluding excess cash flows sweep) and optional prepayments are subject to a yield maintenance fee for the first two years and prepayment premium of 2% in year three and 1% in year four. Upon the final payment and termination of the Senior Secured Term Loan, we are subject to an exit fee equal to 2.0% of the principal amount of loans then outstanding and the aggregate optional prepayment of principal amounts repaid during the 120 days that occurred prior to such final payment. On April 1, 2020, the Company, USWS LLC, as the borrower, and all the other subsidiaries of the Company entered into a Second Amendment (the “Second Term Loan Amendment”) to the Senior Secured Term Loan with CLMG Corp., as administrative and collateral agent, and the lenders party thereto. Pursuant to the Second Term Loan Amendment, the interest rate on amounts outstanding under the Senior Secured Term Loan was reduced to 0.0% and scheduled principal amortization payments were suspended for the period beginning April 1, 2020 and ending March 31, 2022. Beginning April 1, 2022, the Senior Secured Term Loan, as amended by the Second Term Loan Amendment, will resume incurring interest at the applicable LIBOR rate, subject to a 2.0% floor, plus 8.25%, and scheduled principal amortization payments equal to 0.5% of the initial principal balance of the term loans will resume on a quarterly basis commencing June 30, 2022. Additionally, pursuant to the Second Term Loan Amendment, certain other covenants were amended including, but not limited to, covenants relating to collateral inspections and excess cash flow, and the maturity date of the S enior S ecured T erm L oan was extended to December 5, 2025 . In exchange for entering into the Second Term Loan Amendment, the lenders under the Senior Secured Term Loan received an extension fee comprised of a $20,000 cash payment, 1,050 shares of Series B preferred stock valued at $1,050 based on the stated liquidation preference of $1,000 per share, and 5,529,622 shares of Class A common stock valued at $1,438 based on the closing price of the Class A common stock at the date of issuance. The Series B preferred stock issued to the lenders under the Senior Secured Term Loan had the same terms as the Series B preferred stock issued to certain institutional investors as described in “Note 12 – Mezzanine Equity”. The total fair value of cash and non-cash consideration transferred to the lenders under the Senior Secured Term Loan were accounted for as discount on debt issuance and amortized to interest expense using the effective interest method over the remaining term of the Senior Secured Term Loan. On July 30, 2020, the Company, USWS LLC, as the borrower, and all the other subsidiaries of the Company entered into a Third Amendment (the “Third Term Loan Amendment”) to the Senior Secured Term Loan with CLMG Corp., as administrative and collateral agent, and the lenders party thereto. Pursuant to the Third Term Loan Amendment, the agents and the lenders agreed to make certain modifications and amendments to the Senior Secured Term Loan to, among other things, consent to the entry into the PPP Loan (described within this section), subject to the amended terms and conditions specified for the same in the Third Term Loan Amendment. Additionally, the Third Term Loan Amendment made certain modifications to the Senior Secured Term Loan which limits the Company’s ability to deploy and use collateral outside of the continental United States and other than in connection with oil and gas fracking and exploration without the prior consent of the administrative agent. In the Third Term Loan Amendment the Company further agreed to specific conditions and covenants regarding a turbine rental and services agreement entered on June 19, 2020 and which affect the equipment which is the subject thereof. On November 12, 2020, the Company, USWS LLC, as the borrower, and all of the other subsidiaries of the Company entered into a Fourth Amendment (the “Fourth Term Loan Amendment”) to the Senior Secured Term Loan with CLMG Corp., as administrative and collateral agent, and the lenders party thereto. Pursuant to the Fourth Term Loan Amendment, the agents and the lenders agreed to make certain modifications and amendments to the Senior Secured Term Loan to, among other things, consent to entry into the USDA Loan (described within this section), subject to the amended terms and conditions specified for the same in the Fourth Term Loan Amendment. Additionally, the principal amortization schedule was modified as follows: (1) Commencing on December 31, 2020, required quarterly principal payment of $1,250 until September 30, 2025 (2) Additional principal payment of $2,500 on May 31, 2021 (3) Principal payment of $2,500 on September 30, 2021, subject to certain conditions as defined in the Fourth Term Loan Amendment The Company accounted for the Second Term Loan Amendment and Fourth Term Loan Amendment as a troubled debt restructuring under ASC 470-60, Troubled Debt Restructurings by Debtors As of December 31, 2020, the outstanding principal balance of the Senior Secured Term Loan was $246,250, of which $10,000 was due within one year from the balance sheet date. ABL Credit Facility On May 7, 2019, the Company, USWS LLC, and all the other subsidiaries of the Company entered into a $75,000 ABL Credit Agreement (the “ABL Credit Facility”) with the lenders party thereto and Bank of America, N.A., as the administrative agent, swing line lender and letter of credit issuer. The ABL Credit Facility had original maturity date of February 6, 2024. The ABL Credit Facility is subject to a borrowing base which is calculated based on a formula referencing the eligible accounts receivables of the Borrower. Borrowings under the ABL Credit Facility bear interest at LIBOR, plus an applicable LIBOR rate margin of 1.5% to 2.0% or base rate margin of 0.5% to 1.0% as defined in the ABL Credit Facility. The unused portion of the ABL Credit Facility is subject to an unused commitment fee of 0.250% to 0.375%. The Company recorded the related debt issuance costs amounting to $1,205 as part of deferred financing costs, net in the consolidated balance sheets, and records the amortization as interest expense ratably over the term of the ABL Credit Facility. All borrowings under the ABL Credit Facility are subject to the satisfaction of customary conditions, including the absence of a default and the accuracy of representations and warranties and certifications regarding sales of certain inventory, and to a borrowing base (described above). In addition, the ABL Credit Facility includes a springing consolidated fixed charge coverage ratio of 1.00 to 1.00 but only when a financial covenant trigger period is in effect as defined in the ABL Credit Facility. Borrowings under the ABL Credit Facility are fully and unconditionally guaranteed jointly and severally by the Company and its subsidiaries, other than future unrestricted subsidiaries. In April, August, and November of 2020, the Company, USWS LLC, and all the other subsidiaries of the Company entered into the First Amendment (the “First ABL Amendment”), Second Amendment (the “Second ABL Amendment”), and Third Amendment (the “Third ABL Amendment”), respectively, to the ABL Credit Facility with the lenders party thereto and Bank of America, N.A., as the administrative agent, swing line lender and letter of credit issuer. Pursuant to the First ABL Amendment, the aggregate revolving commitment under the ABL Credit Facility was reduced from $75,000 to $60,000, the maturity date was extended to April 1, 2025, and the interest rate margin applicable to borrowings under the ABL Credit Facility was increased by 0.50% per annum and a LIBOR floor of 1% was added. In addition, the borrowing base under the ABL Credit Facility was amended to include a FILO Amount (as defined in the ABL Amendment) which increases borrowing base availability by up to the lesser of (i) $4.0 million and (ii) 5.0% of the value of eligible accounts receivable, subject to scheduled monthly reductions. Loans under the ABL Credit Facility which are advanced in respect of the FILO Amount accrue interest at a rate that is 1.50% higher than the rate applicable to other loans under the ABL Credit Facility, and may be repaid only after all other loans under the ABL Credit Facility have been repaid. Pursuant to the Second ABL Amendment, the aggregate revolving commitment under the ABL Credit Facility was reduced from $60,000 to $50,000 and certain modifications were made to eligible accounts in the borrowing base and to the applicable thresholds in the cash dominion trigger period and financial covenant trigger period, among other things. The Company’s option to request an increase in commitments under the accordion feature was also removed under the terms of the Second ABL Amendment. Pursuant to the Third ABL Amendment, the lenders agreed to make certain modifications and amendments to the ABL Credit Facility to, among other things, consent to entry into the USDA Loan (described within this section). Based on ASC 470-50, Modifications and Extinguishments The Paycheck Protection Program (PPP) Loan In July 2020, the Company received an unsecured loan (the “PPP Loan”) amounting to $10,000 that bears interest at a rate of 1.0% per annum and matures in five years under the Paycheck Protection Program from a commercial bank. The Paycheck Protection Program was established under the Coronavirus Aid, Relief and Economic Security Act (as amended, the “CARES Act”) and is administered by the U.S. Small Business Administration. Under the terms of the CARES Act, loan recipients can apply for and be granted forgiveness for all or a portion of the loan. Forgiveness is determined, subject to certain limitations, based on the use of the loan proceeds for payroll costs, interest on mortgages or other debt obligations, rents and utilities. At least 60% of the proceeds must be used for payroll costs. No assurance can be given that the Company will obtain forgiveness of the PPP Loan either in whole or in part. Accordingly, the Company accounted for the PPP Loan as part of long-term debt in the consolidated balance sheets. USDA Loan On November 12, 2020, the Company, USWS LLC, and USWS Holdings entered into a Business Loan Agreement (the “USDA Loan”) with a commercial bank pursuant to the United States Department of Agriculture (“USDA”), Business & Industry Coronavirus Aid, Relief, and Economic Security Act Guaranteed Loan Program, in the aggregate principal amount of up to $25,000 for the purpose of providing long-term financing for eligible working capital. The USDA loan bears interest of 5.75% per annum and is payable according to the following schedule: (1) 36 monthly consecutive interest payments, beginning on December 12, 2020 (2) 83 monthly consecutive principal and interest payments beginning December 12, 2023 (3) One final principal and interest payment of the remaining due on November 12, 2030 The Company recorded the related debt discount and debt issuance costs amounting to $506 and $558, respectively, as a direct deduction to the face amount of the USDA Loan and records the amortization of debt discount and debt issue costs to interest expense based on the effective interest rate method over the term of the USDA Loan. The USDA Loan is secured by specific equipment collateral and is guaranteed by the USDA for up to 90% of the total proceeds. The USDA Loan is subject to certain financial covenants. The Company is required to maintain a Debt Service Coverage Ratio (as defined in the USDA Loan) of not less than 1.25:1, to be monitored annually, beginning in calendar year 2021. Additionally, the Company is required to maintain a Debt to Net Worth Ratio (as defined in the USDA Loan) of not more than 9:1, to be monitored annually based upon year-end financial statements beginning in calendar year 2022. As of December 31, 2020, the outstanding principal balance of the USDA Loan was $21,996, presented as long-term debt in the consolidated balance sheets. In January 2021, the Company received the remaining principal amount of $3,004. Equipment Financing In March 2020, the Company entered into an agreement to consolidate various individual equipment financing agreements, which represented substantially all our equipment financing notes, into four notes. The new notes are held by the same lender as the original equipment financing agreements. The amendments under the consolidated equipment financing agreements pertain to maturity date, interest rate, and date of first installment payment. The Company evaluated the debt modification in accordance with ASC 470-50 and concluded that the debt modification did not result in a substantially different debt, and accordingly, no gain or loss was recorded. The total outstanding balance of the consolidated equipment financing agreements as of December 31, 2020 was $12,866, payable in equal monthly installments through May 1, 2024, at an interest rate of 5.7%. The weighted average interest rate of amounts outstanding under the equipment financing agreements was 5.7% and 6.4% per annum as of December 31, 2020 and December 31, 2019, respectively. Payments of Debt Obligations due by Period Presented below is a schedule of the repayment requirements of long-term debt as of December 31, 2020: Principal Amount of Long-term Debt 2021 $ 13,573 2022 10,017 2023 9,203 2024 9,397 2025 256,503 Thereafter 16,358 Total $ 315,051

Mezzanine Equity

Mezzanine Equity	12 Months Ended
	Dec. 31, 2020
Temporary Equity Disclosure [Abstract]
MEZZANINE EQUITY	NOTE 12 – MEZZANINE EQUITY (As Restated) Series A Redeemable Convertible Preferred Stock The following table summarizes the Company’s Series A Redeemable Convertible Preferred Stock, par value $0.0001 per share (“Series A preferred stock”) activities for the year ended December 31, 2020: Shares Amount (As Restated) Series A preferred stock as of December 31, 2019 55,000 $ 35,591 Deemed and imputed dividends on Series A preferred stock - 13,022 Accrued Series A preferred stock dividends - 7,214 Conversion of Series A preferred stock to Class A common stock (5,000 ) (4,852 ) Series A preferred stock as of December 31, 2020 50,000 $ 50,975 The Company is authorized to issue up to 10,000,000 shares of preferred stock, par value $0.0001 per share. On May 23, 2019, the Company entered into a Purchase Agreement (the “Purchase Agreement”) with certain institutional investors (collectively, the “Purchasers”) to issue and sell in a private placement 55,000 shares of Series A preferred stock, which was a newly created series of convertible redeemable preferred stock of the Company, for an aggregate purchase price of $1,000 per share, for total gross proceeds of $55,000. At the initial closing on May 24, 2019 (“Closing Date”), the Purchasers purchased all the Series A preferred stock and 2,933,333 initial warrants exercisable for shares of Class A common stock. Subject to there being Series A preferred stock outstanding, the Company will issue an additional 4,399,992 warrants to the Purchasers in quarterly installments of 488,888 warrants beginning nine months after the Closing Date. Crestview III USWS, L.P. and Crestview III USWS TE, LLC, two of the Purchasers, are part of an affiliate group which, prior to the Closing Date, held an aggregate 29.80% ownership interest in the Company and is entitled to designate for nomination by the Company for election two directors to serve on the Company’s Board of Directors. During the year ended December 31, 2020, the Company issued 1,911,108 additional warrants to the Purchasers. Holders of shares of Series A preferred stock are entitled to receive cumulative dividends, compounding and accruing quarterly in arrears, from the Closing Date until the second anniversary of the Closing Date, at an annual rate of 12.0%, and thereafter, 16% of the stated value of $1,000 per share, subject to increase in connection with the payment of dividends in kind. Dividends are payable, at the Company’s option, in cash from legally available funds or in kind by increasing the stated value of the outstanding Series A preferred stock by the amount per share of the dividend on February 24, May 24, August 24, and November 24 of each year. During the year ended December 31, 2020, the Company’s Board of Directors did not declare a dividend on the Series A preferred stock resulting in the dividends for these periods being paid-in-kind in accordance with the Series A preferred stock’s Certificate of Designations. The Series A preferred stock is redeemable by the Company at any time for cash equal to the stated value per share on the date of redemption, except for a redemption occurring prior to the nine-month anniversary of the Closing Date, in which case the redemption price shall be $1,092.73 per share. If the Company notifies the holders that it has elected to redeem the Series A preferred stock, the holder may instead elect to convert such shares into Class A common stock. If the Company funds the redemption with proceeds of an equity offering within one year of the Closing Date, then any converting shares will convert at a ratio that is based on the higher of the price to the public in the offering or the ordinary conversion price of $6.67. Otherwise, such converting shares will convert by reference to the ordinary conversion price. In any event, the Series A preferred stock converting in response to a redemption notice will net settle for a combination of cash and Class A common stock. Following the first anniversary of the Closing Date, each holder of Series A preferred stock may convert all or any portion of its shares of Series A preferred stock into Class A common stock based on the then-applicable liquidation preference at a conversion price of $6.67, subject to anti-dilution adjustments, at any time, but not more than once per quarter, so long as any conversion is for an underlying conversion value of Class A Common Stock of at least $1,000. The Company has the option to force a conversion of any then outstanding shares of Series A preferred stock following the third anniversary of the Closing Date, and contingent upon (i) the closing price of the Company’s Class A common stock being greater than 130% of the Conversion Price for 20 trading days during any 30-day consecutive trading day period, (ii) the average daily trading volume of the Class A common stock exceeding 250,000 for 20 trading days and (iii) the Company having an effective registration statement on file with the Securities and Exchange Commission (“SEC”) covering resales of the underlying Class A common stock to be received upon such conversion. On the Closing Date, the Company estimated the fair value of the warrants at $12,786 using the Black-Scholes option pricing model using the following primary assumptions: contractual term of 6.5 years, volatility rate of 53.0%, risk-free interest rate of 2.2% and expected dividend rate of 0%. The fair value of $12,786 was allocated to the warrants, creating a corresponding preferred stock discount in the same amount. Due to the reduction of allocated proceeds to Series A preferred stock, the effective conversion price was approximately $5.40 per share creating a beneficial conversion feature of $22,104 which further reduced the carrying value of the Series A preferred stock. Since the holders’ conversion option of the Series A preferred stock could only be exercisable after the first anniversary of the Closing Date, the discount resulting from the beneficial conversion feature was accreted over one year as deemed preferred dividends using the effective yield method, resulting in a corresponding increase in the carrying value of the Series A preferred stock over the same time period. The Series A preferred stock had similar characteristics of an “Increasing Rate Security” as described by SEC Staff Accounting Bulletin Topic 5Q, Increasing Rate Preferred Stock. As a result, the discount on Series A preferred stock is considered an unstated dividend cost that is amortized over the period preceding commencement of the perpetual dividend using the effective interest method, by charging imputed dividend cost against retained earnings, or additional paid in capital in the absence of retained earnings, and increasing the carrying amount of the Series A preferred stock by a corresponding amount. The discount is therefore being amortized over two years using the effective yield method. The amortization in each period is the amount which, together with the stated dividend in the period, results in a constant rate of effective cost with regard to the carrying amount of the Series A preferred stock. The Series A preferred stock was recorded as Mezzanine Equity, net of issuance cost, on the consolidated balance sheets because it has redemption features upon certain triggering events that are outside the Company’s control, such as change in control. The Company accounted for the warrants as a liability measured at fair value upon issuance, with subsequent changes in fair value reported in the Company’s consolidated statement of operations each reporting period. During the year ended December 31, 2020, one of the Purchasers converted 5,000 shares of Series A preferred stock and accrued dividends into 876,448 shares of Class A common stock pursuant to the certificate of designations authorizing and establishing the rights, preferences, and privileges of the Series A preferred stock. Accordingly, the Company recorded a reduction of $4,852 in the carrying value of the Series A preferred stock. On December 31, 2020, there were 50,000 shares of Series A preferred stock outstanding and convertible into 9,146,254 shares of Class A common stock, and dividends accrued and outstanding with respect to the Series A preferred stock were $11,264 and reflected in the carrying value of Series A preferred stock. Series B Redeemable Convertible Preferred Stock The following table summarizes the Company’s Series B Redeemable Convertible Preferred Stock, par value $0.0001 per share (“Series B preferred stock”) activities for the year ended December 31, 2020: Shares Amount Series B preferred stock as of December 31, 2019 $ - $ - Proceeds from issuance of Series B preferred stock 21,000 21,000 Issuance of Series B preferred stock to senior secured term loan lenders 1,050 1,050 Issuance cost associated with Series B preferred stock - (1,413 ) Accrued Series B preferred stock dividends - 2,049 Series B preferred stock as of December 31, 2020 22,050 $ 22,686 On March 31, 2020, the Company entered into a purchase agreement with certain institutional investors (collectively, the “Series B Purchasers”), pursuant to which the Company agreed to issue and sell in a private placement 21,000 shares of Series B preferred stock, for an aggregate purchase price of $21,000. On April 1, 2020 (the “Series B Closing Date”), the Series B Purchasers purchased the Series B preferred stock. Two of the Series B Purchasers were affiliates of Crestview Partners, which held, prior to the issuance, an aggregate 36.67% ownership interest in the Company and is entitled to designate for nomination by the Company for election two directors to serve on the Company’s Board of Directors. The Series B preferred stock ranks senior to the Class A common stock and Class B common stock and in parity with the Series A preferred stock, with respect to distributions. The Series B preferred stock has only specified voting rights, including with respect to the issuance or creation of senior securities, amendments to the Company’s Second Amended and Restated Certificate of Incorporation that negatively impact the rights of the Series B preferred stock and the payment of dividends on, or repurchase or redemption of, Class A common stock. Holders of the Series B Preferred Shares will receive distributions of 12.00% per annum on the then-applicable liquidation preference until May 24, 2021 and 16.00% per annum on the liquidation preference thereafter. Distributions are not required to be paid in cash and, if not paid in cash, will automatically accrue and be added to the liquidation preference. The Company has the option, but no obligation, to redeem the Series B preferred stock for cash. If the Company notifies the holders that it has elected to redeem the Series B preferred stock, a holder may instead elect to convert its shares of Series B preferred stock at the specified conversion price, which is initially $0.308 per share. The Series B preferred stock converted in response to a redemption notice will net settle for a combination of cash and Class A common stock. Each holder of Series B preferred stock may convert all or any portion of its Series B preferred stock into Class A common stock based on the then-applicable liquidation preference, subject to anti-dilution adjustments, at any time, but not more than once per quarter, so long as any conversion is for at least $1,000 based on the liquidation preference on the date of the conversion notice. Following the eighteen-month anniversary of the Series B Closing Date, the Company may cause the conversion of all or any portion of the Series B preferred stock into Class A common stock if (i) the closing price of the Class A common stock is greater than 130% of the conversion price for 20 days over any 30-day trading period; (ii) the average daily trading volume of the Class A common stock exceeded 250,000 for 20 days over any 30-day trading period; and (iii) the Company has an effective registration statement on file with the SEC covering resales of the underlying Class A common stock to be received upon such conversion. The Series B preferred stock was recorded as Mezzanine Equity, net of issuance cost, on the consolidated balance sheets because it has redemption features upon certain triggering events that are outside the Company’s control, such as change in control. On December 31, 2020, there were 22,050 shares of Series B preferred stock outstanding and convertible into 78,245,727 shares of Class A common stock, and dividends accrued and outstanding with respect to the Series B preferred stock was $2,049 and reflected in the carrying value of Series B preferred stock. In February 2021, 762 shares of Series B preferred stock were converted into 2,745,778 shares of Class A common stock.

Stockholders' Equity

Stockholders' Equity	12 Months Ended
	Dec. 31, 2020
Equity [Abstract]
Stockholders' Equity	NOTE 13 – STOCKHOLDERS’ EQUITY (As Restated) Shares Authorized and Outstanding Preferred Stock The Company is authorized to issue 10,000,000 shares of preferred stock with a par value of $0.0001 per share with such designation, rights and preferences as may be determined from time to time by the Company’s Board of Directors. The Company adopted and filed with the Secretary of State of the State of Delaware each of the Certificate of Designations for the Series A preferred stock and the Series B preferred stock as amendments to the Company’s Second Amended and Restated Certificate of Incorporation (as amended, the “Charter”) each on May 24, 2019 and March 31, 2020, to authorize and establish the rights, preferences and privileges of the Series A preferred stock and Series B preferred stock, respectively. See “Note 12 – Mezzanine Equity” for the discussion of preferred stock issued and outstanding. Class A Common Stock The Company is authorized to issue 400,000,000 shares of Class A common stock with a par value of $0.0001 per share. On December 31, 2020 and December 31, 2019, there were 72,515,342 and 62,857,624 shares of Class A common stock issued and outstanding, respectively. At December 31, 2020, 1,000,000 outstanding shares of Class A common stock were subject to cancellation on November 9, 2024, unless the closing price per share of the Class A common stock has equaled or exceeded $12.00 for any 20 trading days within any 30-trading day period, and 609,677 outstanding shares of Class A common stock were subject to the same cancellation provision, but at a closing price per share of $13.50. On June 26, 2020, the Company entered into an Equity Distribution Agreement (the “ATM Agreement”) with Piper Sandler & Co. relating to the Company’s shares of Class A common stock. In accordance with the terms of the ATM Agreement, the Company may offer and sell over a period, up to $10,275 of our Class A common stock. The ATM Agreement relates to an “at-the-market” offering program. Under the ATM Agreement, the Company will pay Piper Sandler an aggregate commission of up to 3% of the gross sales price per share of Class A common stock sold under the ATM Agreement. The Company sold 792,258 shares of Class A common stock for total net proceeds of $400 under this ATM Agreement as of December 31, 2020. The Company paid $12 in commissions with respect to this sale. In January 2021, we sold an additional 8,340,608 shares of Class A common stock for a total net proceeds of $5,679, after payment of $176 in commissions. Class B Common Stock The Company is authorized to issue 20,000,000 shares of Class B common stock with a par value of $0.0001 per share. The shares of Class B common stock are non-economic; however, holders are entitled to one vote per share. Each share of Class B common stock, together with one unit of USWS Holdings, is exchangeable for one share of Class A common stock or, at the Company’s election, the cash equivalent to the market value of one share of Class A common stock. During the year ended December 31, 2020, 3,197,756 shares of Class B common stock were converted to an equivalent number of shares of Class A common stock. As of December 31, 2020 and 2019, there were 2,302,936 and 5,500,692 shares, respectively, of Class B common stock issued and outstanding. Noncontrolling Interest The Company’s noncontrolling ownership interest in consolidated subsidiaries is presented in the consolidated balance sheet within stockholders’ equity (deficit) as a separate component and represents approximately 3% ownership of USWS Holdings as of December 31, 2020. Long-Term Incentive Plan Pursuant to the U.S. Well Services, Inc. 2018 Stock Incentive Plan (the “LTIP”), there were an aggregate 8,160,500 shares of Class A common stock initially made available for issuance under the LTIP. On November 5, 2020, pursuant to the Amended and Restated U.S. Well Services, Inc. 2018 Stock Incentive Plan (the “A&R LTIP”), the Company made grants of deferred stock units and performance incentive awards to certain key employees of the Company. The A&R LTIP, which was approved by the Board of Directors, upon the recommendation of the Compensation Committee of the Board of Directors on September 1, 2020, is expected to be included in the Company’s Proxy Statement for its 2021 Annual Meeting of Stockholders for approval by the Company’s stockholders. Shares issued under the LTIP and A&R LTIP are further discussed in “Note 15 - Share-Based Compensation”. There were no shares available for issuance under the LTIP as of December 31, 2020.

Earnings (Loss) Per Share

Earnings (Loss) Per Share	12 Months Ended
	Dec. 31, 2020
Earnings Per Share [Abstract]
Earnings (Loss) Per Share	NOTE 14 – EARNINGS (LOSS) PER SHARE (As Restated) Basic earnings (loss) per share is computed by dividing income (loss) available to common stockholders by the weighted average number of common shares outstanding during the period. Diluted earnings per share is computed in the same manner as basic earnings per share except that the denominator is increased to include the number of additional common shares that could have been outstanding assuming the exercise of stock options, exercise of warrants, conversion of Series A and Series B preferred stock, conversion of Class B common stock, vesting of restricted shares of Class A common stock, and issuance of Class A common stock associated with the deferred stock units and certain performance awards. Basic and diluted net income (loss) per share excludes the income (loss) attributable to and shares associated with the 1,609,677 Class A shares that are subject to cancellation on November 9, 2024 if certain market conditions have not been met. The Company included in the calculation accrued dividends on Series A and Series B preferred stock and related deemed and imputed dividends. The following table sets forth the calculation of basic and diluted earnings (loss) per share for the periods indicated based on the weighted average number of shares of Class A common stock outstanding for the period: Years Ended December 31, 2020 (As Restated) 2019 (As Restated) Basic Net Income (Loss) Per Share Numerator: Net loss attributable to U.S. Well Services, Inc. $ (229,340 ) $ (81,810 ) Net loss attributable to cancellable Class A shares 5,560 2,540 Basic net loss attributable to U.S. Well Services, Inc. shareholders (223,780 ) (79,270 ) Dividends accrued on Series A preferred stock (7,214 ) (4,050 ) Dividends accrued on Series B preferred stock (2,049 ) - Deemed and imputed dividends on Series A preferred stock (13,022 ) (11,796 ) Deemed dividends on Series B preferred stock (564 ) - Basic net loss attributable to U.S. Well Services, Inc. common shareholders $ (246,629 ) $ (95,116 ) Denominator: Weighted average shares outstanding 66,400,924 51,853,183 Cancellable Class A common stock (1,609,677 ) (1,609,677 ) Basic and diluted weighted average shares outstanding 64,791,247 50,243,506 Basic and diluted net income (loss) per share attributable to Class A shareholders $ (3.81 ) $ (1.89 ) A summary of securities excluded from the computation of diluted earnings per share is presented below for the applicable periods: Years Ended December 31, 2020 2019 Diluted earnings per share: Anti-dilutive stock options 877,266 1,068,162 Anti-dilutive warrants 14,428,150 15,680,651 Anti-dilutive restricted stock 1,449,287 2,723,637 Anti-dilutive deferred stock units 8,911,858 - Anti-dilutive Pool B awards 10,142,494 - Anti-dilutive Class B common stock convertible into Class A common stock 2,302,936 5,500,692 Anti-dilutive Series A preferred stock convertible into Class A common stock 9,058,176 8,853,028 Anti-dilutive Series B preferred stock convertible into Class A common stock 78,245,727 - Potentially dilutive securities excluded as anti-dilutive 125,415,894 33,826,170

Share-based Compensation

Share-based Compensation	12 Months Ended
	Dec. 31, 2020
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Share-based Compensation	NOTE 15 – SHARE-BASED COMPENSATION Share-based compensation expense consisted of the following: Years Ended December 31, 2020 2019 Restricted stock $ 4,719 $ 6,496 Unrestricted stock - 418 Stock options 905 841 DSUs 984 - Pool A awards 2,328 - Pool B awards 1,120 - Total $ 10,056 (1) $ 7,755 (2) (1) administrative expenses in the consolidated statement of operations. (2) administrative expenses in the consolidated statement of operations. Restricted Stock The following table summarizes restricted stock activity in 2020: Number of shares Weighted- average grant-date fair value (per share data) Non-vested restricted stock as of December 31, 2019 2,723,637 $ 8.87 Granted - - Vested (690,237 ) 8.87 Forfeited (584,113 ) 8.91 Non-vested restricted stock as of December 31, 2020 1,449,287 $ 8.85 In 2019, the Company granted shares of restricted Class A common stock (“restricted stock”) totaling 2,218,183 to certain employees of the Company pursuant to the LTIP. Restricted stock is subject to restrictions on transfer and is generally subject to a risk of forfeiture if the award recipient is no longer an employee of the Company prior to the lapse of the restriction. The restricted stock granted in 2019 had a total fair value of $19,764 and vests over four years in equal installments each year on the anniversary of the grant date. The fair value of the restricted stock granted in 2019 was determined using the closing price of the Company’s Class A common stock on the grant date. As of December 31, 2020, the total unrecognized compensation cost related to restricted stock was $7,345 which is expected to be recognized over a weighted-average period of 2.15 years. Unrestricted stock In 2019, the Company granted 46,875 shares of fully vested and unrestricted Class A common stock (“unrestricted stock”) under the LTIP to certain board members in exchange for their services as a director of the Company, in accordance with the existing compensation plan of the Board of Directors. The fair value of the unrestricted stock was $8.91 per share, which was determined using the closing price of the Company’s Class A common stock on the grant date. Stock options The following table summarizes stock option activity in 2020: Number of shares Weighted average exercise price (per share data) Weighted Average Remaining Contractual Life (years) Outstanding as of December 31, 2019 1,068,162 $ 8.91 6.21 Granted - $ - - Exercised - - - Forfeited/Expired (190,896 ) 8.91 - Outstanding as of December 31, 2020 877,266 $ 8.91 5.21 Exercisable as of December 31, 2020 219,317 $ 8.91 5.21 In 2019, the Company granted a total of 1,068,162 stock options under the LTIP to certain employees of the Company. The fair value of stock options on the date of grant was $3.95 per option, which was calculated using the Black-Scholes valuation model. These stock options were granted with seven-year As of December 31, 2020, the total unrecognized compensation cost related to stock options was $1,906 which is expected to be recognized over a weighted average period of 2.21 years. Deferred Stock Units In 2020, the Company granted 8,911,858 Deferred Stock Units (“DSUs”) to certain key employees of the Company pursuant to the A&R LTIP. Each DSU represents the right to receive one share of the Company’s Class A common stock. DSUs granted in 2020 had total fair value of $ 2,954 , which was determined using the closing price of Class A common stock on each grant date. DSUs vest over three years in equal installments each year on the anniversary of the vesting effective date , subject to the grantee’s continuous service through each vesting period. As of December 31, 2020, the total unrecognized compensation cost related to DSUs was $1,969 which is expected to be recognized over a weighted average period of 2 years. Pool A Performance Award In 2020, the Company made grants of Pool A Performance Awards (“Pool A Award”) to certain key employees of the Company. Each Pool A Award represents the right to receive, at the Company’s election, a fixed monetary amount either in cash or a variable number of shares of the Company’s Class A common stock based on its closing share price on the date of settlement. The Pool A Award became fully vested as of January 1, 2021 but settlement will not occur until the fifth anniversary of the grant date. The Company accounts for the Pool A Award under liability accounting as a result of the fixed monetary amount that could be settled either in cash or a variable number of shares of the Company’s Class A common stock. The Company considers the delayed settlement as a post-vesting restriction which would impact the determination of grant-date fair value of the award. The Pool A Award granted in 2020 had a total fair value of $2,328, which was estimated using a risk-adjusted discount rate, which reflects the weighted average cost of capital of similarly traded public companies. As of December 31, 2020, we recorded Pool A Award liability of $2,328, presented as part of other long-term liabilities in the consolidated balance sheets. Subsequent changes in the fair value of the liability from December 31, 2020 through the date of settlement will be recorded as additional compensation cost. Pool B Performance Award In 2020, the Company made grants of Pool B Performance Awards (“Pool B Award”) to certain key employees of the Company. Each Pool B Award represents the right to receive, at the Company’s election, either a cash payment calculated in accordance with the award agreement, or a fixed number of shares of the Company’s Class A common stock. The Pool B Award granted in 2020 had total fair value of $3,362, which was determined using the closing price of Class A common stock on each grant date. The Pool B Award vests over three years in equal installments each year on the anniversary of the vesting effective date, subject to the grantee’s continuous services through each vesting period. As of December 31, 2020, the total unrecognized compensation cost related to Pool B Award was $2,241, which is expected to be recognized over a weighted average period of 2 years.

Employee Benefit Plan

Employee Benefit Plan	12 Months Ended
	Dec. 31, 2020
Compensation And Retirement Disclosure [Abstract]
Employee Benefit Plan	NOTE 16 – EMPLOYEE BENEFIT PLAN On March 1, 2013, the Company established the U.S. Well Services 401(k) Plan. The Company matched 100% of employee contributions up to 6% of the employee’s salary, subject to cliff vesting after two years of service. At the end of the first quarter of 2020, the Company suspended its match of employee contributions. Our matching contributions were $976 and $3,843 for the years ended December 31, 2020 and 2019, respectively, and included in cost of services and selling, general and administrative expenses in the statements of operations.

Income Taxes (As Restated)

Income Taxes (As Restated)	12 Months Ended
	Dec. 31, 2020
Income Tax Disclosure [Abstract]
Income Taxes (As Restated)	NOTE 17 – INCOME TAXES (As Restated) The Company’s net deferred tax assets are as follows: December 31, Deferred Tax Assets 2020 (As Restated) 2019 Net Operating Loss Carryforward $ 56,815 $ 30,485 Startup/Organization Expenses 177 163 Investment in Partnership 70,244 19,489 Interest Expense 1,652 911 Attributes/Other 137 186 Total Deferred Tax Assets 129,025 51,234 Less Valuation Allowance (129,025 ) (51,234 ) Total Deferred Tax Assets, net $ - $ - Deferred Tax Liabilities - - Net Deferred Tax Assets $ - $ - The income tax provision consists of the following: Years ended December 31, Current 2020 2019 Federal $ (757 ) $ - State (67 ) (77 ) Total Current (824 ) (77 ) Deferred Federal - - State - - Total Deferred - - Total $ (824 ) $ (77 ) A reconciliation of the federal income tax rate to the Company’s effective tax rate at December 31, 2020 is as follows (As Restated): Pre-tax book loss $ 241,212 Federal Provision (Benefit) (50,656 ) -21.00 % Noncontrolling Interest (14,259 ) -5.91 % Permanent Differences 501 0.21 % State Income Taxes, net of Federal Benefit (53 ) -0.02 % NOL Carryback, effect of rate change (289 ) -0.12 % Return to Provision, Other 1,846 0.76 % Valuation Allowance 62,086 25.74 % Total Provision (Benefit) $ (824 ) -0.34 % As of December 31, 2020, the Company had total U.S. federal net operating loss ("NOL") carryforwards of $240,463 and state NOLs of $277,305 available to offset future taxable income. $28,387 of the federal NOLs would begin to expire in 2036 if unused. Federal NOLs generated after December 31, 2017 do not expire and the state rules vary by state. After consideration of all the information available, management has established a valuation allowance against the deferred tax assets of the Company's tax loss carryforwards to the extent it is not more likely than not they will be realized. As of December 31, 2020, the valuation allowance totaled $129,025. In assessing the realization of the deferred tax assets, management considers whether it is more likely than not that some portion of all the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which temporary differences representing net future deductible amounts become deductible. Management considers the positive and negative evidence with respect to sources of taxable income for purposes of determining the realization of deferred tax assets. In accordance with Section 382 of the Internal Revenue Code, deductibility of the Company’s NOLs may be subject to an annual limitation in the event of a change in control as defined under the regulations. The Company files income tax returns in the U.S. federal jurisdiction and various state and local jurisdictions and is subject to examination by the taxing authorities. We follow guidance issued by the Financial Accounting Standards Board (“FASB”) in accounting for uncertainty in income taxes. This guidance clarifies the accounting for income taxes by prescribing the minimum recognition threshold an income tax position is required to meet before being recognized in the consolidated financial statements and applies to all income tax positions. Each income tax position is assessed using a two-step process. A determination is first made as to whether it is more likely than not that the income tax position will be sustained, based upon technical merits, upon examination by the taxing authorities. If the income tax position is expected to meet the more likely than not criteria, the benefit recorded in the consolidated financial statements equals the largest amount that is greater than 50% likely to be realized upon its ultimate settlement. We have considered our exposure under the standard at both the federal and state tax levels. We did not record any liabilities for uncertain tax positions as of December 31, 2020 or December 31, 2019. We record income tax-related interest and penalties, if any, as a component of income tax expense. We did not incur any material interest or penalties on income taxes.

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2020
Commitments And Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	NOTE 18 – COMMITMENTS AND CONTINGENCIES Litigation Liabilities for loss contingencies arising from claims, assessments, litigation, fines, and penalties, and other sources are recorded when it is probable that a liability has been incurred and the amount can be reasonably estimated. Legal costs incurred in connection with loss contingencies are expensed as incurred. The Company was named a defendant in a case filed on January 14, 2019 in the Superior Court of the State of Delaware styled Smart Sand, Inc. v. U.S. Well Services LLC In addition to the case noted above, the Company is involved in various pending or potential legal actions in the ordinary course of business. Management is unable to predict the ultimate outcome of these actions because of the inherent uncertainty of litigation. However, management believes that the most probable, ultimate resolution of the remaining matters will not have a material adverse effect on our consolidated financial position, results of operations or cash flows. Sand Purchase Agreements The Company entered into agreements for the supply of proppant for use in its hydraulic fracturing operations. Under the terms of these agreements, the Company is subject to minimum purchase quantities on a monthly, quarterly, or annual basis at fixed prices or may pay penalties in the event of any shortfall. As of December 31, 2020, we estimated and accrued for a shortfall in quantities. This accrual is presented as part of accrued liabilities on the consolidated balance sheets. As of December 31, 2020, the Company’s contracted volumes in dollars was $16,002. The Company’s minimum commitments was $13,393, which represents the aggregate amounts that we would be obligated to pay if we procured no additional proppant under the contracts after December 31, 2020. Operating Lease Agreements The Company has various operating leases for facilities with terms ranging from 24 to 76 months. Rent expense was $2,359 and $2,646 for the years ended December 31, 2020 and 2019, respectively, of which $1,655 and $2,130, respectively, are recorded as part of cost of services and $704, and $516, respectively, are recorded as part of selling, general and administrative expenses in the consolidated statements of operations. The following is a schedule of future minimum payments on non-cancellable operating leases as of December 31, 2020: 2021 $ 1,114 2022 828 2023 308 2024 258 2025 67 Thereafter - Total future minimum rentals $ 2,575 On April 1, 2020, the Company entered into an agreement to extend the lease on one of its facilities. The extended term of the lease is for a period of 36 months commencing on April 1, 2020, with rent throughout the term totaling $0.7 million. Self-insurance The Company establishes a self-insured plan for employees’ healthcare benefits except for losses more than varying threshold amounts. The Company charges to expense all actual claims made during each reporting period, as well as an estimate of claims incurred, but not yet reported. The amount of estimated claims incurred, but not reported as of December 31, 2020 and 2019 was $189 and $588, respectively, and was reported as accrued expenses in the consolidated balance sheets. We believe that the liabilities we have recorded are appropriate based on the known facts and circumstances and do not expect further losses materially more than the amounts already accrued for existing claims.

Related Party Transactions

Related Party Transactions	12 Months Ended
	Dec. 31, 2020
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	NOTE 19 – RELATED PARTY TRANSACTIONS On May 24, 2019, Crestview Partners purchased 20,000 shares of Series A preferred stock for a total payment of $20,000. Along with the Series A preferred stock, Crestview received 1,066,666 initial warrants with the right to receive additional warrants. During the year ended December 31, 2020, Crestview received 711,112 additional warrants. On April 1, 2020, Crestview Partners purchased 11,500 shares of Series B preferred stock for a total payment of $11,500. The TCW Group, Inc. purchased 6,500 shares of Series B preferred stock for a total payment of $6,500 and David Matlin, a member of the Company’s Board of Directors, purchased 1,878 shares of Series B preferred stock for a total payment of $1,878.

Significant Accounting Polici_2

Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2020
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying consolidated financial statements and related notes have been prepared in conformity with generally accepted accounting principles in the United States of America (“GAAP”) and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Our operations are organized into a single business segment, which consists of hydraulic fracturing services, and we have one reportable geographical business segment, the United States.
Principles of Consolidation	Principles of Consolidation The consolidated financial statements comprise the financial statements of the Company, its wholly owned subsidiaries, and subsidiaries that it controls due to ownership of a majority voting interest. Subsidiaries are fully consolidated from the date of acquisition, being the date on which the Company obtains control, and continue to be consolidated until the date when such control ceases. The financial statements of the subsidiaries are prepared for the same reporting period as the Company. All significant intercompany balances and transactions are eliminated upon consolidation.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. We regularly evaluate estimates and judgments based on historical experience and other relevant facts and circumstances. Significant estimates included in these financial statements primarily relate to allowance for doubtful accounts, allowance for inventory obsolescence, useful lives for depreciation and amortization of property and equipment and intangibles, impairment assessments of goodwill and long-lived assets, Level 2 inputs used in fair value estimation of warrant liabilities, term loans and certain liability-classified share-based compensation, and the assumptions used in our Black-Scholes and Monte Carlo option pricing models associated with the valuation of warrant liabilities, share-based compensation and certain equity instruments. Actual results could differ from those estimates.
Cash and Cash Equivalents	Cash and Cash Equivalents Cash equivalents are highly liquid investments with an original maturity at the date of acquisition of three months or less. Cash and cash equivalents consist of cash on deposit with domestic banks and, at times, may exceed federally insured limits.
Restricted Cash	Restricted Cash Cash and cash equivalents that are restricted as to withdrawal or use under the terms of certain contractual agreements, or are reserved for a specific purpose, that are not readily available for immediate or general use are recorded in restricted cash in our consolidated balance sheets. The restricted cash in our consolidated balance sheet represents cash transferred into a trust account to support our workers’ compensation obligations and cash held for use in approved capital expenditures amounting to $513 and $1,056, respectively, as of December 31, 2020, and $513 and $7,097, respectively, as of December 31, 2019. The following table provides a reconciliation of the amount of cash and cash equivalents reported on the consolidated balance sheets to the total of cash and cash equivalents and restricted cash shown on the consolidated statements of cash flows: As of December 31, 2020 2019 Cash and cash equivalents $ 3,693 $ 33,794 Restricted cash 1,569 7,610 Cash and cash equivalents and restricted cash $ 5,262 $ 41,404
Inventory	Inventory Inventory consists of proppant, chemicals, and other consumable materials and supplies used in our high-pressure hydraulic fracturing operations. Inventories are stated at the lower of cost or net realizable value. Cost is determined principally on a first-in-first-out cost basis. All inventories are purchased and used by the Company in the delivery of its services with no inventory being sold separately to outside parties. Inventory quantities on hand are reviewed regularly and write-downs for obsolete inventory are recorded based on our forecast of the inventory item demand in the near future . As of December 31, 20 20 and 201 9 , the Company ha d established inventory reserves of $ 315 and $ , respectively, for obsolete and slow-moving inventory. The following table shows the change in the inventory reserves: As of December 31, 2020 2019 Balance at beginning of period $ 579 $ 572 Charges to costs and expenses 620 359 Recoveries and write-offs (884 ) (352 ) Balance at end of period $ 315 $ 579
Property and Equipment	Property and Equipment Property and equipment are carried at cost, with depreciation provided on a straight-line basis over their estimated useful lives. Expenditures for renewals and betterments that extend the lives of the assets are capitalized. Amounts spent for maintenance and repairs, which do not improve or extend the life of the related asset, are charged to expense as incurred. The Company separately identifies and accounts for certain critical components of its hydraulic fracturing units including the engine, transmission, and pump, which requires us to separately estimate the useful lives of these components. For our other service equipment, we do not separately identify and track depreciation of specific original components. When we replace components of these assets, we typically estimate the net book values of the components that are retired, which are based primarily upon their replacement costs, their ages, and their original estimated useful lives. In the first quarter of 2020, our review of impairment of long-lived assets (refer to “Note 6 – Goodwill and Intangible Assets”) necessitated a review of the useful lives of our property and equipment. Current trends in hydraulic fracturing equipment operating conditions, such as increasing treating pressures and higher pumping rates, along with the increase in daily pumping time are shortening the useful life of certain critical components we use. We determined that the average useful life of fluid ends and fuel injectors is now less than one year, resulting in our determination that costs associated with the replacement of these components will no longer be capitalized, but instead expensed as they are used in operations. This change in accounting estimate was made effective in March 2020 and accounted for prospectively.
Long-lived Assets	Long-lived Assets Long-lived assets, such as property and equipment and amortizable identifiable intangible assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. When making this assessment, the following factors are considered: current operating results, trends, and prospects, as well as the effects of obsolescence, demand, competition, and other economic factors. We determine recoverability by evaluating whether the undiscounted estimated future net cash flows of the asset or asset group are less than its carrying value. When impairment is indicated, we proceed to Step 2 of the impairment test and measure the impairment as the amount by which the assets carrying value exceeds its fair value. Management considers several factors such as estimated future cash flows, appraisals, and current market value analysis in determining fair value. Assets are written down to fair value if the concluded current fair value is below the net carrying value. Impairment loss on long-lived assets of $147,543 was recorded during the first quarter of 2020 (refer to “Note 6 – Goodwill and Intangible Assets”).
Goodwill	Goodwill Goodwill is not amortized, but is reviewed for impairment annually, or more frequently when events or changes in circumstances indicate that the carrying value may not be recoverable. Judgements regarding indicators of potential impairment are based on market conditions and operational performance of the business. As of December 31 of each year, or as required, the Company performs an impairment analysis of goodwill. The Company may assess its goodwill for impairment initially using a qualitative approach to determine whether conditions exist that indicate it is more likely than not that a reporting unit’s carrying value is greater than its fair value, and if such conditions are identified, then a quantitative analysis will be performed to determine if there is any impairment. The Company may also elect to perform a single step quantitative analysis in which the carrying amount of the reporting unit is compared to its fair value, which the Company estimates using a guideline public company method, a form of the market approach. The guideline public company method utilized the trading multiples of similarly traded public companies as they related to the Company’s operating metrics. An impairment charge would be recognized for the amount by which the carrying amount of the reporting unit exceeds the reporting unit’s fair value, and only limited to the total amount of goodwill allocated to the reporting unit.
Deferred Financing Costs	Deferred Financing Costs Costs incurred to obtain financing are capitalized and amortized to interest expense using the effective interest method over the contractual term of the debt. At the balance sheet date, deferred financing costs related to term loans are presented as a direct deduction from the debt liability, while deferred financing costs related to the revolver facility are presented as deferred financing costs, net, on the consolidated balance sheets.
Warrant Liabilities	Warrant Liabilities The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480, Distinguishing Liabilities from Equity Derivatives and Hedging—Embedded Derivatives The Company issued public warrants and private placement warrants (collectively, the “public and private placement warrants”) in connection with its initial public offering (the “IPO”) in November 2018. Additionally, the Company issued warrants to certain institutional investors in connection with its private placement of Series A Preferred Stock on May 24, 2019 (“Series A warrants,” and together with the public and private placement warrants, the “warrants”). All of our outstanding warrants are recognized as liabilities. Accordingly, we recognize the warrant instruments as liabilities at fair value upon issuance and adjust the instruments to fair value at the end of each reporting period. Any change in fair value is recognized in our consolidated statement of operations. The public warrants are valued using their quoted market price since they are publicly traded and thus had an observable market price. The private placement warrants are valued using a Monte Carlo simulation model. The Series A warrants are valued using the Black-Scholes option pricing model.
Fair Value of Financial Instruments	Fair Value of Financial Instruments Fair value is defined under ASC 820, Fair Value Measurement Level 1–inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2–inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly. Level 3–inputs are unobservable for the asset or liability. The following is a summary of the carrying amounts and estimated fair values of our financial instruments as of December 31, 2020 and December 31, 2019: Senior Secured Term Loan . The fair value of the Senior Secured Term Loan is $198.0 Equipment financing . The carrying value of the equipment financing approximates fair value as its terms are consistent with and comparable to current market rates as of December 31, 2020 and December 31, 2019, respectively. See “Note 9 – Warrant Liabilities” for fair value measurements associated with the Company’s warrants.
Revenue Recognition	Revenue Recognition Effective January 1, 2019, the Company adopted ASC 606, Revenue from Contracts with Customers, Under the standard, revenue recognition is based on the customer’s ability to benefit from the services rendered in an amount that reflects the consideration expected to be received in exchange for those services. Taxes collected from customers and remitted to governmental authorities are accounted for on a net basis and therefore excluded from revenues in the Company’s financial statements. The Company’s revenues consist of providing hydraulic fracturing services for either a pre-determined term or number of stages/wells to E&P companies operating in the onshore oil and natural gas basins of the United States. In the performance of these services, and at the request of our customers, we may also provide consumables such as chemicals and sand. Revenues are earned as services are rendered, which is generally on a per stage or daily rate basis. Customers are invoiced according to contract terms upon the completion of a well or monthly with payment due typically 30 days from invoice date. Hydraulic fracturing is a well-stimulation technique intended to optimize hydrocarbon flow paths during the completion phase of wellbores. The process involves the injection of water, sand, and chemicals under high pressure into shale formations. The Company’s performance obligations are satisfied over time, typically measured in number of stages completed or the number of pumping days a fleet is available to pump for a customer in a month. A field ticket is created for each stage completed that records all services performed, including any chemicals and proppant we provided and consumed in completing the stage. The field ticket is signed by a customer representative and evidences the amounts to which the Company has a right to invoice and thus to recognize as revenue. All revenue is recognized when a contract with a customer exists, collectability of amounts subject to invoice is probable, the performance obligations under the contract have been satisfied over time, and the amount to which the Company has the right to invoice has been determined. A portion of the Company’s contracts contain variable consideration; however, this variable consideration is typically unknown at the time of contract inception, and is not known until the job is complete, at which time the variability is resolved. The Company has elected to use the “as invoiced” practical expedient to recognize revenue based upon the amount it has a right to invoice upon the completion of each performance obligation per the terms of the contract. The practical expedient permits an entity to recognize revenue in the amount to which it has a right to invoice the customer if that amount corresponds directly with the value to the customer of the entity’s performance completed to date. The Company believes that this is an accurate reflection of the value transferred to the customer as each incremental obligation is performed. The Company has elected to expense sales commissions paid upon the successful signing of a new customer contract as incurred if the related contract will be fully satisfied within one year. For contracts that will not be fully satisfied within one year, these incremental costs of obtaining a contract with a customer will be recognized as a contract asset and amortized on a straight-line basis over the life of the contract.
Accounts Receivable	Accounts Receivable Accounts receivable are recorded at their outstanding balances adjusted for an allowance for doubtful accounts. The allowance for doubtful accounts is determined by analyzing the payment history and credit worthiness of each debtor. Receivable balances are charged off when they are considered uncollectible by management. Recoveries of receivables previously charged off are recorded as income when received. The Company held a reserve for doubtful accounts of $12,000 and $22 as of December 31, 2020 and 2019, respectively. The reserve was recorded due to growing uncertainty as to collectability of billed amounts from customers weakened by the economic downturn in 2020. The following table shows the change in allowance for doubtful accounts: As of December 31, 2020 2019 Balance at beginning of period $ 22 $ 189 Charges to costs and expenses 12,031 434 Recoveries and write-offs (53 ) (601 ) Balance at end of period $ 12,000 $ 22
Major Customer and Concentration of Credit Risk	Major Customer and Concentration of Credit Risk The concentration of our customers in the oil and natural gas industry may impact our overall exposure to credit risk, either positively or negatively, in that customers may be similarly affected by changes in economic and industry conditions. We perform ongoing credit evaluations of our customers and do not generally require collateral in support of our trade receivables. The following table shows the percentage of revenues from our significant customers: Years Ended December 31, 2020 2019 Customer A 11.2% 18.4% Customer B 19.7% * Customer C 18.4% * Customer D * 18.3% Customer E 13.2% * Customer F 18.2% * Customer G * 15.7% An asterisk indicates that revenue is less than ten percent. The following table shows the percentage of trade receivables from our significant customers: Years Ended December 31, 2020 2019 Customer A * 12.0% Customer B 32.2% 10.3% Customer C 17.0% * Customer D * 12.1% Customer E * * Customer F 12.7% * Customer G 12.5% 34.5% Customer H * 15.9% Customer I 13.5% * An asterisk indicates that trade receivable is less than ten percent.
Share-Based Compensation	Share-Based Compensation Share based compensation is measured on the grant date and fair value is recognized as expense over the requisite service period, which is generally the vesting period of the award. The Company recognizes forfeitures as they occur rather than estimating expected forfeitures. The fair value of time-based restricted stock, DSUs, or other performance incentive awards is determined based on the number of shares or units granted and the closing price of Class A common stock on the date of grant. The fair value of stock options is determined by applying the Black-Sholes model on the grant-date market value of the underlying Class A common stock. Restricted stock with market conditions is valued using a Monte Carlo simulation analysis. Deferred compensation expense associated with liability-based awards, such as certain performance incentive awards that could be settled either in cash or through issuance of a variable number of shares based on a fixed monetary amount at inception, is recognized at the fixed monetary amount at inception and is amortized on a straight-line basis over the requisite service period, which is generally the vesting period. However, the Company considers any delayed settlement as a post-vesting restriction which impacts the determination of the grant-date fair value of the award. The Company estimates fair value by using a risk-adjusted discount rate, which reflects the weighted average cost of capital of similarly traded public companies.
Fair Value of Preferred Stock	Fair Value of Preferred Stock The fair value of Series A preferred stock at the date of issuance was estimated by calculating the present value of its one-year The fair value of Series B preferred stock is the stated value, which is equal to the proceeds received from issuance.
Embedded Conversion Features	Embedded Conversion Features The Company evaluates embedded conversion features within a convertible instrument under ASC 815, Derivatives and Hedging Debt with Conversion and Other Options The Company records a beneficial conversion feature (“BCF”) when the convertible instrument is issued with conversion features at fixed or adjustable rates that are below market value when issued. The BCF for convertible instruments is recognized and measured by allocating a portion of the proceeds equal to the intrinsic value of that feature to additional paid-in capital. The intrinsic value is generally calculated at the commitment date as the difference between the conversion price and the fair value of the common stock or other securities into which the security is convertible, multiplied by the number of shares into which the security is convertible. If certain other securities are issued with the convertible security, the proceeds are allocated among the different components. The portion of the proceeds allocated to the convertible security is divided by the contractual number of the conversion shares to determine the effective conversion price, which is used to measure the BCF. The effective conversion price is used to compute the intrinsic value. The value of the BCF is limited to the basis that is initially allocated to the convertible security. The BCF for the convertible instrument is recorded as a reduction, or discount, to the carrying amount of the convertible instrument equal to the fair value of the conversion feature. The discount is then amortized as deemed dividends over the period from the date of the convertible instrument’s issuance to the earliest redemption date, provided that the convertible instrument is not currently redeemable but probable of becoming redeemable in the future.
Income Taxes	Income Taxes The Company, under ASC 740, uses the asset and liability method of accounting for income taxes, under which deferred tax assets and liabilities are recognized for the future tax consequences of (i) temporary differences between the financial statement carrying amounts and the tax bases of existing assets and liabilities and (ii) operating loss and tax credit carryforwards. Deferred income tax assets and liabilities are based on enacted tax rates applicable to the future period when those temporary differences are expected to be recovered or settled. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in income in the period the rate change is enacted. A valuation allowance is provided for deferred tax assets when it is more likely than not the deferred tax assets will not be realized. Our deferred tax calculation and valuation allowance requires us to make certain estimates about future operations. Changes in state or federal tax laws, as well as changes in our financial condition or the carrying value of existing assets and liabilities, could affect those estimates. The effect of a change in tax rates is recognized as income or expense in the period that the rate is enacted. ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties at December 31, 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals, or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.
Recent Accounting Pronouncements	Recently Adopted Accounting Pronouncements The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended, (the “Securities Act”), as modified by the Jumpstart our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. In January 2017, the FASB issued ASU 2017-04, Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework-Changes to the Disclosure Requirements for Fair Value Measurement In March 2020, the FASB issued ASU 2020-03, Codification Improvements to Financial Instruments ASU 2020 03 In June 2020, the FASB issued ASU 2020-05, Revenue from Contracts with Customers (Topic 606) and Leases (Topic 842) - Effective Dates for Certain Entities Recent Accounting Pronouncements Not Yet Adopted In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842) liabilities and right-of-use assets upon our adoption of Topic 842, which will increase our total assets and total liabilities that we report relative to such amounts prior to adoption. The Company will use the modified retrospective with applied transition method upon adoption of the standard. Under this adoption method, all leases that are in effect and in existence as of, and after transition date will be applied as of the transition date, with a cumulative impact to retained earnings in that period. Prior period financial statements would be stated under the old guidance ASC 840 with no change to prior periods or disclosures associated with prior period. In June 2016, the FASB issued ASU 2016-13, Financial Instruments – Credit Losses (Topic 326) In August 2018, the FASB issued ASU 2018-15, Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That is a Service Contract, In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes In August 2020, the FASB issued ASU 2020-06 Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity , which simplifies accounting for convertible instruments by removing major separation models required under current GAAP. It also amends the accounting for certain contracts in an entity’s own equity that are currently accounted for as derivatives because of specific settlement provisions. In addition, the new guidance modifies how particular convertible instruments and certain contracts that may be settled in cash or shares impact the diluted EPS computation. The new guidance will be effective for small reporting companies for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Early adoption is permitted. The Company is currently evaluating the impact of adopting the new guidance on the consolidated financial statements.

Restatement of Previously Iss_2

Restatement of Previously Issued Consolidated Financial Statements (Tables)	12 Months Ended
	Dec. 31, 2020
Prior Period Adjustment [Abstract]
Schedule of Consolidated Balance Sheets	CONSOLIDATED BALANCE SHEETS As Previously Reported Adjustments As Restated As of December 31, 2020 Warrant liabilities $ - $ 1,619 $ 1,619 Total liabilities 353,155 1,619 354,774 Series A Redeemable Convertible Preferred Stock 52,776 (1,801 ) 50,975 Additional paid in capital 241,465 (24,253 ) 217,212 Accumulated deficit (346,866 ) 24,435 (322,431 ) Total stockholders' equity (deficit) (105,394 ) 182 (105,212 ) As of December 31, 2019 Warrant liabilities $ - $ 8,147 $ 8,147 Total liabilities 426,114 8,147 434,261 Series A Redeemable Convertible Preferred Stock 38,928 (3,337 ) 35,591 Additional paid in capital 248,302 (22,920 ) 225,382 Accumulated deficit (111,201 ) 18,110 (93,091 ) Total stockholders' equity attributable to U.S. Well Services, Inc. 137,107 (4,810 ) 132,297 Total stockholders' equity 147,740 (4,810 ) 142,930 As of December 31, 2018 Warrant liabilities $ - $ 29,110 $ 29,110 Total liabilities 239,881 29,110 268,991 Additional paid in capital 204,928 (35,117 ) 169,811 Accumulated deficit (17,383 ) 6,007 (11,376 ) Total stockholders' equity attributable to U.S. Well Services, Inc. 187,551 (29,110 ) 158,441 Total stockholders' equity 240,349 (29,110 ) 211,239 CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited) As Previously Reported Adjustments As Restated As of September 30, 2020 Warrant liabilities $ - $ 1,187 $ 1,187 Total liabilities 322,100 1,187 323,287 Series A Redeemable Convertible Preferred Stock 50,907 (183 ) 50,724 Additional paid in capital 240,547 (26,073 ) 214,474 Accumulated deficit (317,642 ) 25,069 (292,573 ) Total stockholders' equity (deficit) (77,088 ) (1,004 ) (78,092 ) As of June 30, 2020 Warrant liabilities $ - $ 2,966 $ 2,966 Total liabilities 328,069 2,966 331,035 Series A Redeemable Convertible Preferred Stock 53,277 (1,976 ) 51,301 Additional paid in capital 237,872 (24,281 ) 213,591 Accumulated deficit (301,705 ) 23,291 (278,414 ) Total stockholders' equity (deficit) (63,826 ) (990 ) (64,816 ) As of March 31, 2020 Warrant liabilities $ - $ 1,599 $ 1,599 Total liabilities 410,090 1,599 411,689 Series A Redeemable Convertible Preferred Stock 46,928 (2,615 ) 44,313 Additional paid in capital 242,143 (23,643 ) 218,500 Accumulated deficit (283,568 ) 24,659 (258,909 ) Total stockholders' equity (deficit) (41,419 ) 1,016 (40,403 ) As of September 30, 2019 Warrant liabilities $ - $ 16,391 $ 16,391 Total liabilities 431,877 16,391 448,268 Series A Redeemable Convertible Preferred Stock 31,968 (3,735 ) 28,233 Additional paid in capital 232,080 (22,522 ) 209,558 Accumulated deficit (78,008 ) 9,866 (68,142 ) Total stockholders' equity attributable to U.S. Well Services, Inc. 154,078 (12,656 ) 141,422 Total stockholders' equity 192,155 (12,656 ) 179,499 As of June 30, 2019 Warrant liabilities $ - $ 33,978 $ 33,978 Total liabilities 458,611 33,978 492,589 Series A Redeemable Convertible Preferred Stock 25,892 (3,905 ) 21,987 Additional paid in capital 236,398 (22,352 ) 214,046 Accumulated deficit (61,039 ) (7,721 ) (68,760 ) Total stockholders' equity attributable to U.S. Well Services, Inc. 175,365 (30,073 ) 145,292 Total stockholders' equity 217,279 (30,073 ) 187,206 As of March 31, 2019 Warrant liabilities $ - $ 38,049 $ 38,049 Total liabilities 394,659 38,049 432,708 Additional paid in capital 206,008 (25,339 ) 180,669 Accumulated deficit (39,560 ) (12,710 ) (52,270 ) Total stockholders' equity attributable to U.S. Well Services, Inc. 166,454 (38,049 ) 128,405 Total stockholders' equity 213,355 (38,049 ) 175,306
Schedule of Consolidated Statements of Operations	CONSOLIDATED STATEMENTS OF OPERATIONS As Previously Reported Adjustments As Restated For the year ended December 31, 2020 Interest expense, net $ (25,209 ) $ (17 ) $ (25,226 ) Change in fair value of warrant liabilities - 6,342 6,342 Loss before income taxes (247,537 ) 6,325 (241,212 ) Net loss (246,713 ) 6,325 (240,388 ) Net loss attributable to U.S. Well Services, Inc. (235,665 ) 6,325 (229,340 ) Deemed and imputed dividends on Series A preferred stock (11,666 ) (1,356 ) (13,022 ) Net loss attributable to U.S. Well Services, Inc. common stockholders (257,158 ) 4,969 (252,189 ) Loss per common share - Basic and diluted $ (3.88 ) $ 0.07 $ (3.81 ) For the year ended December 31, 2019 Interest expense, net $ (30,099 ) $ (10 ) $ (30,109 ) Change in fair value of warrant liabilities - 12,113 12,113 Loss before income taxes (116,159 ) 12,103 (104,056 ) Net loss (116,082 ) 12,103 (103,979 ) Net loss attributable to U.S. Well Services, Inc. (93,913 ) 12,103 (81,810 ) Deemed and imputed dividends on Series A preferred stock (11,206 ) (590 ) (11,796 ) Net loss attributable to U.S. Well Services, Inc. common stockholders (109,169 ) 11,513 (97,656 ) Loss per common share - Basic and diluted $ (2.11 ) $ 0.22 $ (1.89 ) For the year ended December 31, 2018 Change in fair value of warrant liabilities $ - $ 6,007 $ 6,007 Loss before income taxes (70,462 ) 6,007 (64,455 ) Net loss (70,814 ) 6,007 (64,807 ) Net loss attributable to U.S. Well Services, Inc. (65,896 ) 6,007 (59,889 ) Loss per common share - Basic and diluted $ (1.33 ) $ 0.12 $ (1.21 ) CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited) Three Months Ended September 30, 2020 June 30, 2020 March 31, 2020 September 30, 2019 June 30, 2019 March 31, 2019 Interest expense, net As Previously Reported $ (5,744 ) $ (5,661 ) $ (7,952 ) $ (8,449 ) $ (7,820 ) $ (5,115 ) Adjustments (4 ) (4 ) (4 ) (4 ) (2 ) - As Restated (5,748 ) (5,665 ) (7,956 ) (8,453 ) (7,822 ) (5,115 ) Change in fair value of warrant liabilities As Previously Reported $ - $ - $ - $ - $ - $ - Adjustments 1,783 (1,364 ) 6,553 17,591 4,991 (18,717 ) As Restated 1,783 (1,364 ) 6,553 17,591 4,991 (18,717 ) Loss before income taxes As Previously Reported $ (16,075 ) $ (18,221 ) $ (183,917 ) $ (21,210 ) $ (26,605 ) $ (28,365 ) Adjustments 1,779 (1,368 ) 6,549 17,587 4,989 (18,717 ) As Restated (14,296 ) (19,589 ) (177,368 ) (3,623 ) (21,616 ) (47,082 ) Net loss As Previously Reported $ (15,988 ) $ (18,234 ) $ (183,167 ) $ (21,249 ) $ (26,911 ) $ (28,489 ) Adjustments 1,779 (1,368 ) 6,549 17,587 4,989 (18,717 ) As Restated (14,209 ) (19,602 ) (176,618 ) (3,662 ) (21,922 ) (47,206 ) Net income (loss) attributable to U.S. Well Services, Inc. As Previously Reported $ (15,937 ) $ (18,137 ) $ (172,367 ) $ (16,969 ) $ (21,479 ) $ (22,272 ) Adjustments 1,779 (1,368 ) 6,549 17,587 4,989 (18,717 ) As Restated (14,158 ) (19,505 ) (165,818 ) 618 (16,490 ) (40,989 ) Deemed and imputed dividends on Series A preferred stock As Previously Reported $ (467 ) $ (4,504 ) $ (6,249 ) $ (4,406 ) $ (1,560 ) $ - Adjustments 3 (638 ) (723 ) (170 ) (22 ) - As Restated (464 ) (5,142 ) (6,972 ) (4,576 ) (1,582 ) - Net loss attributable to U.S. Well Services, Inc. common stockholders As Previously Reported $ (18,939 ) $ (25,152 ) $ (180,367 ) $ (23,045 ) $ (23,699 ) $ (22,272 ) Adjustments 1,782 (2,006 ) 5,826 17,417 4,967 (18,717 ) As Restated (17,157 ) (27,158 ) (174,541 ) (5,628 ) (18,732 ) (40,989 ) Loss per common share - Basic and diluted As Previously Reported $ (0.28 ) $ (0.38 ) $ (3.00 ) $ (0.45 ) $ (0.46 ) $ (0.45 ) Adjustments 0.03 (0.03 ) 0.10 0.34 0.09 (0.39 ) As Restated (0.25 ) (0.41 ) (2.90 ) (0.11 ) (0.37 ) (0.84 ) CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited) Nine Months Ended September 30, Six Months Ended June 30, 2020 2019 2020 2019 Interest expense, net As Previously Reported $ (19,357 ) $ (21,384 ) $ (13,613 ) $ (12,935 ) Adjustments (12 ) (6 ) (8 ) (2 ) As Restated (19,369 ) (21,390 ) (13,621 ) (12,937 ) Change in fair value of warrant liabilities As Previously Reported $ - $ - $ - $ - Adjustments 6,972 3,865 5,189 (13,726 ) As Restated 6,972 3,865 5,189 (13,726 ) Loss before income taxes As Previously Reported $ (218,213 ) $ (76,180 ) $ (202,138 ) $ (54,970 ) Adjustments 6,960 3,859 5,181 (13,728 ) As Restated (211,253 ) (72,321 ) (196,957 ) (68,698 ) Net loss As Previously Reported $ (217,389 ) $ (76,649 ) $ (201,401 ) $ (55,400 ) Adjustments 6,960 3,859 5,181 (13,728 ) As Restated (210,429 ) (72,790 ) (196,220 ) (69,128 ) Net loss attributable to U.S. Well Services, Inc. As Previously Reported $ (206,441 ) $ (60,720 ) $ (190,504 ) $ (43,751 ) Adjustments 6,960 3,859 5,181 (13,728 ) As Restated (199,481 ) (56,861 ) (185,323 ) (57,479 ) Deemed and imputed dividends on Series A preferred stock As Previously Reported $ (11,220 ) $ (5,966 ) $ (10,753 ) $ (1,560 ) Adjustments (1,358 ) (192 ) (1,361 ) (22 ) As Restated (12,578 ) (6,158 ) (12,114 ) (1,582 ) Net loss attributable to U.S. Well Services, Inc. common stockholders As Previously Reported $ (224,458 ) $ (69,016 ) $ (205,519 ) $ (45,971 ) Adjustments 5,602 3,667 3,820 (13,750 ) As Restated (218,856 ) (65,349 ) (201,699 ) (59,721 ) Loss per common share - Basic and diluted As Previously Reported $ (3.46 ) $ (1.36 ) $ (3.25 ) $ (0.92 ) Adjustments 0.09 0.07 0.06 (0.27 ) As Restated (3.37 ) (1.29 ) (3.19 ) (1.19 )

Significant Accounting Polici_3

Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2020
Accounting Policies [Abstract]
Cash and Cash Equivalents and Restricted Cash	The following table provides a reconciliation of the amount of cash and cash equivalents reported on the consolidated balance sheets to the total of cash and cash equivalents and restricted cash shown on the consolidated statements of cash flows: As of December 31, 2020 2019 Cash and cash equivalents $ 3,693 $ 33,794 Restricted cash 1,569 7,610 Cash and cash equivalents and restricted cash $ 5,262 $ 41,404
Change in the Inventory Reserves	As of December 31, 2020 2019 Balance at beginning of period $ 579 $ 572 Charges to costs and expenses 620 359 Recoveries and write-offs (884 ) (352 ) Balance at end of period $ 315 $ 579
Change in Allowance for Doubtful Accounts	The following table shows the change in allowance for doubtful accounts: As of December 31, 2020 2019 Balance at beginning of period $ 22 $ 189 Charges to costs and expenses 12,031 434 Recoveries and write-offs (53 ) (601 ) Balance at end of period $ 12,000 $ 22
Schedule of Percentage of Revenues and Trade Receivables from Customers	The following table shows the percentage of revenues from our significant customers: Years Ended December 31, 2020 2019 Customer A 11.2% 18.4% Customer B 19.7% * Customer C 18.4% * Customer D * 18.3% Customer E 13.2% * Customer F 18.2% * Customer G * 15.7% An asterisk indicates that revenue is less than ten percent. The following table shows the percentage of trade receivables from our significant customers: Years Ended December 31, 2020 2019 Customer A * 12.0% Customer B 32.2% 10.3% Customer C 17.0% * Customer D * 12.1% Customer E * * Customer F 12.7% * Customer G 12.5% 34.5% Customer H * 15.9% Customer I 13.5% * An asterisk indicates that trade receivable is less than ten percent.

Prepaids and Other Current As_2

Prepaids and Other Current Assets (Tables)	12 Months Ended
	Dec. 31, 2020
Prepaid Expense And Other Assets Current [Abstract]
Schedule of Prepaids and Other Current Assets	Prepaids and other current assets include the following: As of December 31, 2020 2019 Prepaid insurance $ 3,162 $ 11,127 Recoverable costs from insurance 4,635 - Income tax receivable 1,567 810 Other current assets 1,343 1,395 Total prepaid expenses and other current assets $ 10,707 $ 13,332

Goodwill and Intangible Assets

Goodwill and Intangible Assets (Tables)	12 Months Ended
	Dec. 31, 2020
Goodwill And Intangible Assets Disclosure [Abstract]
Schedule of Intangible Assets	Intangible assets consisted of the following: Estimated Useful Life (in years) Gross Carrying Value Accumulated Amortization Net Book Value As of December 31, 2020 Trademarks 10 $ 1,415 $ 156 $ 1,259 Patents 20 12,775 568 12,207 $ 14,190 $ 724 $ 13,466 As of December 31, 2019 Trademarks 10 3,132 913 2,219 Patents 20 22,955 3,348 19,607 $ 26,087 $ 4,261 $ 21,826
Schedule of Estimated Future Amortization Expense	The estimated amortization expense for future periods is as follows: Fiscal Year Estimated Amortization Expense 2021 $ 966 2022 966 2023 966 2024 966 2025 966 Thereafter 8,636 Total $ 13,466

Property and Equipment, Net (Ta

Property and Equipment, Net (Tables)	12 Months Ended
	Dec. 31, 2020
Property Plant And Equipment [Abstract]
Schedule of Property and Equipment	Property and equipment consisted of the following: Estimated Useful Life (in years) December 31, 2020 December 31, 2019 Fracturing equipment 1.5 to 25 $ 263,869 $ 651,162 Light duty vehicles 5 2,483 8,188 Furniture and fixtures 5 67 277 IT equipment 3 1,676 6,724 Auxiliary equipment 2 to 20 11,058 38,502 Leasehold improvements Term of lease 287 725 279,440 705,578 Less: Accumulated depreciation and amortization (44,108 ) (263,968 ) Property and equipment, net $ 235,332 $ 441,610

Accrued Expenses and Other Cu_2

Accrued Expenses and Other Current Liabilities (Tables)	12 Months Ended
	Dec. 31, 2020
Payables And Accruals [Abstract]
Schedule of Accrued Expenses and Other Current Liabilities	Accrued expenses and other current liabilities consisted of the following: As of December 31, 2020 2019 Accrued payroll and benefits $ 7,208 $ 9,356 Accrued taxes 5,380 9,817 Accrued interest 317 18,190 Other current liabilities 1,876 3,118 Accrued expenses and other current liabilities $ 14,781 $ 40,481

Warrant Liabilities (As Resta_2

Warrant Liabilities (As Restated) (Tables)	12 Months Ended
	Dec. 31, 2020
Warrant Liabilities [Abstract]
Summary of Fair Value Hierarchy Liabilities Measured at Fair Value on Recurring Basis	The following tables present the Company's fair value hierarchy for liabilities measured at fair value on a recurring basis: Quoted prices in active markets (Level 1) Other observable inputs (Level 2) Unobservable inputs (Level 3) Total As of December 31, 2020 Public warrants $ 254 $ - $ - $ 254 Private placement warrants - 248 - 248 Series A warrants - 1,117 - 1,117 $ 254 $ 1,365 $ - $ 1,619 As of December 31, 2019 Public warrants $ 1,299 $ - $ - $ 1,299 Private placement warrants - 2,108 - 2,108 Series A warrants - 4,740 - 4,740 $ 1,299 $ 6,848 $ - $ 8,147
Schedule of Activities, Including Changes in Fair Values of Warrant Liabilities	The following table summarizes the activities, including changes in fair values of the Company’s warrant liabilities for the years ended December 31, 2020 and 2019: As of December 31, 2020 2019 Balance at beginning of period $ 8,147 $ 29,110 Issuance of Series A warrants, net - 12,675 Exercise of warrants - (21,535 ) Reclassification of warrant liability upon forfeiture (203 ) - Change in fair value of warrant liabilities (6,342 ) (12,113 ) Amortization of warrant issuance costs 17 10 Balance at end of period $ 1,619 $ 8,147

Debt (Tables)

Debt (Tables)	12 Months Ended
	Dec. 31, 2020
Debt Disclosure [Abstract]
Schedule of Long-term Debt	Long-term debt consisted of the following: As of December 31, 2020 2019 Senior Secured Term Loan $ 246,250 $ 250,000 ABL Credit Facility 23,710 40,090 PPP Loan 10,000 - USDA Loan 21,996 - Equipment financing 12,866 16,065 Capital leases 229 10,474 Total debt principal balance 315,051 316,629 Unamortized discount on debt and debt issuance costs (17,576 ) (9,449 ) Current maturities (13,573 ) (22,288 ) Net Long-term debt $ 283,902 $ 284,892
Schedule of Repayment Requirements of Long-term Debt	Presented below is a schedule of the repayment requirements of long-term debt as of December 31, 2020: Principal Amount of Long-term Debt 2021 $ 13,573 2022 10,017 2023 9,203 2024 9,397 2025 256,503 Thereafter 16,358 Total $ 315,051

Mezzanine Equity (Tables)

Mezzanine Equity (Tables)	12 Months Ended
	Dec. 31, 2020
Temporary Equity Disclosure [Abstract]
Summary of Series A and Series B Redeemable Convertible Preferred Stock (Series A and Series B Preferred Stock) Activities	The following table summarizes the Company’s Series A Redeemable Convertible Preferred Stock, par value $0.0001 per share (“Series A preferred stock”) activities for the year ended December 31, 2020: Shares Amount (As Restated) Series A preferred stock as of December 31, 2019 55,000 $ 35,591 Deemed and imputed dividends on Series A preferred stock - 13,022 Accrued Series A preferred stock dividends - 7,214 Conversion of Series A preferred stock to Class A common stock (5,000 ) (4,852 ) Series A preferred stock as of December 31, 2020 50,000 $ 50,975 The following table summarizes the Company’s Series B Redeemable Convertible Preferred Stock, par value $0.0001 per share (“Series B preferred stock”) activities for the year ended December 31, 2020: Shares Amount Series B preferred stock as of December 31, 2019 $ - $ - Proceeds from issuance of Series B preferred stock 21,000 21,000 Issuance of Series B preferred stock to senior secured term loan lenders 1,050 1,050 Issuance cost associated with Series B preferred stock - (1,413 ) Accrued Series B preferred stock dividends - 2,049 Series B preferred stock as of December 31, 2020 22,050 $ 22,686

Earnings (Loss) Per Share (Tabl

Earnings (Loss) Per Share (Tables)	12 Months Ended
	Dec. 31, 2020
Earnings Per Share [Abstract]
Calculation of Basic And Diluted Earnings (Loss) Per Share	The following table sets forth the calculation of basic and diluted earnings (loss) per share for the periods indicated based on the weighted average number of shares of Class A common stock outstanding for the period: Years Ended December 31, 2020 (As Restated) 2019 (As Restated) Basic Net Income (Loss) Per Share Numerator: Net loss attributable to U.S. Well Services, Inc. $ (229,340 ) $ (81,810 ) Net loss attributable to cancellable Class A shares 5,560 2,540 Basic net loss attributable to U.S. Well Services, Inc. shareholders (223,780 ) (79,270 ) Dividends accrued on Series A preferred stock (7,214 ) (4,050 ) Dividends accrued on Series B preferred stock (2,049 ) - Deemed and imputed dividends on Series A preferred stock (13,022 ) (11,796 ) Deemed dividends on Series B preferred stock (564 ) - Basic net loss attributable to U.S. Well Services, Inc. common shareholders $ (246,629 ) $ (95,116 ) Denominator: Weighted average shares outstanding 66,400,924 51,853,183 Cancellable Class A common stock (1,609,677 ) (1,609,677 ) Basic and diluted weighted average shares outstanding 64,791,247 50,243,506 Basic and diluted net income (loss) per share attributable to Class A shareholders $ (3.81 ) $ (1.89 )
Summary of Securities Excluded from Computation of Diluted Earnings Per Share	A summary of securities excluded from the computation of diluted earnings per share is presented below for the applicable periods: Years Ended December 31, 2020 2019 Diluted earnings per share: Anti-dilutive stock options 877,266 1,068,162 Anti-dilutive warrants 14,428,150 15,680,651 Anti-dilutive restricted stock 1,449,287 2,723,637 Anti-dilutive deferred stock units 8,911,858 - Anti-dilutive Pool B awards 10,142,494 - Anti-dilutive Class B common stock convertible into Class A common stock 2,302,936 5,500,692 Anti-dilutive Series A preferred stock convertible into Class A common stock 9,058,176 8,853,028 Anti-dilutive Series B preferred stock convertible into Class A common stock 78,245,727 - Potentially dilutive securities excluded as anti-dilutive 125,415,894 33,826,170

Share-based Compensation (Table

Share-based Compensation (Tables)	12 Months Ended
	Dec. 31, 2020
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Summary of Share-based Compensation Expense	Share-based compensation expense consisted of the following: Years Ended December 31, 2020 2019 Restricted stock $ 4,719 $ 6,496 Unrestricted stock - 418 Stock options 905 841 DSUs 984 - Pool A awards 2,328 - Pool B awards 1,120 - Total $ 10,056 (1) $ 7,755 (2) (1) administrative expenses in the consolidated statement of operations. (2) administrative expenses in the consolidated statement of operations.
Schedule of Restricted Stock Transactions	The following table summarizes restricted stock activity in 2020: Number of shares Weighted- average grant-date fair value (per share data) Non-vested restricted stock as of December 31, 2019 2,723,637 $ 8.87 Granted - - Vested (690,237 ) 8.87 Forfeited (584,113 ) 8.91 Non-vested restricted stock as of December 31, 2020 1,449,287 $ 8.85
Schedule of Stock Option Activity	The following table summarizes stock option activity in 2020: Number of shares Weighted average exercise price (per share data) Weighted Average Remaining Contractual Life (years) Outstanding as of December 31, 2019 1,068,162 $ 8.91 6.21 Granted - $ - - Exercised - - - Forfeited/Expired (190,896 ) 8.91 - Outstanding as of December 31, 2020 877,266 $ 8.91 5.21 Exercisable as of December 31, 2020 219,317 $ 8.91 5.21

Income Taxes (As Restated) (Tab

Income Taxes (As Restated) (Tables)	12 Months Ended
	Dec. 31, 2020
Income Tax Disclosure [Abstract]
Schedule of Deferred Tax Assets and Liabilities	The Company’s net deferred tax assets are as follows: December 31, Deferred Tax Assets 2020 (As Restated) 2019 Net Operating Loss Carryforward $ 56,815 $ 30,485 Startup/Organization Expenses 177 163 Investment in Partnership 70,244 19,489 Interest Expense 1,652 911 Attributes/Other 137 186 Total Deferred Tax Assets 129,025 51,234 Less Valuation Allowance (129,025 ) (51,234 ) Total Deferred Tax Assets, net $ - $ - Deferred Tax Liabilities - - Net Deferred Tax Assets $ - $ -
Schedule of Components of Income Tax Expense (Benefit)	The income tax provision consists of the following: Years ended December 31, Current 2020 2019 Federal $ (757 ) $ - State (67 ) (77 ) Total Current (824 ) (77 ) Deferred Federal - - State - - Total Deferred - - Total $ (824 ) $ (77 )
Schedule of Effective Income Tax Rate Reconciliation	A reconciliation of the federal income tax rate to the Company’s effective tax rate at December 31, 2020 is as follows (As Restated): Pre-tax book loss $ 241,212 Federal Provision (Benefit) (50,656 ) -21.00 % Noncontrolling Interest (14,259 ) -5.91 % Permanent Differences 501 0.21 % State Income Taxes, net of Federal Benefit (53 ) -0.02 % NOL Carryback, effect of rate change (289 ) -0.12 % Return to Provision, Other 1,846 0.76 % Valuation Allowance 62,086 25.74 % Total Provision (Benefit) $ (824 ) -0.34 %

Commitments and Contingencies (

Commitments and Contingencies (Tables)	12 Months Ended
	Dec. 31, 2020
Commitments And Contingencies Disclosure [Abstract]
Schedule of Future Minimum Payments on Non-Cancelable Operating Leases	The following is a schedule of future minimum payments on non-cancellable operating leases as of December 31, 2020: 2021 $ 1,114 2022 828 2023 308 2024 258 2025 67 Thereafter - Total future minimum rentals $ 2,575

Description of Business (Detail

Description of Business (Details Narrative)	Dec. 31, 2020
Merger and Contribution Agreement [Member] | USWS Holdings [Member]
Description Of Business [Line Items]
Equity interests ownership	97.00%

Restatement of Previously Iss_3

Restatement of Previously Issued Consolidated Financial Statements - CONSOLIDATED BALANCE SHEETS (Details) - USD ($) $ in Thousands	Dec. 31, 2020	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Dec. 31, 2018
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Warrant liabilities	$ 1,619	$ 1,187	$ 2,966	$ 1,599	$ 8,147	$ 16,391	$ 33,978	$ 38,049	$ 29,110
Total liabilities	354,774	323,287	331,035	411,689	434,261	448,268	492,589	432,708	268,991
Additional paid in capital	217,212	214,474	213,591	218,500	225,382	209,558	214,046	180,669	169,811
Accumulated deficit	(322,431)	(292,573)	(278,414)	(258,909)	(93,091)	(68,142)	(68,760)	(52,270)	(11,376)
Total stockholders' equity (deficit)	(105,212)	(78,092)			132,297	141,422	145,292	128,405	158,441
Total stockholders' equity	(105,212)		(64,816)	(40,403)	142,930	179,499	187,206	175,306	211,239
Series A Convertible Redeemable Preferred Stock [Member]
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Redeemable Convertible Preferred Stock	50,975				35,591
Series A Convertible Redeemable Preferred Stock [Member]
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Redeemable Convertible Preferred Stock		50,724	51,301	44,313		28,233	21,987
As Previously Reported [Member]
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Total liabilities	353,155	322,100	328,069	410,090	426,114	431,877	458,611	394,659	239,881
Additional paid in capital	241,465	240,547	237,872	242,143	248,302	232,080	236,398	206,008	204,928
Accumulated deficit	(346,866)	(317,642)	(301,705)	(283,568)	(111,201)	(78,008)	(61,039)	(39,560)	(17,383)
Total stockholders' equity (deficit)	(105,394)	(77,088)			137,107	154,078	175,365	166,454	187,551
Total stockholders' equity			(63,826)	(41,419)	147,740	192,155	217,279	213,355	240,349
As Previously Reported [Member] | Series A Convertible Redeemable Preferred Stock [Member]
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Redeemable Convertible Preferred Stock	52,776				38,928
As Previously Reported [Member] | Series A Convertible Redeemable Preferred Stock [Member]
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Redeemable Convertible Preferred Stock		50,907	53,277	46,928		31,968	25,892
Restatement Adjustments [Member]
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Warrant liabilities	1,619	1,187	2,966	1,599	8,147	16,391	33,978	38,049	29,110
Total liabilities	1,619	1,187	2,966	1,599	8,147	16,391	33,978	38,049	29,110
Additional paid in capital	(24,253)	(26,073)	(24,281)	(23,643)	(22,920)	(22,522)	(22,352)	(25,339)	(35,117)
Accumulated deficit	24,435	25,069	23,291	24,659	18,110	9,866	(7,721)	(12,710)	6,007
Total stockholders' equity (deficit)	182	(1,004)			(4,810)	(12,656)	(30,073)	(38,049)	(29,110)
Total stockholders' equity			(990)	1,016	(4,810)	(12,656)	(30,073)	$ (38,049)	$ (29,110)
Restatement Adjustments [Member] | Series A Convertible Redeemable Preferred Stock [Member]
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Redeemable Convertible Preferred Stock	$ (1,801)				$ (3,337)
Restatement Adjustments [Member] | Series A Convertible Redeemable Preferred Stock [Member]
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Redeemable Convertible Preferred Stock		$ (183)	$ (1,976)	$ (2,615)		$ (3,735)	$ (3,905)

Restatement of Previously Iss_4

Restatement of Previously Issued Consolidated Financial Statements - CONSOLIDATED STATEMENTS OF OPERATIONS (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended						6 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Jun. 30, 2020	Jun. 30, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Interest expense, net	$ (5,748)	$ (5,665)	$ (7,956)	$ (8,453)	$ (7,822)	$ (5,115)	$ (13,621)	$ (12,937)	$ (19,369)	$ (21,390)	$ (25,226)	$ (30,109)
Change in fair value of warrant liabilities	(1,783)	1,364	(6,553)	(17,591)	(4,991)	18,717	(5,189)	13,726	(6,972)	(3,865)	6,342	12,113	$ 6,007
Loss before income taxes	(14,296)	(19,589)	(177,368)	(3,623)	(21,616)	(47,082)	(196,957)	(68,698)	(211,253)	(72,321)	(241,212)	(104,056)	(64,455)
Net loss	(14,209)	(19,602)	(176,618)	(3,662)	(21,922)	(47,206)	(196,220)	(69,128)	(210,429)	(72,790)	(240,388)	(103,979)	(64,807)
Net loss attributable to U.S. Well Services, Inc.	(14,158)	(19,505)	(165,818)	618	(16,490)	(40,989)	(185,323)	(57,479)	(199,481)	(56,861)	(229,340)	(81,810)	$ (59,889)
Deemed and imputed dividends on Series A preferred stock	(464)	(5,142)	(6,972)	(4,576)	(1,582)		(12,114)	(1,582)	(12,578)	(6,158)	(13,022)	(11,796)
Net loss attributable to U.S. Well Services, Inc. common stockholders	$ (17,157)	$ (27,158)	$ (174,541)	$ (5,628)	$ (18,732)	$ (40,989)	$ (201,699)	$ (59,721)	$ (218,856)	$ (65,349)	$ (252,189)	$ (97,656)
Basic and diluted	$ (0.25)	$ (0.41)	$ (2.90)	$ (0.11)	$ (0.37)	$ (0.84)	$ (3.19)	$ (1.19)	$ (3.37)	$ (1.29)	$ (3.81)	$ (1.89)	$ (1.21)
Change in fair value of warrant liabilities	$ 1,783	$ (1,364)	$ 6,553	$ 17,591	$ 4,991	$ (18,717)	$ 5,189	$ (13,726)	$ 6,972	$ 3,865	$ (6,342)	$ (12,113)	$ (6,007)
As Previously Reported [Member]
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Interest expense, net	(5,744)	(5,661)	(7,952)	(8,449)	(7,820)	(5,115)	(13,613)	(12,935)	(19,357)	(21,384)	(25,209)	(30,099)
Loss before income taxes	(16,075)	(18,221)	(183,917)	(21,210)	(26,605)	(28,365)	(202,138)	(54,970)	(218,213)	(76,180)	(247,537)	(116,159)	(70,462)
Net loss	(15,988)	(18,234)	(183,167)	(21,249)	(26,911)	(28,489)	(201,401)	(55,400)	(217,389)	(76,649)	(246,713)	(116,082)	(70,814)
Net loss attributable to U.S. Well Services, Inc.	(15,937)	(18,137)	(172,367)	(16,969)	(21,479)	(22,272)	(190,504)	(43,751)	(206,441)	(60,720)	(235,665)	(93,913)	$ (65,896)
Deemed and imputed dividends on Series A preferred stock	(467)	(4,504)	(6,249)	(4,406)	(1,560)		(10,753)	(1,560)	(11,220)	(5,966)	(11,666)	(11,206)
Net loss attributable to U.S. Well Services, Inc. common stockholders	$ (18,939)	$ (25,152)	$ (180,367)	$ (23,045)	$ (23,699)	$ (22,272)	$ (205,519)	$ (45,971)	$ (224,458)	$ (69,016)	$ (257,158)	$ (109,169)
Basic and diluted	$ (0.28)	$ (0.38)	$ (3)	$ (0.45)	$ (0.46)	$ (0.45)	$ (3.25)	$ (0.92)	$ (3.46)	$ (1.36)	$ (3.88)	$ (2.11)	$ (1.33)
Restatement Adjustments [Member]
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Interest expense, net	$ (4)	$ (4)	$ (4)	$ (4)	$ (2)		$ (8)	$ (2)	$ (12)	$ (6)	$ (17)	$ (10)
Change in fair value of warrant liabilities	(1,783)	1,364	(6,553)	(17,591)	(4,991)	$ 18,717	(5,189)	13,726	(6,972)	(3,865)	6,342	12,113	$ 6,007
Loss before income taxes	1,779	(1,368)	6,549	17,587	4,989	(18,717)	5,181	(13,728)	6,960	3,859	6,325	12,103	6,007
Net loss	1,779	(1,368)	6,549	17,587	4,989	(18,717)	5,181	(13,728)	6,960	3,859	6,325	12,103	6,007
Net loss attributable to U.S. Well Services, Inc.	1,779	(1,368)	6,549	17,587	4,989	(18,717)	5,181	(13,728)	6,960	3,859	6,325	12,103	$ 6,007
Deemed and imputed dividends on Series A preferred stock	3	(638)	(723)	(170)	(22)		(1,361)	(22)	(1,358)	(192)	(1,356)	(590)
Net loss attributable to U.S. Well Services, Inc. common stockholders	$ 1,782	$ (2,006)	$ 5,826	$ 17,417	$ 4,967	$ (18,717)	$ 3,820	$ (13,750)	$ 5,602	$ 3,667	$ 4,969	$ 11,513
Basic and diluted	$ 0.03	$ (0.03)	$ 0.10	$ 0.34	$ 0.09	$ (0.39)	$ 0.06	$ (0.27)	$ 0.09	$ 0.07	$ 0.07	$ 0.22	$ 0.12
Change in fair value of warrant liabilities	$ 1,783	$ (1,364)	$ 6,553	$ 17,591	$ 4,991	$ (18,717)	$ 5,189	$ (13,726)	$ 6,972	$ 3,865	$ (6,342)	$ (12,113)	$ (6,007)

Significant Accounting Polici_4

Significant Accounting Policies (Details Narrative)	3 Months Ended	12 Months Ended
	Mar. 31, 2020USD ($)	Dec. 31, 2020USD ($)Segment	Dec. 31, 2019USD ($)	Dec. 31, 2018USD ($)
Accounting Policies [Line Items]
Number of reportable segments | Segment		1
Cash equivalents original maturity date of acquisition		3 months
Restricted cash		$ 1,569,000	$ 7,610,000
Inventory valuation reserves		315,000	579,000	$ 572,000
Impairment of long-lived assets	$ 147,543,000	147,543,000
Reserve for doubtful accounts		12,000,000	22,000
Accrued for payment of interest and penalties		$ 0
Series A Preferred Stock [Member]
Accounting Policies [Line Items]
Estimated fair value of Series A preferred stock, calculation period		1 year
Senior Secured Term Loan [Member]
Accounting Policies [Line Items]
Long term debt fair value		$ 198,000,000	198,000,000
Workers’ Compensation Obligations [Member]
Accounting Policies [Line Items]
Restricted cash		513,000	513,000
Approved Capital Expenditures [Member]
Accounting Policies [Line Items]
Restricted cash		$ 1,056,000	$ 7,097,000

Significant Accounting Polici_5

Significant Accounting Policies (Details) - USD ($) $ in Thousands	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Accounting Policies [Abstract]
Cash and cash equivalents	$ 3,693	$ 33,794
Restricted cash	1,569	7,610
Cash and cash equivalents and restricted cash	$ 5,262	$ 41,404	$ 30,036

Significant Accounting Polici_6

Significant Accounting Policies (Details 1) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Accounting Policies [Abstract]
Balance at beginning of period	$ 579	$ 572
Charges to costs and expenses	620	359
Recoveries and write-offs	(884)	(352)
Balance at end of period	$ 315	$ 579

Significant Accounting Polici_7

Significant Accounting Policies (Details 2) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Accounting Policies [Abstract]
Balance at beginning of period	$ 22	$ 189
Charges to costs and expenses	12,031	434
Recoveries and write-offs	(53)	(601)
Balance at end of period	$ 12,000	$ 22

Significant Accounting Polici_8

Significant Accounting Policies (Details 3)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Revenues [Member]
Concentration risk, Percentage	10.00%
Revenues [Member] | Customer Concentration Risk [Member] | Customer A [Member]
Concentration risk, Percentage	11.20%	18.40%
Revenues [Member] | Customer Concentration Risk [Member] | Customer B [Member]
Concentration risk, Percentage	19.70%
Revenues [Member] | Customer Concentration Risk [Member] | Customer C [Member]
Concentration risk, Percentage	18.40%
Revenues [Member] | Customer Concentration Risk [Member] | Customer D [Member]
Concentration risk, Percentage		18.30%
Revenues [Member] | Customer Concentration Risk [Member] | Customer E [Member]
Concentration risk, Percentage	13.20%
Revenues [Member] | Customer Concentration Risk [Member] | Customer F [Member]
Concentration risk, Percentage	18.20%
Revenues [Member] | Customer Concentration Risk [Member] | Customer G [Member]
Concentration risk, Percentage		15.70%
Trade Receivables [Member]
Concentration risk, Percentage	10.00%
Trade Receivables [Member] | Customer Concentration Risk [Member] | Customer A [Member]
Concentration risk, Percentage		12.00%
Trade Receivables [Member] | Customer Concentration Risk [Member] | Customer B [Member]
Concentration risk, Percentage	32.20%	10.30%
Trade Receivables [Member] | Customer Concentration Risk [Member] | Customer C [Member]
Concentration risk, Percentage	17.00%
Trade Receivables [Member] | Customer Concentration Risk [Member] | Customer D [Member]
Concentration risk, Percentage		12.10%
Trade Receivables [Member] | Customer Concentration Risk [Member] | Customer F [Member]
Concentration risk, Percentage	12.70%
Trade Receivables [Member] | Customer Concentration Risk [Member] | Customer G [Member]
Concentration risk, Percentage	12.50%	34.50%
Trade Receivables [Member] | Customer Concentration Risk [Member] | Customer H [Member]
Concentration risk, Percentage		15.90%
Trade Receivables [Member] | Customer Concentration Risk [Member] | Customer I [Member]
Concentration risk, Percentage	13.50%

Significant Accounting Polici_9

Significant Accounting Policies (Parenthetical) (Details 3)	12 Months Ended
	Dec. 31, 2020
Revenues [Member]
Concentration risk, Percentage	10.00%
Trade Receivables [Member]
Concentration risk, Percentage	10.00%

Prepaids and Other Current As_3

Prepaids and Other Current Assets (Details) - USD ($) $ in Thousands	Dec. 31, 2020	Dec. 31, 2019
Prepaid Expense And Other Assets Current [Abstract]
Prepaid insurance	$ 3,162	$ 11,127
Recoverable costs from insurance	4,635
Income tax receivable	1,567	810
Other current assets	1,343	1,395
Total prepaid expenses and other current assets	$ 10,707	$ 13,332

Prepaids and Other Current As_4

Prepaids and Other Current Assets (Details Narrative) $ in Thousands	12 Months Ended
	Dec. 31, 2020USD ($)
Prepaid Expense And Other Assets Current [Abstract]
Insurance reimbursement	$ 4,854
Recoverable costs from insurance	$ 4,635

Goodwill and Intangible Asset_2

Goodwill and Intangible Assets (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Finite Lived Intangible Assets [Line Items]
Gross Carrying Value	$ 14,190	$ 26,087
Accumulated Amortization	724	4,261
Net Book Value	$ 13,466	$ 21,826
Trademarks [Member]
Finite Lived Intangible Assets [Line Items]
Estimated Useful Life (in years)	10 years	10 years
Gross Carrying Value	$ 1,415	$ 3,132
Accumulated Amortization	156	913
Net Book Value	$ 1,259	$ 2,219
Patents [Member]
Finite Lived Intangible Assets [Line Items]
Estimated Useful Life (in years)	20 years	20 years
Gross Carrying Value	$ 12,775	$ 22,955
Accumulated Amortization	568	3,348
Net Book Value	$ 12,207	$ 19,607

Goodwill and Intangible Asset_3

Goodwill and Intangible Assets (Details Narrative) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Mar. 31, 2020	Dec. 31, 2020	Dec. 31, 2019
Finite Lived Intangible Assets [Line Items]
Amortization of intangible assets		$ 1,090	$ 6,064
Intangible Assets [Member]
Finite Lived Intangible Assets [Line Items]
Impairment charge	$ 7,200
Intangible Assets [Member] | Maximum [Member]
Finite Lived Intangible Assets [Line Items]
Impairment charge	21,400
Intangible Assets [Member] | Minimum [Member]
Finite Lived Intangible Assets [Line Items]
Impairment charge	$ 14,200

Goodwill and Intangible Asset_4

Goodwill and Intangible Assets (Details 1) - USD ($) $ in Thousands	Dec. 31, 2020	Dec. 31, 2019
Goodwill And Intangible Assets Disclosure [Abstract]
2021	$ 966
2022	966
2023	966
2024	966
2025	966
Thereafter	8,636
Net Book Value	$ 13,466	$ 21,826

Property and Equipment, Net (De

Property and Equipment, Net (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Property Plant And Equipment [Line Items]
Property and equipment, gross	$ 279,440	$ 705,578
Less: Accumulated depreciation and amortization	(44,108)	(263,968)
Property and equipment, net	235,332	441,610
Fracturing Equipment [Member]
Property Plant And Equipment [Line Items]
Property and equipment, gross	$ 263,869	651,162
Fracturing Equipment [Member] | Minimum [Member]
Property Plant And Equipment [Line Items]
Estimated Useful Life (in years)	1 year 6 months
Fracturing Equipment [Member] | Maximum [Member]
Property Plant And Equipment [Line Items]
Estimated Useful Life (in years)	25 years
Light Duty Vehicles [Member]
Property Plant And Equipment [Line Items]
Property and equipment, gross	$ 2,483	8,188
Estimated Useful Life (in years)	5 years
Furniture and fixtures [Member]
Property Plant And Equipment [Line Items]
Property and equipment, gross	$ 67	277
Estimated Useful Life (in years)	5 years
IT Equipment [Member]
Property Plant And Equipment [Line Items]
Property and equipment, gross	$ 1,676	6,724
Estimated Useful Life (in years)	3 years
Auxiliary Equipment [Member]
Property Plant And Equipment [Line Items]
Property and equipment, gross	$ 11,058	38,502
Auxiliary Equipment [Member] | Minimum [Member]
Property Plant And Equipment [Line Items]
Estimated Useful Life (in years)	2 years
Auxiliary Equipment [Member] | Maximum [Member]
Property Plant And Equipment [Line Items]
Estimated Useful Life (in years)	20 years
Leasehold Improvements [Member]
Property Plant And Equipment [Line Items]
Property and equipment, gross	$ 287	$ 725
Estimated Useful Life	Term of lease

Property and Equipment, Net - (

Property and Equipment, Net - (Details Narrative) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Mar. 31, 2020	Dec. 31, 2020	Dec. 31, 2019
Property Plant And Equipment [Line Items]
Depreciation and amortization		$ 80,353	$ 154,149
Property and Equipment [Member]
Property Plant And Equipment [Line Items]
Depreciation and amortization		$ 79,263	$ 148,149
Impairment charge	$ 140,300
Property and Equipment [Member] | Maximum [Member]
Property Plant And Equipment [Line Items]
Impairment charge	414,100
Property and Equipment [Member] | Minimum [Member]
Property Plant And Equipment [Line Items]
Impairment charge	$ 273,800

Accrued Expenses and Other Cu_3

Accrued Expenses and Other Current Liabilities - Schedule of Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands	Dec. 31, 2020	Dec. 31, 2019
Payables And Accruals [Abstract]
Accrued payroll and benefits	$ 7,208	$ 9,356
Accrued taxes	5,380	9,817
Accrued interest	317	18,190
Other current liabilities	1,876	3,118
Accrued expenses and other current liabilities	$ 14,781	$ 40,481

Warrant Liabilities (As Resta_3

Warrant Liabilities (As Restated) (Details Narrative) $ / shares in Units, $ in Thousands	May 24, 2019USD ($)$ / shares	May 23, 2019USD ($)	Mar. 31, 2020	Apr. 30, 2019$ / sharesshares	Mar. 31, 2019$ / sharesshares	Dec. 31, 2020USD ($)$ / sharesDividendshares	Dec. 31, 2019$ / shares
Warrant Liabilities [Line Items]
Warrants issued to purchase stock | shares						1
Closing price per share | $ / shares						$ 24
Common stock maximum trading period						30 days
Exercise price per half share | $ / shares						$ 5.75
Exercise price per full share equivalent | $ / shares						$ 11.50
Warrants expiration term						5 years
Redemption price of outstanding warrants | $ / shares						$ 0.01
Number of warrants forfeited | shares						6,327,218
Warrants forfeited consideration received | $						$ 0
Estimated fair value of warrant | $		$ 12,786
Series A Warrants [Member]
Warrant Liabilities [Line Items]
Contractual term						4 years 10 months 24 days	5 years 10 months 24 days
Estimated fair value of warrant | $	$ 12,786
Stock Price [Member] | Series A Warrants [Member]
Warrant Liabilities [Line Items]
Alternative investment, measurement input | $ / shares						0.41	1.89
Volatility [Member] | Series A Warrants [Member]
Warrant Liabilities [Line Items]
Alternative investment, measurement input						115.8	70.9
Risk-free Interest Rate [Member] | Series A Warrants [Member]
Warrant Liabilities [Line Items]
Alternative investment, measurement input						0.4	1.8
Dividend Rate [Member] | Series A Warrants [Member]
Warrant Liabilities [Line Items]
Alternative investment, measurement input						0	0
Valuation Technique, Option Pricing Mode [Member] | Volatility [Member] | Series A Warrants [Member]
Warrant Liabilities [Line Items]
Alternative investment, measurement input	53
Valuation Technique, Option Pricing Mode [Member] | Risk-free Interest Rate [Member] | Series A Warrants [Member]
Warrant Liabilities [Line Items]
Alternative investment, measurement input	2.2
Valuation Technique, Option Pricing Mode [Member] | Exercise Price [Member] | Series A Warrants [Member]
Warrant Liabilities [Line Items]
Alternative investment, measurement input | $ / shares	7.66
Valuation Technique, Option Pricing Mode [Member] | Expected Term [Member] | Series A Warrants [Member]
Warrant Liabilities [Line Items]
Contractual term	6 years 6 months
Valuation Technique, Option Pricing Mode [Member] | Expected Dividend Rate [Member] | Series A Warrants [Member]
Warrant Liabilities [Line Items]
Alternative investment, measurement input	0
Public Warrants [Member]
Warrant Liabilities [Line Items]
Warrants outstanding | shares						9,994,635
Private Placement Warrant [Member]
Warrant Liabilities [Line Items]
Warrants outstanding | shares						9,172,782
Common Class A [Member]
Warrant Liabilities [Line Items]
Warrants issued to purchase stock | shares						9,583,709
Common stock maximum trading period			30 days			30 days
Exercise price per full share equivalent | $ / shares				$ 0.13	$ 0.13
Number of warrants exchanged | shares				11,640,974	10,864,391
Sponsor and Underwriter [Member]
Warrant Liabilities [Line Items]
Warrants issued to purchase stock | shares						15,500,000
Purchasers [Member] | Common Class A [Member] | Private Placement Warrant [Member]
Warrant Liabilities [Line Items]
Warrants outstanding | shares						4,844,441
Purchasers [Member] | Series A Convertible Redeemable Preferred Stock [Member] | Private Placement Warrant [Member]
Warrant Liabilities [Line Items]
Warrants issued to purchase stock | shares						4,844,441
Warrants outstanding | shares						4,844,441
Initial Public Offering [Member]
Warrant Liabilities [Line Items]
Warrants issued to purchase stock | shares						32,500,000
Private Placement Warrants [Member]
Warrant Liabilities [Line Items]
Derivative liability, fair value measurement input | Dividend						0
Derivative Liability, Measurement Input [Extensible List]						Dividend Rate [Member]
Contractual term						2 years 10 months 9 days	3 years 10 months 9 days
Private Placement Warrants [Member] | Stock Price [Member]
Warrant Liabilities [Line Items]
Alternative investment, measurement input | $ / shares						0.41	1.89
Private Placement Warrants [Member] | Volatility [Member]
Warrant Liabilities [Line Items]
Alternative investment, measurement input						115.8	70.9
Private Placement Warrants [Member] | Risk-free Interest Rate [Member]
Warrant Liabilities [Line Items]
Alternative investment, measurement input						0.2	1.6
Private Placement Warrants [Member] | Dividend Rate [Member]
Warrant Liabilities [Line Items]
Alternative investment, measurement input						0	0
Private Placement Warrants [Member] | Valuation Technique, Monte Carlo Simulation Model [Member]
Warrant Liabilities [Line Items]
Contractual term						5 years
Private Placement Warrants [Member] | Valuation Technique, Monte Carlo Simulation Model [Member] | Exercise Price of Half Share [Member]
Warrant Liabilities [Line Items]
Alternative investment, measurement input | $ / shares						5.75
Private Placement Warrants [Member] | Valuation Technique, Monte Carlo Simulation Model [Member] | Exercise Price of Full Share [Member]
Warrant Liabilities [Line Items]
Alternative investment, measurement input | $ / shares						11.50
Private Placement Warrants [Member] | Valuation Technique, Monte Carlo Simulation Model [Member] | Stock Price [Member]
Warrant Liabilities [Line Items]
Alternative investment, measurement input | $ / shares						9.91
Private Placement Warrants [Member] | Valuation Technique, Monte Carlo Simulation Model [Member] | Volatility [Member]
Warrant Liabilities [Line Items]
Alternative investment, measurement input						16.7
Private Placement Warrants [Member] | Valuation Technique, Monte Carlo Simulation Model [Member] | Risk-free Interest Rate [Member]
Warrant Liabilities [Line Items]
Alternative investment, measurement input						3
Private Placement Warrants [Member] | Valuation Technique, Monte Carlo Simulation Model [Member] | Dividend Rate [Member]
Warrant Liabilities [Line Items]
Alternative investment, measurement input						0

Warrant Liabilities (As Resta_4

Warrant Liabilities (As Restated) (Details) - USD ($) $ in Thousands	Dec. 31, 2020	Dec. 31, 2019
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Liabilities measured at fair value on recurring basis	$ 1,619	$ 8,147
Public Warrants [Member]
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Liabilities measured at fair value on recurring basis	254	1,299
Private Placement Warrant [Member]
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Liabilities measured at fair value on recurring basis	248	2,108
Series A Warrants [Member]
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Liabilities measured at fair value on recurring basis	1,117	4,740
Level 1 [Member]
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Liabilities measured at fair value on recurring basis	254	1,299
Level 1 [Member] | Public Warrants [Member]
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Liabilities measured at fair value on recurring basis	254	1,299
Level 2 [Member]
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Liabilities measured at fair value on recurring basis	1,365	6,848
Level 2 [Member] | Private Placement Warrant [Member]
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Liabilities measured at fair value on recurring basis	248	2,108
Level 2 [Member] | Series A Warrants [Member]
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Liabilities measured at fair value on recurring basis	$ 1,117	$ 4,740

Warrant Liabilities (As Resta_5

Warrant Liabilities (As Restated) (Details 1) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Warrant Liabilities [Abstract]
Balance at beginning of period	$ 8,147	$ 29,110
Issuance of Series A warrants, net		12,675
Exercise of warrants		(21,535)
Reclassification of warrant liability upon forfeiture	(203)
Change in fair value of warrant liabilities	(6,342)	(12,113)
Amortization of warrant issuance costs	17	10
Balance at end of period	$ 1,619	$ 8,147

Notes Payable (Details Narrativ

Notes Payable (Details Narrative) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Short Term Debt [Line Items]
Notes payable, current portion	$ 998	$ 8,068
Premium Finance Agreement [Member] | Directors and Officers Liability, General liability, Workers' Compensation, Umbrella, Auto and Pollution Coverage [Member]
Short Term Debt [Line Items]
Short term debt, term	the Company entered into various premium finance agreements with a credit finance institution to pay the premiums on insurance policies for its directors’ and officers’ liability, general liability, workers’ compensation, umbrella, auto and pollution coverage needs. For the years ended December 31, 2020 and 2019, the aggregate amount of the premiums financed was $1,121 and $9,928, respectively, payable in equal monthly installments at an interest rate of 5.3% and 4.8%, respectively. These premium finance agreements had a total balance of $998 and $8,068 as of December 31, 2020 and 2019, respectively.
Aggregate amount of premiums financed	$ 1,121	$ 9,928
Insurance premium interest rate	5.30%	4.80%
Insurance premium payment term	payable in equal monthly installments
Notes payable, current portion	$ 998,000	$ 8,068,000

Debt (Details)

Debt (Details) - USD ($) $ in Thousands	Dec. 31, 2020	Dec. 31, 2019
Debt Instrument [Line Items]
Capital leases	$ 229	$ 10,474
Total debt principal balance	315,051	316,629
Unamortized discount on debt and debt issuance costs	(17,576)	(9,449)
Current maturities	(13,573)	(22,288)
Net Long-term debt	283,902	284,892
Senior Secured Term Loan [Member]
Debt Instrument [Line Items]
Credit Facility	246,250	250,000
ABL Credit Facility [Member]
Debt Instrument [Line Items]
Credit Facility	23,710	40,090
PPP Loan [Member]
Debt Instrument [Line Items]
Credit Facility	10,000
USDA Loan [Member]
Debt Instrument [Line Items]
Credit Facility	21,996
Equipment Financing [Member]
Debt Instrument [Line Items]
Credit Facility	$ 12,866	$ 16,065

Debt - (Details Narrative)

Debt - (Details Narrative) - Senior Secured Term Loan [Member] $ in Thousands	May 07, 2019USD ($)
Debt Instrument [Line Items]
Debt instrument, face amount	$ 250,000
Debt instrument, maturity date	May 7, 2024
Debt instrument, frequency of periodic payment	quarterly
Debt instrument periodic payment percentage of principal amount	2.00%
Debt instrument, discount amount	$ 5,000
Debt issuance costs	$ 5,758
Debt instrument, floor interest rate percentage	2.00%
Line of credit facility, interest rate	8.25%

Debt - (Details Narrative 2)

Debt - (Details Narrative 2)	Apr. 01, 2020	May 07, 2019	Sep. 30, 2019	Dec. 31, 2020
Term Loan Amendment [Member]
Debt Instrument [Line Items]
Debt instrument, reduction percentage	0.00%
Debt instrument, floor interest rate percentage	2.00%
Line of credit facility, interest rate	8.25%
Debt instrument periodic payment percentage of principal amount	0.50%
Debt instrument, frequency of periodic payment	quarterly
Debt instrument, extended maturity date	Dec. 5, 2025
Senior Secured Term Loan [Member]
Debt Instrument [Line Items]
Debt instrument, prepayment percentage			100.00%
Debt instrument, exit fee percentage				2.00%
Debt instrument, repayment period				120 days
Debt instrument, floor interest rate percentage		2.00%
Line of credit facility, interest rate		8.25%
Debt instrument periodic payment percentage of principal amount		2.00%
Debt instrument, frequency of periodic payment		quarterly
Senior Secured Term Loan [Member] | Debt Instrument, Redemption, Period Three [Member]
Debt Instrument [Line Items]
Debt instrument, prepayment percentage				2.00%
Senior Secured Term Loan [Member] | Debt Instrument, Redemption, Period Four [Member]
Debt Instrument [Line Items]
Debt instrument, prepayment percentage				1.00%

Debt - (Details Narrative 3)

Debt - (Details Narrative 3) - USD ($) $ / shares in Units, $ in Thousands	Apr. 01, 2020	Dec. 31, 2020	Dec. 31, 2019
Common Class A [Member]
Debt Instrument [Line Items]
Common stock		$ 7	$ 5
Term Loan Amendment [Member] | Senior Secured Term Loan [Member]
Debt Instrument [Line Items]
Extension fee	$ 20,000
Term Loan Amendment [Member] | Senior Secured Term Loan [Member] | Series B Preferred Stock [Member]
Debt Instrument [Line Items]
Debt instrument, floor interest rate percentage	1,050
Preferred stock, liquidation preference value	$ 1,050
Preferred stock, liquidation preference per share	$ 1,000
Term Loan Amendment [Member] | Senior Secured Term Loan [Member] | Common Class A [Member]
Debt Instrument [Line Items]
Debt instrument, floor interest rate percentage	5,529,622
Common stock	$ 1,438

Debt - (Details Narrative 4)

Debt - (Details Narrative 4) - USD ($)	Sep. 30, 2021	May 31, 2021	Dec. 31, 2020	Dec. 31, 2020	Dec. 31, 2019
Debt Instrument [Line Items]
Repayments of lines of credit				$ 85,497,000	$ 65,844,000
Term Loan Amendment [Member]
Debt Instrument [Line Items]
Gain recognized				0
Senior Secured Term Loan [Member]
Debt Instrument [Line Items]
Long term debt, principal outstanding balance			$ 246,250,000	246,250,000
Outstanding principal balance due within one year				$ 10,000,000
Senior Secured Term Loan [Member] | Term Loan Amendment [Member]
Debt Instrument [Line Items]
Repayments of lines of credit			$ 1,250,000
Senior Secured Term Loan [Member] | Term Loan Amendment [Member] | Scenario Forecast [Member]
Debt Instrument [Line Items]
Repayments of lines of credit	$ 2,500,000	$ 2,500,000

Debt - (Details Narrative 5)

Debt - (Details Narrative 5)	Apr. 01, 2020USD ($)	May 07, 2019USD ($)	Mar. 31, 2020USD ($)	Dec. 31, 2020USD ($)
ABL Amendment [Member]
Debt Instrument [Line Items]
Line of credit facility, maximum borrowing capacity	$ 60,000,000		$ 75,000,000
Line of credit facility, extend maturity description			the maturity date was extended to April 1, 2025
Line of credit facility, extended maturity date	Apr. 1, 2025
Line of credit facility, percentage increase in interest rate	0.50%
Debt instrument, floor interest rate percentage	1.00%
Line of credit facility, available borrowing capacity	$ 4,000,000
Line of credit facility, eligible accounts receivable percentage	5.00%
Line of credit facility, FILO amount accrue interest rate percentage	1.50%
ABL Credit Facility [Member]
Debt Instrument [Line Items]
Line of credit facility, maximum borrowing capacity		$ 75,000,000		$ 32,438,000
Line of credit facility, maturity description				The ABL Credit Facility had original maturity date of February 6, 2024.
Debt issuance costs		$ 1,205,000
Line of credit facility, fixed charge coverage ratio		1
ABL Credit Facility [Member] | Minimum [Member]
Debt Instrument [Line Items]
Unused portion of applicable fee rate		0.25%
ABL Credit Facility [Member] | Maximum [Member]
Debt Instrument [Line Items]
Unused portion of applicable fee rate		0.375%
Base Rate | ABL Credit Facility [Member] | Minimum [Member]
Debt Instrument [Line Items]
Line of credit facility, interest rate		0.50%
Base Rate | ABL Credit Facility [Member] | Maximum [Member]
Debt Instrument [Line Items]
Line of credit facility, interest rate		1.00%
LIBOR [Member] | ABL Credit Facility [Member] | Minimum [Member]
Debt Instrument [Line Items]
Line of credit facility, interest rate		1.50%
LIBOR [Member] | ABL Credit Facility [Member] | Maximum [Member]
Debt Instrument [Line Items]
Line of credit facility, interest rate		2.00%

Debt - (Details Narrative 6)

Debt - (Details Narrative 6) - USD ($)	Dec. 31, 2020	Aug. 31, 2020	Aug. 01, 2020	Jul. 31, 2020	May 07, 2019
ABL Credit Facility [Member]
Debt Instrument [Line Items]
Line of credit facility, maximum borrowing capacity	$ 32,438,000				$ 75,000,000
Outstanding revolver loan	$ 23,710,000
Second ABL Amendment [Member]
Debt Instrument [Line Items]
Line of credit facility, maximum borrowing capacity			$ 50,000,000	$ 60,000,000
Unamortized deferred financing cost		$ 200,000

Debt - (Details Narrative 7)

Debt - (Details Narrative 7) - Paycheck Protection Program CARES Act [Member] $ in Thousands	Jul. 31, 2020USD ($)
Debt Instrument [Line Items]
Unsecured loan received	$ 10,000
Unsecured loan interest rate	1.00%
Unsecured loan maturity term	5 years
Percentage of minimum amount of unsecured loan used for payroll cost	60.00%

Debt - (Details Narrative 8)

Debt - (Details Narrative 8)	Nov. 12, 2020USD ($)	Jan. 31, 2021USD ($)	Dec. 31, 2020USD ($)	Dec. 31, 2019USD ($)
Debt Instrument [Line Items]
Proceeds from revolving credit facility			$ 68,957,000	$ 49,960,000
USDA Loan [Member]
Debt Instrument [Line Items]
Line of credit facility, maximum borrowing capacity	$ 25,000,000
Line of credit facility, interest rate	5.75%
Line of credit facility, interest rate description			(1) 36 monthly consecutive interest payments, beginning on December 12, 2020   (2) 83 monthly consecutive principal and interest payments beginning December 12, 2023   (3) One final principal and interest payment of the remaining due on November 12, 2030
Debt instrument, discount amount	$ 506,000
Debt issuance costs	$ 558,000
Line of credit facility, percentage of equipment collateral guarantee	90.00%
Debt instrument, covenant description			The USDA Loan is subject to certain financial covenants. The Company is required to maintain a Debt Service Coverage Ratio (as defined in the USDA Loan) of not less than 1.25:1, to be monitored annually, beginning in calendar year 2021. Additionally, the Company is required to maintain a Debt to Net Worth Ratio (as defined in the USDA Loan) of not more than 9:1, to be monitored annually based upon year-end financial statements beginning in calendar year 2022.
Long term debt, principal outstanding balance			$ 21,996,000
USDA Loan [Member] | Subsequent Event [Member]
Debt Instrument [Line Items]
Proceeds from revolving credit facility		$ 3,004,000
USDA Loan [Member] | Minimum [Member]
Debt Instrument [Line Items]
Debt service coverage ratio	1.25
USDA Loan [Member] | Maximum [Member]
Debt Instrument [Line Items]
Debt to net worth ratio	9

Debt - (Details Narrative 9)

Debt - (Details Narrative 9) - Equipment Financing [Member] - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Debt Instrument [Line Items]
Credit Facility	$ 12,866
Equipment financing agreements interest rate	5.70%
Equipment financing agreements payment term	payable in equal monthly installments through May 1, 2024
Debt instrument, weighted average interest rate of amount outstanding	5.70%	6.40%

Debt (Details 1)

Debt (Details 1) $ in Thousands	Dec. 31, 2020USD ($)
Debt Disclosure [Abstract]
2021	$ 13,573
2022	10,017
2023	9,203
2024	9,397
2025	256,503
Thereafter	16,358
Principal Amount of Long-term Debt	$ 315,051

Mezzanine Equity (Details Narra

Mezzanine Equity (Details Narrative)	Apr. 01, 2020	May 23, 2019USD ($)$ / sharesshares	Feb. 28, 2021shares	Mar. 31, 2020USD ($)$ / sharesshares	Dec. 31, 2020USD ($)$ / sharesshares	Dec. 31, 2019USD ($)$ / sharesshares
Temporary Equity [Line Items]
Preferred stock, authorized					10,000,000
Preferred stock, par value | $ / shares					$ 0.0001
Number of warrants exercisable for shares of class A common stock					1
Common stock maximum trading period					30 days
Estimated fair value of warrant | $		$ 12,786,000
Warrants [Member] | Valuation Technique, Option Pricing Mode [Member] | Expected Term [Member]
Temporary Equity [Line Items]
Contractual term		6 years 6 months
Warrants [Member] | Valuation Technique, Option Pricing Mode [Member] | Volatility Rate [member]
Temporary Equity [Line Items]
Alternative investment, measurement input		53
Warrants [Member] | Valuation Technique, Option Pricing Mode [Member] | Risk Free Interest Rate [Member]
Temporary Equity [Line Items]
Alternative investment, measurement input		2.2
Warrants [Member] | Valuation Technique, Option Pricing Mode [Member] | Expected Dividend Rate
Temporary Equity [Line Items]
Alternative investment, measurement input		0
Private Placement Warrants [Member]
Temporary Equity [Line Items]
Contractual term					2 years 10 months 9 days	3 years 10 months 9 days
Private Placement Warrants [Member] | Volatility Rate [member]
Temporary Equity [Line Items]
Alternative investment, measurement input					115.8	70.9
Private Placement Warrants [Member] | Risk Free Interest Rate [Member]
Temporary Equity [Line Items]
Alternative investment, measurement input					0.2	1.6
Series A Redeemable Convertible Preferred Stock [Member]
Temporary Equity [Line Items]
Mezzanine Equity, par value | $ / shares					$ 0.0001
Preferred stock, authorized					10,000,000
Preferred stock, par value | $ / shares					$ 0.0001
Aggregate purchase price per share | $ / shares					$ 1,000
Temporary equity, dividend rate till second anniversary of closing date at annual rate					12.00%
Temporary equity, dividend rate after second anniversary					16.00%
Dividend declared | $					$ 0
Redemption price per share, redeemable within year from closing date | $ / shares					$ 1,092.73
Temporary equity, conversion price per share | $ / shares					6.67
Temporary equity, effective conversion | $ / shares					$ 5.40
Temporary equity, reduction in carrying value, beneficial conversion feature | $					$ 22,104,000
Temporary equity, amortization period of discount					2 years
Conversion of Series A preferred stock to Class A common stock, shares					5,000
Conversion of Series A preferred stock to Class A common stock, reduction in carrying value | $					$ 4,852,000
Number of shares outstanding					50,000	55,000
Dividends accrued on preferred stock | $					$ 11,264,000
Mezzanine Equity, outstanding					50,000	55,000
Series A Redeemable Convertible Preferred Stock [Member] | Minimum [Member]
Temporary Equity [Line Items]
Temporary Equity to Conversion of Preferred Stock | $					$ 1,000,000
Temporary equity, minimum percentage of conversion price to the closing price					130.00%
Series A Redeemable Convertible Preferred Stock [Member] | Dividends Payable in February [Member]
Temporary Equity [Line Items]
Dividend payable date					--02-24
Series A Redeemable Convertible Preferred Stock [Member] | Series A Redeemable Convertible Preferred Stock [Member]
Temporary Equity [Line Items]
Dividend payable date					--05-24
Series A Redeemable Convertible Preferred Stock [Member] | Dividends Payable in August [Member]
Temporary Equity [Line Items]
Dividend payable date					--08-24
Series A Redeemable Convertible Preferred Stock [Member] | Dividends Payable in November [Member]
Temporary Equity [Line Items]
Dividend payable date					--11-24
Series A Redeemable Convertible Preferred Stock [Member] | Private Placement Warrants [Member] | Purchasers [Member]
Temporary Equity [Line Items]
Number of shares issued		55,000
Aggregate purchase price per share | $ / shares		$ 1,000
Gross proceeds from convertible preferred stock | $		$ 55,000,000
Number of warrants exercisable for shares of class A common stock		2,933,333
Number of additional warrants issued to the purchasers		4,399,992			1,911,108
Warrants outstanding		488,888
Percentage of warrants ownership interest		29.80%
Number of shares issued		55,000
Gross proceeds from convertible preferred stock | $		$ 55,000,000
Common Class A [Member]
Temporary Equity [Line Items]
Number of warrants exercisable for shares of class A common stock					9,583,709
Average daily trading volume of common stock				250,000	250,000
Conversion of common stock consecutive trading period				20 days	20 days
Common stock maximum trading period				30 days	30 days
Number of Class A common stock converted from accrued dividends					876,448
Number of shares issued upon conversion					9,146,254
Common Class A [Member] | Subsequent Event [Member]
Temporary Equity [Line Items]
Number of shares issued upon conversion			2,745,778
Series B Convertible Redeemable Preferred Stock [Member]
Temporary Equity [Line Items]
Mezzanine Equity, par value | $ / shares					$ 0.0001	$ 0.0001
Number of shares issued					22,050	0
Temporary equity, conversion price per share | $ / shares				$ 0.308
Number of shares outstanding					22,050	0
Dividends accrued on preferred stock | $					$ 2,049,000
Number of shares issued					22,050	0
Distributions on then-applicable liquidation preference shares, percentage per annum				12.00%
Distributions on then-applicable liquidation preference shares, percentage, expiration				May 24, 2021
Distributions on liquidation preference share thereafter, percentage				16.00%
Mezzanine Equity, outstanding					22,050	0
Series B Convertible Redeemable Preferred Stock [Member] | Subsequent Event [Member]
Temporary Equity [Line Items]
Conversion of stock			762
Series B Convertible Redeemable Preferred Stock [Member] | Minimum [Member]
Temporary Equity [Line Items]
Temporary Equity to Conversion of Preferred Stock | $				$ 1,000,000
Series B Convertible Redeemable Preferred Stock [Member] | Private Placement Warrants [Member] | Purchasers [Member]
Temporary Equity [Line Items]
Number of shares issued				21,000
Gross proceeds from convertible preferred stock | $				$ 21,000,000
Percentage of warrants ownership interest	36.67%
Number of shares issued				21,000
Gross proceeds from convertible preferred stock | $				$ 21,000,000
Series A Convertible Redeemable Preferred Stock [Member]
Temporary Equity [Line Items]
Mezzanine Equity, par value | $ / shares					$ 0.0001	$ 0.0001
Number of shares issued					50,000	55,000
Number of shares outstanding					50,000	55,000
Dividends accrued on preferred stock | $					$ 7,214,000	$ 4,050,000
Number of shares issued					50,000	55,000
Mezzanine Equity, outstanding					50,000	55,000
Series A Convertible Redeemable Preferred Stock [Member] | Minimum [Member]
Temporary Equity [Line Items]
Temporary equity, minimum percentage of conversion price to the closing price				130.00%
Common Class B [Member]
Temporary Equity [Line Items]
Number of shares issued upon conversion					78,245,727

Mezzanine Equity (Details)

Mezzanine Equity (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2020USD ($)shares
Series A Redeemable Convertible Preferred Stock [Member]
Temporary Equity [Line Items]
Preferred stock as of December 31, 2019, shares | shares	55,000
Preferred stock as of December 31, 2019	$ 35,591
Deemed and imputed dividends on Series A preferred stock	13,022
Accrued preferred stock dividends	$ 7,214
Conversion of Series A preferred stock to Class A common stock, shares | shares	(5,000)
Conversion of Series A preferred stock to Class A common stock	$ (4,852)
Preferred stock as of December 31, 2020, shares | shares	50,000
Preferred stock as of December 31, 2020	$ 50,975
Series B Convertible Redeemable Preferred Stock [Member]
Temporary Equity [Line Items]
Preferred stock as of December 31, 2019, shares | shares	0
Proceeds from issuance of Series B preferred stock, shares | shares	21,000
Proceeds from issuance of Series B preferred stock	$ 21,000
Issuance of Series B preferred stock to senior secured term loan lenders, shares | shares	1,050
Issuance of Series B preferred stock to senior secured term loan lenders	$ 1,050
Issuance cost associated with Series B preferred stock	(1,413)
Accrued preferred stock dividends	$ 2,049
Preferred stock as of December 31, 2020, shares | shares	22,050
Preferred stock as of December 31, 2020	$ 22,686

Stockholders' Equity (Details N

Stockholders' Equity (Details Narrative) - USD ($)	Jun. 26, 2020	Jan. 31, 2021	Mar. 31, 2020	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Class Of Stock [Line Items]
Preferred Stock, Par or Stated Value Per Share				$ 0.0001
Preferred stock, authorized				10,000,000
Common stock maximum trading period				30 days
Proceeds from issuance of common stock, net				$ 400,000
Long Term Incentive Plan [Member]
Class Of Stock [Line Items]
Shares of Restricted Stock Granted				0
USWS Holdings [Member]
Class Of Stock [Line Items]
Noncontrolling Interest, Ownership Percentage by Parent				3.00%
Common Class A [Member]
Class Of Stock [Line Items]
Common stock, par value				$ 0.0001	$ 0.0001
Common stock, authorized				400,000,000	400,000,000
Common stock, issued				72,515,342	62,857,624
Common stock, outstanding				72,515,342	62,857,624	49,254,760
Common stock maximum trading period			30 days	30 days
Conversion of Class B common stock to Class A common stock (in shares)				3,197,756	8,436,640
Shares of Restricted Stock Granted					2,218,183
Common Class A [Member] | Long Term Incentive Plan [Member]
Class Of Stock [Line Items]
Common Stock Available For Issuance				8,160,500
Common Class A [Member] | ATM Agreement [Member]
Class Of Stock [Line Items]
Shares issued				792,258
Proceeds from issuance of common stock, net				$ 400,000
Payments for commission				$ 12,000
Common Class A [Member] | ATM Agreement [Member] | Piper Sandler & Co. [Member]
Class Of Stock [Line Items]
Common Stock, Shares Authorized	$ 10,275,000
Common Class A [Member] | ATM Agreement [Member] | Piper Sandler & Co. [Member] | Maximum [Member]
Class Of Stock [Line Items]
Sale of common stock commission on gross sale price	3.00%
Common Class A [Member] | ATM Agreement [Member] | Subsequent Event [Member]
Class Of Stock [Line Items]
Shares issued		8,340,608
Proceeds from issuance of common stock, net		$ 5,679,000
Payments for commission		$ 176,000
Common Class A [Member] | Stock Price Equaled or Exceeded 12.00 [Member]
Class Of Stock [Line Items]
Common stock, shares outstanding subject to cancellation				1,000,000
Closing price per share				$ 12
Common stock maximum trading period				30 days
Common Class A [Member] | Stock Price 13.50 [Member]
Class Of Stock [Line Items]
Common stock, shares outstanding subject to cancellation				609,677
Closing price per share				$ 13.50
Common Class B [Member]
Class Of Stock [Line Items]
Common stock, par value				$ 0.0001	$ 0.0001
Common stock, authorized				20,000,000	20,000,000
Common stock, issued				2,302,936	5,500,692
Common stock, outstanding				2,302,936	5,500,692	13,937,332
Common stock, voting rights				one
Conversion of Class B common stock to Class A common stock (in shares)				(3,197,756)	(8,436,640)

Earnings (Loss) Per Share - (De

Earnings (Loss) Per Share - (Details Narrative) - shares	Nov. 09, 2024	Dec. 31, 2020	Dec. 31, 2019
Earnings Per Share Basic [Line Items]
Basic and diluted net income (loss) per share excludes the income (loss) attributable and shares associated to cancellation		1,609,677	1,609,677
Class A Common Stock [Member] | Scenario, Forecast [Member]
Earnings Per Share Basic [Line Items]
Basic and diluted net income (loss) per share excludes the income (loss) attributable and shares associated to cancellation	1,609,677

Earnings (Loss) Per Share (Deta

Earnings (Loss) Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended						6 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Jun. 30, 2020	Jun. 30, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Basic Net Income (Loss) Per Share
Net loss attributable to U.S. Well Services, Inc.	$ (14,158)	$ (19,505)	$ (165,818)	$ 618	$ (16,490)	$ (40,989)	$ (185,323)	$ (57,479)	$ (199,481)	$ (56,861)	$ (229,340)	$ (81,810)	$ (59,889)
Net loss attributable to cancellable Class A shares											5,560	2,540
Basic net loss attributable to U.S. Well Services, Inc. shareholders											(223,780)	(79,270)
Deemed and imputed dividends on Series A preferred stock	$ (464)	$ (5,142)	$ (6,972)	$ (4,576)	$ (1,582)		$ (12,114)	$ (1,582)	$ (12,578)	$ (6,158)	(13,022)	(11,796)
Deemed dividends on Series B preferred stock											(564)
Basic net loss attributable to U.S. Well Services, Inc. common shareholders											$ (246,629)	$ (95,116)
Weighted average shares outstanding											66,400,924	51,853,183
Cancellable Class A common stock											(1,609,677)	(1,609,677)
Basic and diluted weighted average shares outstanding											64,791,247	50,243,506
Basic and diluted net income (loss) per share attributable to Class A shareholders	$ (0.25)	$ (0.41)	$ (2.90)	$ (0.11)	$ (0.37)	$ (0.84)	$ (3.19)	$ (1.19)	$ (3.37)	$ (1.29)	$ (3.81)	$ (1.89)	$ (1.21)
Series A Convertible Redeemable Preferred Stock [Member]
Basic Net Income (Loss) Per Share
Dividends accrued on preferred stock											$ (7,214)	$ (4,050)
Series B Convertible Redeemable Preferred Stock [Member]
Basic Net Income (Loss) Per Share
Dividends accrued on preferred stock											$ (2,049)

Earnings (Loss) Per Share (De_2

Earnings (Loss) Per Share (Details1) - shares	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Potentially dilutive securities excluded as anti-dilutive	125,415,894	33,826,170
Anti-dilutive Stock Options [Member]
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Potentially dilutive securities excluded as anti-dilutive	877,266	1,068,162
Anti-dilutive Warrants [Member]
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Potentially dilutive securities excluded as anti-dilutive	14,428,150	15,680,651
Anti-dilutive Restricted Stock [Member]
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Potentially dilutive securities excluded as anti-dilutive	1,449,287	2,723,637
Anti-dilutive Deferred Stock Units [Member]
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Potentially dilutive securities excluded as anti-dilutive	8,911,858
Anti-dilutive Pool B Awards [Member]
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Potentially dilutive securities excluded as anti-dilutive	10,142,494
Anti-dilutive Class B Common Stock Convertible into Class A Common Stock [Member]
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Potentially dilutive securities excluded as anti-dilutive	2,302,936	5,500,692
Anti-dilutive Series A Preferred Stock Convertible into Class A Common Stock [Member]
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Potentially dilutive securities excluded as anti-dilutive	9,058,176	8,853,028
Anti-dilutive Series B Preferred Stock Convertible into Class A Common Stock [Member]
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Potentially dilutive securities excluded as anti-dilutive	78,245,727

Share-Based Compensation (Detai

Share-Based Compensation (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock based compensation expense	$ 10,056	$ 7,755
Restricted Stock [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock based compensation expense	4,719	6,496
Unrestricted Stock [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock based compensation expense		418
Stock Options [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock based compensation expense	905	$ 841
DSUs [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock based compensation expense	984
Pool A awards [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock based compensation expense	2,328
Pool B Awards [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock based compensation expense	$ 1,120

Share-Based Compensation (Paren

Share-Based Compensation (Parenthetical) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock based compensation expense	$ 10,056	$ 7,755
Cost of Services [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock based compensation expense	1,940	2,513
Selling, General and Administrative Expenses [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock based compensation expense	$ 8,116	$ 5,242

Share-Based Compensation (Det_2

Share-Based Compensation (Details 1) - Restricted Stock [Member]	12 Months Ended
	Dec. 31, 2020$ / sharesshares
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Number of shares, Beginning balance | shares	2,723,637
Number of shares, Vested | shares	(690,237)
Number of shares, Forfeited | shares	(584,113)
Number of shares, Ending balance | shares	1,449,287
Weighted-average grant-date fair value units at beginning of period | $ / shares	$ 8.87
Weighted-average grant-date fair value, Vested | $ / shares	8.87
Weighted-average grant-date fair value, Forfeited | $ / shares	8.91
Weighted-average grant-date fair value units at end of period | $ / shares	$ 8.85

Share-Based Compensation (Det_3

Share-Based Compensation (Details Narrative) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Long Term Incentive Plan [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share vesting period		4 years
Fair value per option		$ 3.95
Terms of stock option grant		7 years
Restricted Stock [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock-based compensation to be recognized	$ 7,345
Period for recognition of unrecognized compensation cost	2 years 1 month 24 days
Weighted-average grant-date fair value, Vested	$ 8.87
Restricted Stock [Member] | Long Term Incentive Plan [Member] | Common Class A [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock granted		2,218,183
Total fair value of shares		$ 19,764
Share vesting period		4 years
Unrestricted [Member] | Long Term Incentive Plan [Member] | Common Class A [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock granted		46,875
Weighted-average grant-date fair value, Vested		$ 8.91
Stock Options [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock-based compensation to be recognized	$ 1,906
Period for recognition of unrecognized compensation cost	2 years 2 months 15 days
Stock Options [Member] | Long Term Incentive Plan [Member] | Common Class A [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share vesting period		4 years
Stock granted		1,068,162
Fair value of stock options		$ 4,219
DSUs [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Period for recognition of unrecognized compensation cost	2 years
Stock-based compensation to be recognized	$ 1,969
DSUs [Member] | Long Term Incentive Plan [Member] | Common Class A [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock granted	8,911,858
Total fair value of shares	$ 2,954
Share vesting period	3 years
DSU represents right to receive number of shares	1
Pool A Performance Award [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share-based liability of other long-term liabilities	$ 2,328
Pool A Performance Award [Member] | Common Class A [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Total fair value of shares	$ 2,328
Pool B Performance Award [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Period for recognition of unrecognized compensation cost	2 years
Stock-based compensation to be recognized	$ 2,241
Pool B Performance Award [Member] | Common Class A [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Total fair value of shares	$ 3,362
Share vesting period	3 years

Share-Based Compensation (Det_4

Share-Based Compensation (Details 2) - Stock Options [Member] - $ / shares	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Number of shares, Beginning balance	1,068,162
Number of shares, Forfeited/Expired	(190,896)
Number of shares, Ending balance	877,266	1,068,162
Number of shares, Exercisable	219,317
Weighted average exercise price, Beginning of period	$ 8.91
Weighted average exercise price, Forfeited/Expired	8.91
Weighted average exercise price, Ending of period	8.91	$ 8.91
Weighted average exercise price, Exercisable	$ 8.91
Weighted average remaining contractual term	5 years 2 months 15 days	6 years 2 months 15 days
Weighted average remaining contractual term, Exercisable	5 years 2 months 15 days

Employee Benefit Plan - (Detail

Employee Benefit Plan - (Details Narrative) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Defined Contribution Plan Disclosure [Line Items]
Defined contribution plan, employer matching contribution	100.00%
Employer matching contributions	$ 976	$ 3,843
Defined contribution plan, vesting period	2 years
Maximum [Member]
Defined Contribution Plan Disclosure [Line Items]
Defined contribution plan, percent of employees' gross pay	6.00%

Income Taxes (As Restated) (Det

Income Taxes (As Restated) (Details) - USD ($) $ in Thousands	Dec. 31, 2020	Dec. 31, 2019
Deferred Tax Assets
Net Operating Loss Carryforward	$ 56,815	$ 30,485
Startup/Organization Expenses	177	163
Investment in Partnership	70,244	19,489
Interest Expense	1,652	911
Attributes/Other	137	186
Total Deferred Tax Assets	129,025	51,234
Less Valuation Allowance	$ (129,025)	$ (51,234)

Income Taxes (As Restated) (D_2

Income Taxes (As Restated) (Details 1) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Current
Federal	$ (757)
State	(67)	$ (77)
Total Current	(824)	(77)
Deferred
Federal	(757)
State	(67)	(77)
Total	$ (824)	$ (77)

Income Taxes (As Restated) (D_3

Income Taxes (As Restated) (Details 2) - USD ($) $ in Thousands	3 Months Ended						6 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Jun. 30, 2020	Jun. 30, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Income Tax Disclosure [Abstract]
Pre-tax book loss	$ 14,296	$ 19,589	$ 177,368	$ 3,623	$ 21,616	$ 47,082	$ 196,957	$ 68,698	$ 211,253	$ 72,321	$ 241,212	$ 104,056	$ 64,455
Federal Provision (Benefit)											(50,656)
Noncontrolling Interest											(14,259)
Permanent Differences											501
State Income Taxes, net of Federal Benefit											(53)
NOL Carryback, effect of rate change											(289)
Return to Provision, Other											1,846
Valuation Allowance											62,086
Total											$ (824)	$ (77)
Federal Provision (Benefit)											(21.00%)
Noncontrolling Interest											(5.91%)
Permanent Differences											0.21%
State Income Taxes, net of Federal Benefit											(0.02%)
NOL Carryback, effect of rate change											(0.12%)
Return to Provision, Other											0.76%
Valuation Allowance											25.74%
Total Provision (Benefit)											(0.34%)

Income Taxes (As Restated) (D_4

Income Taxes (As Restated) (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Income Tax Disclosure [Abstract]
U.S. federal net operating loss carryforwards	$ 240,463,000
State net operating loss carryforwards	277,305,000
Unused federal net operating loss	$ 28,387,000
Federal net operating loss expiration year	2036
Deferred tax assets, valuation allowance	$ 129,025,000	$ 51,234,000
Uncertain tax positions	0	0
Material interest or penalties on income taxes	$ 0	$ 0

Commitments and Contingencies_2

Commitments and Contingencies (Details Narrative) - USD ($) $ in Thousands	Apr. 01, 2020	Dec. 31, 2020	Dec. 31, 2019
Loss Contingencies [Line Items]
Contracted volumes		$ 16,002
Purchase Obligation		13,393
Rent expense	$ 700	2,359	$ 2,646
Expected term of operating leases for facilities	36 months
Operating lease agreement, commencement date	Apr. 1, 2020
Estimated claims incurred, but not reported		189	588
Cost of Services [Member]
Loss Contingencies [Line Items]
Rent expense		1,655	2,130
Selling, General and Administrative Expenses [Member]
Loss Contingencies [Line Items]
Rent expense		$ 704	$ 516
Minimum [Member]
Loss Contingencies [Line Items]
Term of operating leases for facilities		24 months
Maximum [Member]
Loss Contingencies [Line Items]
Term of operating leases for facilities		76 months
Pending Litigation [Member]
Loss Contingencies [Line Items]
Damage claims		$ 54,000

Commitments and Contingencies -

Commitments and Contingencies - (Details1) $ in Thousands	Dec. 31, 2020USD ($)
Commitments And Contingencies Disclosure [Abstract]
2021	$ 1,114
2022	828
2023	308
2024	258
2025	67
Total future minimum rentals	$ 2,575

Related Party Transactions (Det

Related Party Transactions (Details Narrative) - USD ($) $ in Thousands	Apr. 01, 2020	May 24, 2019	Dec. 31, 2020	Dec. 31, 2019
Number of warrants exercisable for shares of class A common stock			1
Series A Convertible Redeemable Preferred Stock [Member]
Number of shares issued			50,000	55,000
Series B Convertible Redeemable Preferred Stock [Member]
Number of shares issued			22,050	0
Rockwater Energy Solutions [Member] | Series A Convertible Redeemable Preferred Stock [Member] | Crestview Partners ("Crestview") [Member]
Number of shares issued		20,000
Payment for purchase of preferred stock		$ 20,000
Number of warrants exercisable for shares of class A common stock		1,066,666
Rockwater Energy Solutions [Member] | Series A Convertible Redeemable Preferred Stock [Member] | Crestview Partners ("Crestview") [Member] | Maximum [Member]
Additional warrants received			711,112
Rockwater Energy Solutions [Member] | Series B Convertible Redeemable Preferred Stock [Member] | Crestview Partners ("Crestview") [Member]
Number of shares issued	11,500
Amount of stock held by related party	$ 11,500
Rockwater Energy Solutions [Member] | Series B Convertible Redeemable Preferred Stock [Member] | TCW Group Inc [Member]
Number of shares issued	6,500
Amount of stock held by related party	$ 6,500
Rockwater Energy Solutions [Member] | Series B Convertible Redeemable Preferred Stock [Member] | David Matlin [Member]
Number of shares issued	1,878
Amount of stock held by related party	$ 1,878